#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Interhemispheric connectivity and hemispheric specialization in schizophrenia patients and their unaffected siblings
1-1	0-16	Interhemispheric	_	
1-2	17-29	connectivity	_	
1-3	30-33	and	_	
1-4	34-45	hemispheric	_	
1-5	46-60	specialization	_	
1-6	61-63	in	_	
1-7	64-77	schizophrenia	_	
1-8	78-86	patients	_	
1-9	87-90	and	_	
1-10	91-96	their	_	
1-11	97-107	unaffected	_	
1-12	108-116	siblings	_	

#Text=Hemispheric integration and specialization are two prominent organizational principles for macroscopic brain function. Impairments of interhemispheric cooperation have been reported in schizophrenia patients, but whether such abnormalities should be attributed to effects of illness or familial risk remains inconclusive. Moreover, it is unclear how abnormalities in interhemispheric connectivity impact hemispheric specialization. To address these questions, we performed magnetic resonance imaging (MRI) in a large cohort of 253 participants, including 84 schizophrenia patients, 106 of their unaffected siblings and 63 healthy controls. Interhemispheric connectivity and hemispheric specialization were calculated from resting-state functional connectivity, and compared across groups. Results showed that schizophrenia patients exhibit lower interhemispheric connectivity as compared to controls and siblings. In addition, patients showed higher levels of hemispheric specialization as compared to siblings. Level of interhemispheric connectivity and hemispheric specialization correlated with duration of illness in patients. No significant alterations were identified in siblings relative to controls on both measurements. Furthermore, alterations in interhemispheric connectivity correlated with changes in hemispheric specialization in patients relative to controls and siblings. Taken together, these results suggest that lower interhemispheric connectivity and associated abnormalities in hemispheric specialization are features of established illness, rather than an expression of preexistent familial risk for schizophrenia.
2-1	117-128	Hemispheric	_	
2-2	129-140	integration	_	
2-3	141-144	and	_	
2-4	145-159	specialization	_	
2-5	160-163	are	_	
2-6	164-167	two	_	
2-7	168-177	prominent	_	
2-8	178-192	organizational	_	
2-9	193-203	principles	_	
2-10	204-207	for	_	
2-11	208-219	macroscopic	_	
2-12	220-225	brain	_	
2-13	226-234	function	_	
2-14	234-235	.	_	
2-15	236-247	Impairments	_	
2-16	248-250	of	_	
2-17	251-267	interhemispheric	_	
2-18	268-279	cooperation	_	
2-19	280-284	have	_	
2-20	285-289	been	_	
2-21	290-298	reported	_	
2-22	299-301	in	_	
2-23	302-315	schizophrenia	_	
2-24	316-324	patients	_	
2-25	324-325	,	_	
2-26	326-329	but	_	
2-27	330-337	whether	_	
2-28	338-342	such	_	
2-29	343-356	abnormalities	_	
2-30	357-363	should	_	
2-31	364-366	be	_	
2-32	367-377	attributed	_	
2-33	378-380	to	_	
2-34	381-388	effects	_	
2-35	389-391	of	_	
2-36	392-399	illness	_	
2-37	400-402	or	_	
2-38	403-411	familial	_	
2-39	412-416	risk	_	
2-40	417-424	remains	_	
2-41	425-437	inconclusive	_	
2-42	437-438	.	_	
2-43	439-447	Moreover	_	
2-44	447-448	,	_	
2-45	449-451	it	_	
2-46	452-454	is	_	
2-47	455-462	unclear	_	
2-48	463-466	how	_	
2-49	467-480	abnormalities	_	
2-50	481-483	in	_	
2-51	484-500	interhemispheric	_	
2-52	501-513	connectivity	_	
2-53	514-520	impact	_	
2-54	521-532	hemispheric	_	
2-55	533-547	specialization	_	
2-56	547-548	.	_	
2-57	549-551	To	_	
2-58	552-559	address	_	
2-59	560-565	these	_	
2-60	566-575	questions	_	
2-61	575-576	,	_	
2-62	577-579	we	_	
2-63	580-589	performed	_	
2-64	590-598	magnetic	_	
2-65	599-608	resonance	_	
2-66	609-616	imaging	_	
2-67	617-618	(	_	
2-68	618-621	MRI	_	
2-69	621-622	)	_	
2-70	623-625	in	_	
2-71	626-627	a	_	
2-72	628-633	large	_	
2-73	634-640	cohort	_	
2-74	641-643	of	_	
2-75	644-647	253	_	
2-76	648-660	participants	_	
2-77	660-661	,	_	
2-78	662-671	including	_	
2-79	672-674	84	_	
2-80	675-688	schizophrenia	_	
2-81	689-697	patients	_	
2-82	697-698	,	_	
2-83	699-702	106	_	
2-84	703-705	of	_	
2-85	706-711	their	_	
2-86	712-722	unaffected	_	
2-87	723-731	siblings	_	
2-88	732-735	and	_	
2-89	736-738	63	_	
2-90	739-746	healthy	_	
2-91	747-755	controls	_	
2-92	755-756	.	_	
2-93	757-773	Interhemispheric	_	
2-94	774-786	connectivity	_	
2-95	787-790	and	_	
2-96	791-802	hemispheric	_	
2-97	803-817	specialization	_	
2-98	818-822	were	_	
2-99	823-833	calculated	_	
2-100	834-838	from	_	
2-101	839-852	resting-state	_	
2-102	853-863	functional	_	
2-103	864-876	connectivity	_	
2-104	876-877	,	_	
2-105	878-881	and	_	
2-106	882-890	compared	_	
2-107	891-897	across	_	
2-108	898-904	groups	_	
2-109	904-905	.	_	
2-110	906-913	Results	_	
2-111	914-920	showed	_	
2-112	921-925	that	_	
2-113	926-939	schizophrenia	_	
2-114	940-948	patients	_	
2-115	949-956	exhibit	_	
2-116	957-962	lower	_	
2-117	963-979	interhemispheric	_	
2-118	980-992	connectivity	_	
2-119	993-995	as	_	
2-120	996-1004	compared	_	
2-121	1005-1007	to	_	
2-122	1008-1016	controls	_	
2-123	1017-1020	and	_	
2-124	1021-1029	siblings	_	
2-125	1029-1030	.	_	
2-126	1031-1033	In	_	
2-127	1034-1042	addition	_	
2-128	1042-1043	,	_	
2-129	1044-1052	patients	_	
2-130	1053-1059	showed	_	
2-131	1060-1066	higher	_	
2-132	1067-1073	levels	_	
2-133	1074-1076	of	_	
2-134	1077-1088	hemispheric	_	
2-135	1089-1103	specialization	_	
2-136	1104-1106	as	_	
2-137	1107-1115	compared	_	
2-138	1116-1118	to	_	
2-139	1119-1127	siblings	_	
2-140	1127-1128	.	_	
2-141	1129-1134	Level	_	
2-142	1135-1137	of	_	
2-143	1138-1154	interhemispheric	_	
2-144	1155-1167	connectivity	_	
2-145	1168-1171	and	_	
2-146	1172-1183	hemispheric	_	
2-147	1184-1198	specialization	_	
2-148	1199-1209	correlated	_	
2-149	1210-1214	with	_	
2-150	1215-1223	duration	_	
2-151	1224-1226	of	_	
2-152	1227-1234	illness	_	
2-153	1235-1237	in	_	
2-154	1238-1246	patients	_	
2-155	1246-1247	.	_	
2-156	1248-1250	No	_	
2-157	1251-1262	significant	_	
2-158	1263-1274	alterations	_	
2-159	1275-1279	were	_	
2-160	1280-1290	identified	_	
2-161	1291-1293	in	_	
2-162	1294-1302	siblings	_	
2-163	1303-1311	relative	_	
2-164	1312-1314	to	_	
2-165	1315-1323	controls	_	
2-166	1324-1326	on	_	
2-167	1327-1331	both	_	
2-168	1332-1344	measurements	_	
2-169	1344-1345	.	_	
2-170	1346-1357	Furthermore	_	
2-171	1357-1358	,	_	
2-172	1359-1370	alterations	_	
2-173	1371-1373	in	_	
2-174	1374-1390	interhemispheric	_	
2-175	1391-1403	connectivity	_	
2-176	1404-1414	correlated	_	
2-177	1415-1419	with	_	
2-178	1420-1427	changes	_	
2-179	1428-1430	in	_	
2-180	1431-1442	hemispheric	_	
2-181	1443-1457	specialization	_	
2-182	1458-1460	in	_	
2-183	1461-1469	patients	_	
2-184	1470-1478	relative	_	
2-185	1479-1481	to	_	
2-186	1482-1490	controls	_	
2-187	1491-1494	and	_	
2-188	1495-1503	siblings	_	
2-189	1503-1504	.	_	
2-190	1505-1510	Taken	_	
2-191	1511-1519	together	_	
2-192	1519-1520	,	_	
2-193	1521-1526	these	_	
2-194	1527-1534	results	_	
2-195	1535-1542	suggest	_	
2-196	1543-1547	that	_	
2-197	1548-1553	lower	_	
2-198	1554-1570	interhemispheric	_	
2-199	1571-1583	connectivity	_	
2-200	1584-1587	and	_	
2-201	1588-1598	associated	_	
2-202	1599-1612	abnormalities	_	
2-203	1613-1615	in	_	
2-204	1616-1627	hemispheric	_	
2-205	1628-1642	specialization	_	
2-206	1643-1646	are	_	
2-207	1647-1655	features	_	
2-208	1656-1658	of	_	
2-209	1659-1670	established	_	
2-210	1671-1678	illness	_	
2-211	1678-1679	,	_	
2-212	1680-1686	rather	_	
2-213	1687-1691	than	_	
2-214	1692-1694	an	_	
2-215	1695-1705	expression	_	
2-216	1706-1708	of	_	
2-217	1709-1720	preexistent	_	
2-218	1721-1729	familial	_	
2-219	1730-1734	risk	_	
2-220	1735-1738	for	_	
2-221	1739-1752	schizophrenia	_	
2-222	1752-1753	.	_	

#Text=Highlights
3-1	1754-1764	Highlights	_	

#Text=Schizophrenia patients show lower interhemispheric connectivity (IC) compared to siblings and controls.
4-1	1765-1778	Schizophrenia	_	
4-2	1779-1787	patients	_	
4-3	1788-1792	show	_	
4-4	1793-1798	lower	_	
4-5	1799-1815	interhemispheric	_	
4-6	1816-1828	connectivity	_	
4-7	1829-1830	(	_	
4-8	1830-1832	IC	_	
4-9	1832-1833	)	_	
4-10	1834-1842	compared	_	
4-11	1843-1845	to	_	
4-12	1846-1854	siblings	_	
4-13	1855-1858	and	_	
4-14	1859-1867	controls	_	
4-15	1867-1868	.	_	

#Text=Lower IC is associated with higher hemispheric specialization (HS) in patients.
5-1	1869-1874	Lower	_	
5-2	1875-1877	IC	_	
5-3	1878-1880	is	_	
5-4	1881-1891	associated	_	
5-5	1892-1896	with	_	
5-6	1897-1903	higher	_	
5-7	1904-1915	hemispheric	_	
5-8	1916-1930	specialization	_	
5-9	1931-1932	(	_	
5-10	1932-1934	HS	_	
5-11	1934-1935	)	_	
5-12	1936-1938	in	_	
5-13	1939-1947	patients	_	
5-14	1947-1948	.	_	

#Text=Siblings do not show changes on IC and HS relative to controls.
6-1	1949-1957	Siblings	_	
6-2	1958-1960	do	_	
6-3	1961-1964	not	_	
6-4	1965-1969	show	_	
6-5	1970-1977	changes	_	
6-6	1978-1980	on	_	
6-7	1981-1983	IC	_	
6-8	1984-1987	and	_	
6-9	1988-1990	HS	_	
6-10	1991-1999	relative	_	
6-11	2000-2002	to	_	
6-12	2003-2011	controls	_	
6-13	2011-2012	.	_	

#Text=Connectivity metrics (IC, HS) correlate with duration of illness in patients.
7-1	2013-2025	Connectivity	_	
7-2	2026-2033	metrics	_	
7-3	2034-2035	(	_	
7-4	2035-2037	IC	_	
7-5	2037-2038	,	_	
7-6	2039-2041	HS	_	
7-7	2041-2042	)	_	
7-8	2043-2052	correlate	_	
7-9	2053-2057	with	_	
7-10	2058-2066	duration	_	
7-11	2067-2069	of	_	
7-12	2070-2077	illness	_	
7-13	2078-2080	in	_	
7-14	2081-2089	patients	_	
7-15	2089-2090	.	_	

#Text=Introduction
8-1	2091-2103	Introduction	_	

#Text=Two prominent features of macroscopic brain organization are hemispheric integration, characterized as a high level of collaboration between bilateral brain regions, and hemispheric specialization, referring to the association of behavioral traits with a particular side of brain. Proper integration and segregation of the two cerebral hemispheres are crucial for a broad repertoire of cognitive functions including language, visuospatial attention, and manual preference. Conversely, disturbances of hemispheric coordination may impact cognitive and behavioral functioning and contribute to neuropsychiatric disorders including schizophrenia.
9-1	2104-2107	Two	_	
9-2	2108-2117	prominent	_	
9-3	2118-2126	features	_	
9-4	2127-2129	of	_	
9-5	2130-2141	macroscopic	_	
9-6	2142-2147	brain	_	
9-7	2148-2160	organization	_	
9-8	2161-2164	are	_	
9-9	2165-2176	hemispheric	_	
9-10	2177-2188	integration	_	
9-11	2188-2189	,	_	
9-12	2190-2203	characterized	_	
9-13	2204-2206	as	_	
9-14	2207-2208	a	_	
9-15	2209-2213	high	_	
9-16	2214-2219	level	_	
9-17	2220-2222	of	_	
9-18	2223-2236	collaboration	_	
9-19	2237-2244	between	_	
9-20	2245-2254	bilateral	_	
9-21	2255-2260	brain	_	
9-22	2261-2268	regions	_	
9-23	2268-2269	,	_	
9-24	2270-2273	and	_	
9-25	2274-2285	hemispheric	_	
9-26	2286-2300	specialization	_	
9-27	2300-2301	,	_	
9-28	2302-2311	referring	_	
9-29	2312-2314	to	_	
9-30	2315-2318	the	_	
9-31	2319-2330	association	_	
9-32	2331-2333	of	_	
9-33	2334-2344	behavioral	_	
9-34	2345-2351	traits	_	
9-35	2352-2356	with	_	
9-36	2357-2358	a	_	
9-37	2359-2369	particular	_	
9-38	2370-2374	side	_	
9-39	2375-2377	of	_	
9-40	2378-2383	brain	_	
9-41	2383-2384	.	_	
9-42	2385-2391	Proper	_	
9-43	2392-2403	integration	_	
9-44	2404-2407	and	_	
9-45	2408-2419	segregation	_	
9-46	2420-2422	of	_	
9-47	2423-2426	the	_	
9-48	2427-2430	two	_	
9-49	2431-2439	cerebral	_	
9-50	2440-2451	hemispheres	_	
9-51	2452-2455	are	_	
9-52	2456-2463	crucial	_	
9-53	2464-2467	for	_	
9-54	2468-2469	a	_	
9-55	2470-2475	broad	_	
9-56	2476-2486	repertoire	_	
9-57	2487-2489	of	_	
9-58	2490-2499	cognitive	_	
9-59	2500-2509	functions	_	
9-60	2510-2519	including	_	
9-61	2520-2528	language	_	
9-62	2528-2529	,	_	
9-63	2530-2542	visuospatial	_	
9-64	2543-2552	attention	_	
9-65	2552-2553	,	_	
9-66	2554-2557	and	_	
9-67	2558-2564	manual	_	
9-68	2565-2575	preference	_	
9-69	2575-2576	.	_	
9-70	2577-2587	Conversely	_	
9-71	2587-2588	,	_	
9-72	2589-2601	disturbances	_	
9-73	2602-2604	of	_	
9-74	2605-2616	hemispheric	_	
9-75	2617-2629	coordination	_	
9-76	2630-2633	may	_	
9-77	2634-2640	impact	_	
9-78	2641-2650	cognitive	_	
9-79	2651-2654	and	_	
9-80	2655-2665	behavioral	_	
9-81	2666-2677	functioning	_	
9-82	2678-2681	and	_	
9-83	2682-2692	contribute	_	
9-84	2693-2695	to	_	
9-85	2696-2712	neuropsychiatric	_	
9-86	2713-2722	disorders	_	
9-87	2723-2732	including	_	
9-88	2733-2746	schizophrenia	_	
9-89	2746-2747	.	_	

#Text=Multiple lines of evidence suggest that schizophrenia may involve abnormalities in interhemispheric connectivity and cooperation, which may contribute to central features of the illness such as auditory verbal hallucinations and cognitive deficits. Behavioral studies indicate that a bilateral processing advantage that is normally present during language tasks is compromised in schizophrenia patients and studies using event-related potentials (ERP) show evidence of impaired information transfer between the hemispheres during cognitive tasks in schizophrenia. Moreover, structural neuroimaging studies report that schizophrenia patients have decreased volume and fiber integrity of the corpus callosum, the major fiber bundle connecting the two hemispheres, and fMRI studies show impaired levels of functional synchronization between homotopic brain regions (i.e., corresponding areas in the left and right hemisphere) at rest.
10-1	2748-2756	Multiple	_	
10-2	2757-2762	lines	_	
10-3	2763-2765	of	_	
10-4	2766-2774	evidence	_	
10-5	2775-2782	suggest	_	
10-6	2783-2787	that	_	
10-7	2788-2801	schizophrenia	_	
10-8	2802-2805	may	_	
10-9	2806-2813	involve	_	
10-10	2814-2827	abnormalities	_	
10-11	2828-2830	in	_	
10-12	2831-2847	interhemispheric	_	
10-13	2848-2860	connectivity	_	
10-14	2861-2864	and	_	
10-15	2865-2876	cooperation	_	
10-16	2876-2877	,	_	
10-17	2878-2883	which	_	
10-18	2884-2887	may	_	
10-19	2888-2898	contribute	_	
10-20	2899-2901	to	_	
10-21	2902-2909	central	_	
10-22	2910-2918	features	_	
10-23	2919-2921	of	_	
10-24	2922-2925	the	_	
10-25	2926-2933	illness	_	
10-26	2934-2938	such	_	
10-27	2939-2941	as	_	
10-28	2942-2950	auditory	_	
10-29	2951-2957	verbal	_	
10-30	2958-2972	hallucinations	_	
10-31	2973-2976	and	_	
10-32	2977-2986	cognitive	_	
10-33	2987-2995	deficits	_	
10-34	2995-2996	.	_	
10-35	2997-3007	Behavioral	_	
10-36	3008-3015	studies	_	
10-37	3016-3024	indicate	_	
10-38	3025-3029	that	_	
10-39	3030-3031	a	_	
10-40	3032-3041	bilateral	_	
10-41	3042-3052	processing	_	
10-42	3053-3062	advantage	_	
10-43	3063-3067	that	_	
10-44	3068-3070	is	_	
10-45	3071-3079	normally	_	
10-46	3080-3087	present	_	
10-47	3088-3094	during	_	
10-48	3095-3103	language	_	
10-49	3104-3109	tasks	_	
10-50	3110-3112	is	_	
10-51	3113-3124	compromised	_	
10-52	3125-3127	in	_	
10-53	3128-3141	schizophrenia	_	
10-54	3142-3150	patients	_	
10-55	3151-3154	and	_	
10-56	3155-3162	studies	_	
10-57	3163-3168	using	_	
10-58	3169-3182	event-related	_	
10-59	3183-3193	potentials	_	
10-60	3194-3195	(	_	
10-61	3195-3198	ERP	_	
10-62	3198-3199	)	_	
10-63	3200-3204	show	_	
10-64	3205-3213	evidence	_	
10-65	3214-3216	of	_	
10-66	3217-3225	impaired	_	
10-67	3226-3237	information	_	
10-68	3238-3246	transfer	_	
10-69	3247-3254	between	_	
10-70	3255-3258	the	_	
10-71	3259-3270	hemispheres	_	
10-72	3271-3277	during	_	
10-73	3278-3287	cognitive	_	
10-74	3288-3293	tasks	_	
10-75	3294-3296	in	_	
10-76	3297-3310	schizophrenia	_	
10-77	3310-3311	.	_	
10-78	3312-3320	Moreover	_	
10-79	3320-3321	,	_	
10-80	3322-3332	structural	_	
10-81	3333-3345	neuroimaging	_	
10-82	3346-3353	studies	_	
10-83	3354-3360	report	_	
10-84	3361-3365	that	_	
10-85	3366-3379	schizophrenia	_	
10-86	3380-3388	patients	_	
10-87	3389-3393	have	_	
10-88	3394-3403	decreased	_	
10-89	3404-3410	volume	_	
10-90	3411-3414	and	_	
10-91	3415-3420	fiber	_	
10-92	3421-3430	integrity	_	
10-93	3431-3433	of	_	
10-94	3434-3437	the	_	
10-95	3438-3444	corpus	_	
10-96	3445-3453	callosum	_	
10-97	3453-3454	,	_	
10-98	3455-3458	the	_	
10-99	3459-3464	major	_	
10-100	3465-3470	fiber	_	
10-101	3471-3477	bundle	_	
10-102	3478-3488	connecting	_	
10-103	3489-3492	the	_	
10-104	3493-3496	two	_	
10-105	3497-3508	hemispheres	_	
10-106	3508-3509	,	_	
10-107	3510-3513	and	_	
10-108	3514-3518	fMRI	_	
10-109	3519-3526	studies	_	
10-110	3527-3531	show	_	
10-111	3532-3540	impaired	_	
10-112	3541-3547	levels	_	
10-113	3548-3550	of	_	
10-114	3551-3561	functional	_	
10-115	3562-3577	synchronization	_	
10-116	3578-3585	between	_	
10-117	3586-3595	homotopic	_	
10-118	3596-3601	brain	_	
10-119	3602-3609	regions	_	
10-120	3610-3611	(	_	
10-121	3611-3614	i.e	_	
10-122	3614-3615	.	_	
10-123	3615-3616	,	_	
10-124	3617-3630	corresponding	_	
10-125	3631-3636	areas	_	
10-126	3637-3639	in	_	
10-127	3640-3643	the	_	
10-128	3644-3648	left	_	
10-129	3649-3652	and	_	
10-130	3653-3658	right	_	
10-131	3659-3669	hemisphere	_	
10-132	3669-3670	)	_	
10-133	3671-3673	at	_	
10-134	3674-3678	rest	_	
10-135	3678-3679	.	_	

#Text=However, important open questions regarding interhemispheric connectivity in schizophrenia remain. First, it is unclear whether interhemispheric connectivity deficits are primarily related to the effects of the illness or a reflection of (genetic) risk for the disorder. Unaffected first-degree relatives of schizophrenia patients are a valuable population to study this question as they share the genetic predisposition and environmental factors for the illness, but are not clinically affected. Previous studies have reported abnormalities in unaffected relatives in large-scale brain regional interactions during tasks and rest, and a limited number of studies have shown subtle abnormalities in functional, and structural connectivity between homotopic brain regions in patients and relatives. In the current study, we examine homotopic interhemispheric functional connectivity in a large cohort of schizophrenia patients and their nonpsychotic siblings to assess how interhemispheric connectivity alterations relate to risk for schizophrenia.
11-1	3680-3687	However	_	
11-2	3687-3688	,	_	
11-3	3689-3698	important	_	
11-4	3699-3703	open	_	
11-5	3704-3713	questions	_	
11-6	3714-3723	regarding	_	
11-7	3724-3740	interhemispheric	_	
11-8	3741-3753	connectivity	_	
11-9	3754-3756	in	_	
11-10	3757-3770	schizophrenia	_	
11-11	3771-3777	remain	_	
11-12	3777-3778	.	_	
11-13	3779-3784	First	_	
11-14	3784-3785	,	_	
11-15	3786-3788	it	_	
11-16	3789-3791	is	_	
11-17	3792-3799	unclear	_	
11-18	3800-3807	whether	_	
11-19	3808-3824	interhemispheric	_	
11-20	3825-3837	connectivity	_	
11-21	3838-3846	deficits	_	
11-22	3847-3850	are	_	
11-23	3851-3860	primarily	_	
11-24	3861-3868	related	_	
11-25	3869-3871	to	_	
11-26	3872-3875	the	_	
11-27	3876-3883	effects	_	
11-28	3884-3886	of	_	
11-29	3887-3890	the	_	
11-30	3891-3898	illness	_	
11-31	3899-3901	or	_	
11-32	3902-3903	a	_	
11-33	3904-3914	reflection	_	
11-34	3915-3917	of	_	
11-35	3918-3919	(	_	
11-36	3919-3926	genetic	_	
11-37	3926-3927	)	_	
11-38	3928-3932	risk	_	
11-39	3933-3936	for	_	
11-40	3937-3940	the	_	
11-41	3941-3949	disorder	_	
11-42	3949-3950	.	_	
11-43	3951-3961	Unaffected	_	
11-44	3962-3974	first-degree	_	
11-45	3975-3984	relatives	_	
11-46	3985-3987	of	_	
11-47	3988-4001	schizophrenia	_	
11-48	4002-4010	patients	_	
11-49	4011-4014	are	_	
11-50	4015-4016	a	_	
11-51	4017-4025	valuable	_	
11-52	4026-4036	population	_	
11-53	4037-4039	to	_	
11-54	4040-4045	study	_	
11-55	4046-4050	this	_	
11-56	4051-4059	question	_	
11-57	4060-4062	as	_	
11-58	4063-4067	they	_	
11-59	4068-4073	share	_	
11-60	4074-4077	the	_	
11-61	4078-4085	genetic	_	
11-62	4086-4100	predisposition	_	
11-63	4101-4104	and	_	
11-64	4105-4118	environmental	_	
11-65	4119-4126	factors	_	
11-66	4127-4130	for	_	
11-67	4131-4134	the	_	
11-68	4135-4142	illness	_	
11-69	4142-4143	,	_	
11-70	4144-4147	but	_	
11-71	4148-4151	are	_	
11-72	4152-4155	not	_	
11-73	4156-4166	clinically	_	
11-74	4167-4175	affected	_	
11-75	4175-4176	.	_	
11-76	4177-4185	Previous	_	
11-77	4186-4193	studies	_	
11-78	4194-4198	have	_	
11-79	4199-4207	reported	_	
11-80	4208-4221	abnormalities	_	
11-81	4222-4224	in	_	
11-82	4225-4235	unaffected	_	
11-83	4236-4245	relatives	_	
11-84	4246-4248	in	_	
11-85	4249-4260	large-scale	_	
11-86	4261-4266	brain	_	
11-87	4267-4275	regional	_	
11-88	4276-4288	interactions	_	
11-89	4289-4295	during	_	
11-90	4296-4301	tasks	_	
11-91	4302-4305	and	_	
11-92	4306-4310	rest	_	
11-93	4310-4311	,	_	
11-94	4312-4315	and	_	
11-95	4316-4317	a	_	
11-96	4318-4325	limited	_	
11-97	4326-4332	number	_	
11-98	4333-4335	of	_	
11-99	4336-4343	studies	_	
11-100	4344-4348	have	_	
11-101	4349-4354	shown	_	
11-102	4355-4361	subtle	_	
11-103	4362-4375	abnormalities	_	
11-104	4376-4378	in	_	
11-105	4379-4389	functional	_	
11-106	4389-4390	,	_	
11-107	4391-4394	and	_	
11-108	4395-4405	structural	_	
11-109	4406-4418	connectivity	_	
11-110	4419-4426	between	_	
11-111	4427-4436	homotopic	_	
11-112	4437-4442	brain	_	
11-113	4443-4450	regions	_	
11-114	4451-4453	in	_	
11-115	4454-4462	patients	_	
11-116	4463-4466	and	_	
11-117	4467-4476	relatives	_	
11-118	4476-4477	.	_	
11-119	4478-4480	In	_	
11-120	4481-4484	the	_	
11-121	4485-4492	current	_	
11-122	4493-4498	study	_	
11-123	4498-4499	,	_	
11-124	4500-4502	we	_	
11-125	4503-4510	examine	_	
11-126	4511-4520	homotopic	_	
11-127	4521-4537	interhemispheric	_	
11-128	4538-4548	functional	_	
11-129	4549-4561	connectivity	_	
11-130	4562-4564	in	_	
11-131	4565-4566	a	_	
11-132	4567-4572	large	_	
11-133	4573-4579	cohort	_	
11-134	4580-4582	of	_	
11-135	4583-4596	schizophrenia	_	
11-136	4597-4605	patients	_	
11-137	4606-4609	and	_	
11-138	4610-4615	their	_	
11-139	4616-4628	nonpsychotic	_	
11-140	4629-4637	siblings	_	
11-141	4638-4640	to	_	
11-142	4641-4647	assess	_	
11-143	4648-4651	how	_	
11-144	4652-4668	interhemispheric	_	
11-145	4669-4681	connectivity	_	
11-146	4682-4693	alterations	_	
11-147	4694-4700	relate	_	
11-148	4701-4703	to	_	
11-149	4704-4708	risk	_	
11-150	4709-4712	for	_	
11-151	4713-4726	schizophrenia	_	
11-152	4726-4727	.	_	

#Text=Another open question is what the consequence of reduced interhemispheric connectivity may be for hemispheric specialization characterized by intrinsic connectivity. Traditionally, hemispheric specialization studies have focused on functional or anatomical asymmetry of homotopic brain regions. More recently, studies have extended the concept of hemispheric specialization to include connectivity asymmetry, by investigating functional interaction patterns of brain regions in the two hemispheres. One such measurement is the hemispheric autonomy index, which calculates the difference in connectivity strength of a brain region with ipsilateral areas versus contralateral areas during rest. Studies have shown that regions with high autonomy values (i.e. preferably connecting to ipsilateral areas) in the left hemisphere overlap with regions showing asymmetrical activation during language tasks, and that regional autonomy index values correlate with verbal and visuospatial behavioral scores in healthy subjects. We hypothesize that impaired interhemispheric connectivity may cause the two hemispheres to function more autonomously, favoring within over between-hemisphere interregional cooperation. To test this hypothesis, we examine how interhemispheric connectivity deficits in schizophrenia patients and their unaffected siblings relate to hemispheric specialization as quantified by the hemispheric autonomy index.
12-1	4728-4735	Another	_	
12-2	4736-4740	open	_	
12-3	4741-4749	question	_	
12-4	4750-4752	is	_	
12-5	4753-4757	what	_	
12-6	4758-4761	the	_	
12-7	4762-4773	consequence	_	
12-8	4774-4776	of	_	
12-9	4777-4784	reduced	_	
12-10	4785-4801	interhemispheric	_	
12-11	4802-4814	connectivity	_	
12-12	4815-4818	may	_	
12-13	4819-4821	be	_	
12-14	4822-4825	for	_	
12-15	4826-4837	hemispheric	_	
12-16	4838-4852	specialization	_	
12-17	4853-4866	characterized	_	
12-18	4867-4869	by	_	
12-19	4870-4879	intrinsic	_	
12-20	4880-4892	connectivity	_	
12-21	4892-4893	.	_	
12-22	4894-4907	Traditionally	_	
12-23	4907-4908	,	_	
12-24	4909-4920	hemispheric	_	
12-25	4921-4935	specialization	_	
12-26	4936-4943	studies	_	
12-27	4944-4948	have	_	
12-28	4949-4956	focused	_	
12-29	4957-4959	on	_	
12-30	4960-4970	functional	_	
12-31	4971-4973	or	_	
12-32	4974-4984	anatomical	_	
12-33	4985-4994	asymmetry	_	
12-34	4995-4997	of	_	
12-35	4998-5007	homotopic	_	
12-36	5008-5013	brain	_	
12-37	5014-5021	regions	_	
12-38	5021-5022	.	_	
12-39	5023-5027	More	_	
12-40	5028-5036	recently	_	
12-41	5036-5037	,	_	
12-42	5038-5045	studies	_	
12-43	5046-5050	have	_	
12-44	5051-5059	extended	_	
12-45	5060-5063	the	_	
12-46	5064-5071	concept	_	
12-47	5072-5074	of	_	
12-48	5075-5086	hemispheric	_	
12-49	5087-5101	specialization	_	
12-50	5102-5104	to	_	
12-51	5105-5112	include	_	
12-52	5113-5125	connectivity	_	
12-53	5126-5135	asymmetry	_	
12-54	5135-5136	,	_	
12-55	5137-5139	by	_	
12-56	5140-5153	investigating	_	
12-57	5154-5164	functional	_	
12-58	5165-5176	interaction	_	
12-59	5177-5185	patterns	_	
12-60	5186-5188	of	_	
12-61	5189-5194	brain	_	
12-62	5195-5202	regions	_	
12-63	5203-5205	in	_	
12-64	5206-5209	the	_	
12-65	5210-5213	two	_	
12-66	5214-5225	hemispheres	_	
12-67	5225-5226	.	_	
12-68	5227-5230	One	_	
12-69	5231-5235	such	_	
12-70	5236-5247	measurement	_	
12-71	5248-5250	is	_	
12-72	5251-5254	the	_	
12-73	5255-5266	hemispheric	_	
12-74	5267-5275	autonomy	_	
12-75	5276-5281	index	_	
12-76	5281-5282	,	_	
12-77	5283-5288	which	_	
12-78	5289-5299	calculates	_	
12-79	5300-5303	the	_	
12-80	5304-5314	difference	_	
12-81	5315-5317	in	_	
12-82	5318-5330	connectivity	_	
12-83	5331-5339	strength	_	
12-84	5340-5342	of	_	
12-85	5343-5344	a	_	
12-86	5345-5350	brain	_	
12-87	5351-5357	region	_	
12-88	5358-5362	with	_	
12-89	5363-5374	ipsilateral	_	
12-90	5375-5380	areas	_	
12-91	5381-5387	versus	_	
12-92	5388-5401	contralateral	_	
12-93	5402-5407	areas	_	
12-94	5408-5414	during	_	
12-95	5415-5419	rest	_	
12-96	5419-5420	.	_	
12-97	5421-5428	Studies	_	
12-98	5429-5433	have	_	
12-99	5434-5439	shown	_	
12-100	5440-5444	that	_	
12-101	5445-5452	regions	_	
12-102	5453-5457	with	_	
12-103	5458-5462	high	_	
12-104	5463-5471	autonomy	_	
12-105	5472-5478	values	_	
12-106	5479-5480	(	_	
12-107	5480-5483	i.e	_	
12-108	5483-5484	.	_	
12-109	5485-5495	preferably	_	
12-110	5496-5506	connecting	_	
12-111	5507-5509	to	_	
12-112	5510-5521	ipsilateral	_	
12-113	5522-5527	areas	_	
12-114	5527-5528	)	_	
12-115	5529-5531	in	_	
12-116	5532-5535	the	_	
12-117	5536-5540	left	_	
12-118	5541-5551	hemisphere	_	
12-119	5552-5559	overlap	_	
12-120	5560-5564	with	_	
12-121	5565-5572	regions	_	
12-122	5573-5580	showing	_	
12-123	5581-5593	asymmetrical	_	
12-124	5594-5604	activation	_	
12-125	5605-5611	during	_	
12-126	5612-5620	language	_	
12-127	5621-5626	tasks	_	
12-128	5626-5627	,	_	
12-129	5628-5631	and	_	
12-130	5632-5636	that	_	
12-131	5637-5645	regional	_	
12-132	5646-5654	autonomy	_	
12-133	5655-5660	index	_	
12-134	5661-5667	values	_	
12-135	5668-5677	correlate	_	
12-136	5678-5682	with	_	
12-137	5683-5689	verbal	_	
12-138	5690-5693	and	_	
12-139	5694-5706	visuospatial	_	
12-140	5707-5717	behavioral	_	
12-141	5718-5724	scores	_	
12-142	5725-5727	in	_	
12-143	5728-5735	healthy	_	
12-144	5736-5744	subjects	_	
12-145	5744-5745	.	_	
12-146	5746-5748	We	_	
12-147	5749-5760	hypothesize	_	
12-148	5761-5765	that	_	
12-149	5766-5774	impaired	_	
12-150	5775-5791	interhemispheric	_	
12-151	5792-5804	connectivity	_	
12-152	5805-5808	may	_	
12-153	5809-5814	cause	_	
12-154	5815-5818	the	_	
12-155	5819-5822	two	_	
12-156	5823-5834	hemispheres	_	
12-157	5835-5837	to	_	
12-158	5838-5846	function	_	
12-159	5847-5851	more	_	
12-160	5852-5864	autonomously	_	
12-161	5864-5865	,	_	
12-162	5866-5874	favoring	_	
12-163	5875-5881	within	_	
12-164	5882-5886	over	_	
12-165	5887-5905	between-hemisphere	_	
12-166	5906-5919	interregional	_	
12-167	5920-5931	cooperation	_	
12-168	5931-5932	.	_	
12-169	5933-5935	To	_	
12-170	5936-5940	test	_	
12-171	5941-5945	this	_	
12-172	5946-5956	hypothesis	_	
12-173	5956-5957	,	_	
12-174	5958-5960	we	_	
12-175	5961-5968	examine	_	
12-176	5969-5972	how	_	
12-177	5973-5989	interhemispheric	_	
12-178	5990-6002	connectivity	_	
12-179	6003-6011	deficits	_	
12-180	6012-6014	in	_	
12-181	6015-6028	schizophrenia	_	
12-182	6029-6037	patients	_	
12-183	6038-6041	and	_	
12-184	6042-6047	their	_	
12-185	6048-6058	unaffected	_	
12-186	6059-6067	siblings	_	
12-187	6068-6074	relate	_	
12-188	6075-6077	to	_	
12-189	6078-6089	hemispheric	_	
12-190	6090-6104	specialization	_	
12-191	6105-6107	as	_	
12-192	6108-6118	quantified	_	
12-193	6119-6121	by	_	
12-194	6122-6125	the	_	
12-195	6126-6137	hemispheric	_	
12-196	6138-6146	autonomy	_	
12-197	6147-6152	index	_	
12-198	6152-6153	.	_	

#Text=Material and methods
13-1	6154-6162	Material	_	
13-2	6163-6166	and	_	
13-3	6167-6174	methods	_	

#Text=Participants
14-1	6175-6187	Participants	_	

#Text=A total of 253 participants, including 84 schizophrenia patients, 106 of their unaffected siblings and 63 healthy controls, were recruited at the University Medical Center Utrecht between September 2004 and April 2008, as part of the Genetic Risk and Outcome of Psychosis (GROUP) study. The GROUP study was conducted by four university psychiatric centers and their affiliated mental health care institutions in the Netherlands. The medical ethics committee of the University Medical Center Utrecht approved the current study. All subjects provided written informed consent prior to participation.
15-1	6188-6189	A	_	
15-2	6190-6195	total	_	
15-3	6196-6198	of	_	
15-4	6199-6202	253	_	
15-5	6203-6215	participants	_	
15-6	6215-6216	,	_	
15-7	6217-6226	including	_	
15-8	6227-6229	84	_	
15-9	6230-6243	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
15-10	6244-6252	patients	_	
15-11	6252-6253	,	_	
15-12	6254-6257	106	_	
15-13	6258-6260	of	_	
15-14	6261-6266	their	_	
15-15	6267-6277	unaffected	_	
15-16	6278-6286	siblings	_	
15-17	6287-6290	and	_	
15-18	6291-6293	63	_	
15-19	6294-6301	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[1]	
15-20	6302-6310	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[1]	
15-21	6310-6311	,	_	
15-22	6312-6316	were	_	
15-23	6317-6326	recruited	_	
15-24	6327-6329	at	_	
15-25	6330-6333	the	_	
15-26	6334-6344	University	_	
15-27	6345-6352	Medical	_	
15-28	6353-6359	Center	_	
15-29	6360-6367	Utrecht	_	
15-30	6368-6375	between	_	
15-31	6376-6385	September	_	
15-32	6386-6390	2004	_	
15-33	6391-6394	and	_	
15-34	6395-6400	April	_	
15-35	6401-6405	2008	_	
15-36	6405-6406	,	_	
15-37	6407-6409	as	_	
15-38	6410-6414	part	_	
15-39	6415-6417	of	_	
15-40	6418-6421	the	_	
15-41	6422-6429	Genetic	_	
15-42	6430-6434	Risk	_	
15-43	6435-6438	and	_	
15-44	6439-6446	Outcome	_	
15-45	6447-6449	of	_	
15-46	6450-6459	Psychosis	_	
15-47	6460-6461	(	_	
15-48	6461-6466	GROUP	_	
15-49	6466-6467	)	_	
15-50	6468-6473	study	_	
15-51	6473-6474	.	_	
15-52	6475-6478	The	_	
15-53	6479-6484	GROUP	_	
15-54	6485-6490	study	_	
15-55	6491-6494	was	_	
15-56	6495-6504	conducted	_	
15-57	6505-6507	by	_	
15-58	6508-6512	four	_	
15-59	6513-6523	university	_	
15-60	6524-6535	psychiatric	_	
15-61	6536-6543	centers	_	
15-62	6544-6547	and	_	
15-63	6548-6553	their	_	
15-64	6554-6564	affiliated	_	
15-65	6565-6571	mental	_	
15-66	6572-6578	health	_	
15-67	6579-6583	care	_	
15-68	6584-6596	institutions	_	
15-69	6597-6599	in	_	
15-70	6600-6603	the	_	
15-71	6604-6615	Netherlands	_	
15-72	6615-6616	.	_	
15-73	6617-6620	The	_	
15-74	6621-6628	medical	_	
15-75	6629-6635	ethics	_	
15-76	6636-6645	committee	_	
15-77	6646-6648	of	_	
15-78	6649-6652	the	_	
15-79	6653-6663	University	_	
15-80	6664-6671	Medical	_	
15-81	6672-6678	Center	_	
15-82	6679-6686	Utrecht	_	
15-83	6687-6695	approved	_	
15-84	6696-6699	the	_	
15-85	6700-6707	current	_	
15-86	6708-6713	study	_	
15-87	6713-6714	.	_	
15-88	6715-6718	All	_	
15-89	6719-6727	subjects	_	
15-90	6728-6736	provided	_	
15-91	6737-6744	written	_	
15-92	6745-6753	informed	_	
15-93	6754-6761	consent	_	
15-94	6762-6767	prior	_	
15-95	6768-6770	to	_	
15-96	6771-6784	participation	_	
15-97	6784-6785	.	_	

#Text=For all participants, presence or absence of current and lifetime psychopathology was established using the Comprehensive Assessment of Symptoms and History (CASH). This semi-structured interview is designed to obtain comprehensive information on current and past signs and symptoms of major psychiatric disorders, premorbid functioning, sociodemographic status, treatment, and course of illness. Patients were included if they met Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) criteria for schizophrenia or schizoaffective disorder. Symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS). The dosage of antipsychotic medication patients were taking at the time of scanning were converted to a chlorpromazine equivalent dosage.
16-1	6786-6789	For	_	
16-2	6790-6793	all	_	
16-3	6794-6806	participants	_	
16-4	6806-6807	,	_	
16-5	6808-6816	presence	_	
16-6	6817-6819	or	_	
16-7	6820-6827	absence	_	
16-8	6828-6830	of	_	
16-9	6831-6838	current	_	
16-10	6839-6842	and	_	
16-11	6843-6851	lifetime	_	
16-12	6852-6867	psychopathology	_	
16-13	6868-6871	was	_	
16-14	6872-6883	established	_	
16-15	6884-6889	using	_	
16-16	6890-6893	the	_	
16-17	6894-6907	Comprehensive	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-18	6908-6918	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-19	6919-6921	of	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-20	6922-6930	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-21	6931-6934	and	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-22	6935-6942	History	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-23	6943-6944	(	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-24	6944-6948	CASH	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-25	6948-6949	)	http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[2]	
16-26	6949-6950	.	_	
16-27	6951-6955	This	_	
16-28	6956-6971	semi-structured	_	
16-29	6972-6981	interview	_	
16-30	6982-6984	is	_	
16-31	6985-6993	designed	_	
16-32	6994-6996	to	_	
16-33	6997-7003	obtain	_	
16-34	7004-7017	comprehensive	_	
16-35	7018-7029	information	_	
16-36	7030-7032	on	_	
16-37	7033-7040	current	_	
16-38	7041-7044	and	_	
16-39	7045-7049	past	_	
16-40	7050-7055	signs	_	
16-41	7056-7059	and	_	
16-42	7060-7068	symptoms	_	
16-43	7069-7071	of	_	
16-44	7072-7077	major	_	
16-45	7078-7089	psychiatric	_	
16-46	7090-7099	disorders	_	
16-47	7099-7100	,	_	
16-48	7101-7110	premorbid	_	
16-49	7111-7122	functioning	_	
16-50	7122-7123	,	_	
16-51	7124-7140	sociodemographic	_	
16-52	7141-7147	status	_	
16-53	7147-7148	,	_	
16-54	7149-7158	treatment	_	
16-55	7158-7159	,	_	
16-56	7160-7163	and	_	
16-57	7164-7170	course	_	
16-58	7171-7173	of	_	
16-59	7174-7181	illness	_	
16-60	7181-7182	.	_	
16-61	7183-7191	Patients	_	
16-62	7192-7196	were	_	
16-63	7197-7205	included	_	
16-64	7206-7208	if	_	
16-65	7209-7213	they	_	
16-66	7214-7217	met	_	
16-67	7218-7228	Diagnostic	_	
16-68	7229-7232	and	_	
16-69	7233-7244	Statistical	_	
16-70	7245-7251	Manual	_	
16-71	7252-7254	of	_	
16-72	7255-7261	Mental	_	
16-73	7262-7271	Disorders	_	
16-74	7272-7278	fourth	_	
16-75	7279-7286	edition	_	
16-76	7287-7288	(	_	
16-77	7288-7294	DSM-IV	_	
16-78	7294-7295	)	_	
16-79	7296-7304	criteria	_	
16-80	7305-7308	for	_	
16-81	7309-7322	schizophrenia	_	
16-82	7323-7325	or	_	
16-83	7326-7341	schizoaffective	_	
16-84	7342-7350	disorder	_	
16-85	7350-7351	.	_	
16-86	7352-7359	Symptom	_	
16-87	7360-7368	severity	_	
16-88	7369-7372	was	_	
16-89	7373-7381	assessed	_	
16-90	7382-7387	using	_	
16-91	7388-7391	the	_	
16-92	7392-7400	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[3]	
16-93	7401-7404	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[3]	
16-94	7405-7413	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[3]	
16-95	7414-7422	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[3]	
16-96	7423-7428	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[3]	
16-97	7429-7430	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[3]	
16-98	7430-7435	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[3]	
16-99	7435-7436	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[3]	
16-100	7436-7437	.	_	
16-101	7438-7441	The	_	
16-102	7442-7448	dosage	_	
16-103	7449-7451	of	_	
16-104	7452-7465	antipsychotic	_	
16-105	7466-7476	medication	_	
16-106	7477-7485	patients	_	
16-107	7486-7490	were	_	
16-108	7491-7497	taking	_	
16-109	7498-7500	at	_	
16-110	7501-7504	the	_	
16-111	7505-7509	time	_	
16-112	7510-7512	of	_	
16-113	7513-7521	scanning	_	
16-114	7522-7526	were	_	
16-115	7527-7536	converted	_	
16-116	7537-7539	to	_	
16-117	7540-7541	a	_	
16-118	7542-7556	chlorpromazine	_	
16-119	7557-7567	equivalent	_	
16-120	7568-7574	dosage	_	
16-121	7574-7575	.	_	

#Text=Demographic and clinical information of the three groups of participants (controls, siblings, schizophrenia N = 63, 106, 84).
17-1	7576-7587	Demographic	_	
17-2	7588-7591	and	_	
17-3	7592-7600	clinical	_	
17-4	7601-7612	information	_	
17-5	7613-7615	of	_	
17-6	7616-7619	the	_	
17-7	7620-7625	three	_	
17-8	7626-7632	groups	_	
17-9	7633-7635	of	_	
17-10	7636-7648	participants	_	
17-11	7649-7650	(	_	
17-12	7650-7658	controls	_	
17-13	7658-7659	,	_	
17-14	7660-7668	siblings	_	
17-15	7668-7669	,	_	
17-16	7670-7683	schizophrenia	_	
17-17	7684-7685	N	_	
17-18	7685-7686	 	_	
17-19	7686-7687	=	_	
17-20	7687-7688	 	_	
17-21	7688-7690	63	_	
17-22	7690-7691	,	_	
17-23	7692-7695	106	_	
17-24	7695-7696	,	_	
17-25	7697-7699	84	_	
17-26	7699-7700	)	_	
17-27	7700-7701	.	_	

#Text=Table 1
18-1	7702-7707	Table	_	
18-2	7708-7709	1	_	

#Text=Controls\tSiblings\tPatients\tStatisticsa\t \tAge\t29.16 ± 7.59\t29.50 ± 7.65\t29.86 ± 5.27\tF(2,250) = 0.18, p = .83\t \tSex (M / F)\t29/34\t49 / 57\t70/14\tχ(2)2 = 31.95, p < .001\t \tIQ\t113.76 ± 15.66\t105.96 ± 17.10\t95.99 ± 15.21\tF(2,250) = 20.54, p < .001\t \tHandedness (right / left / mixed)\t44/8/1\t94/6/6\t70/5/4\tχ(2)2 = 5.63, p = .23\t \tScanner (#1 / #2)\t28 / 28\t59 / 47\t49 / 33\tχ(2)2 = 1.28, p = .53\t \tIllness duration (years)b\t–\t–\t5.91 (4.12)\t–\t \tChlorpromazine dosage (mg/day)\t–\t–\t300 (200, 600)\t–\t \tPANSS total\t–\t–\t48.38 ± 14.89\t–\t \tPANSS positive\t–\t–\t11.58 ± 5.42\t–\t \tPANSS negative\t–\t–\t12.23 ± 4.35\t–\t \tPANSS general psychopathology\t–\t–\t24.57 ± 7.05\t–
19-1	7714-7722	Controls	_	
19-2	7723-7731	Siblings	_	
19-3	7732-7740	Patients	_	
19-4	7741-7752	Statisticsa	_	
19-5	7755-7758	Age	_	
19-6	7759-7764	29.16	_	
19-7	7764-7765	 	_	
19-8	7765-7766	±	_	
19-9	7766-7767	 	_	
19-10	7767-7771	7.59	_	
19-11	7772-7777	29.50	_	
19-12	7777-7778	 	_	
19-13	7778-7779	±	_	
19-14	7779-7780	 	_	
19-15	7780-7784	7.65	_	
19-16	7785-7790	29.86	_	
19-17	7790-7791	 	_	
19-18	7791-7792	±	_	
19-19	7792-7793	 	_	
19-20	7793-7797	5.27	_	
19-21	7798-7799	F	_	
19-22	7799-7800	(	_	
19-23	7800-7805	2,250	_	
19-24	7805-7806	)	_	
19-25	7806-7807	 	_	
19-26	7807-7808	=	_	
19-27	7808-7809	 	_	
19-28	7809-7813	0.18	_	
19-29	7813-7814	,	_	
19-30	7815-7816	p	_	
19-31	7816-7817	 	_	
19-32	7817-7818	=	_	
19-33	7818-7819	 	_	
19-34	7819-7822	.83	_	
19-35	7825-7828	Sex	_	
19-36	7829-7830	(	_	
19-37	7830-7831	M	_	
19-38	7832-7833	/	_	
19-39	7834-7835	F	_	
19-40	7835-7836	)	_	
19-41	7837-7839	29	_	
19-42	7839-7840	/	_	
19-43	7840-7842	34	_	
19-44	7843-7845	49	_	
19-45	7846-7847	/	_	
19-46	7848-7850	57	_	
19-47	7851-7853	70	_	
19-48	7853-7854	/	_	
19-49	7854-7856	14	_	
19-50	7857-7858	χ	_	
19-51	7858-7859	(	_	
19-52	7859-7860	2	_	
19-53	7860-7861	)	_	
19-54	7861-7862	2	_	
19-55	7862-7863	 	_	
19-56	7863-7864	=	_	
19-57	7864-7865	 	_	
19-58	7865-7870	31.95	_	
19-59	7870-7871	,	_	
19-60	7872-7873	p	_	
19-61	7873-7874	 	_	
19-62	7874-7875	<	_	
19-63	7875-7876	 	_	
19-64	7876-7880	.001	_	
19-65	7883-7885	IQ	_	
19-66	7886-7892	113.76	_	
19-67	7892-7893	 	_	
19-68	7893-7894	±	_	
19-69	7894-7895	 	_	
19-70	7895-7900	15.66	_	
19-71	7901-7907	105.96	_	
19-72	7907-7908	 	_	
19-73	7908-7909	±	_	
19-74	7909-7910	 	_	
19-75	7910-7915	17.10	_	
19-76	7916-7921	95.99	_	
19-77	7921-7922	 	_	
19-78	7922-7923	±	_	
19-79	7923-7924	 	_	
19-80	7924-7929	15.21	_	
19-81	7930-7931	F	_	
19-82	7931-7932	(	_	
19-83	7932-7937	2,250	_	
19-84	7937-7938	)	_	
19-85	7938-7939	 	_	
19-86	7939-7940	=	_	
19-87	7940-7941	 	_	
19-88	7941-7946	20.54	_	
19-89	7946-7947	,	_	
19-90	7948-7949	p	_	
19-91	7949-7950	 	_	
19-92	7950-7951	<	_	
19-93	7951-7952	 	_	
19-94	7952-7956	.001	_	
19-95	7959-7969	Handedness	_	
19-96	7970-7971	(	_	
19-97	7971-7976	right	_	
19-98	7977-7978	/	_	
19-99	7979-7983	left	_	
19-100	7984-7985	/	_	
19-101	7986-7991	mixed	_	
19-102	7991-7992	)	_	
19-103	7993-7995	44	_	
19-104	7995-7996	/	_	
19-105	7996-7997	8	_	
19-106	7997-7998	/	_	
19-107	7998-7999	1	_	
19-108	8000-8002	94	_	
19-109	8002-8003	/	_	
19-110	8003-8004	6	_	
19-111	8004-8005	/	_	
19-112	8005-8006	6	_	
19-113	8007-8009	70	_	
19-114	8009-8010	/	_	
19-115	8010-8011	5	_	
19-116	8011-8012	/	_	
19-117	8012-8013	4	_	
19-118	8014-8015	χ	_	
19-119	8015-8016	(	_	
19-120	8016-8017	2	_	
19-121	8017-8018	)	_	
19-122	8018-8019	2	_	
19-123	8019-8020	 	_	
19-124	8020-8021	=	_	
19-125	8021-8022	 	_	
19-126	8022-8026	5.63	_	
19-127	8026-8027	,	_	
19-128	8028-8029	p	_	
19-129	8029-8030	 	_	
19-130	8030-8031	=	_	
19-131	8031-8032	 	_	
19-132	8032-8035	.23	_	
19-133	8038-8045	Scanner	_	
19-134	8046-8047	(	_	
19-135	8047-8049	#1	_	
19-136	8050-8051	/	_	
19-137	8052-8054	#2	_	
19-138	8054-8055	)	_	
19-139	8056-8058	28	_	
19-140	8059-8060	/	_	
19-141	8061-8063	28	_	
19-142	8064-8066	59	_	
19-143	8067-8068	/	_	
19-144	8069-8071	47	_	
19-145	8072-8074	49	_	
19-146	8075-8076	/	_	
19-147	8077-8079	33	_	
19-148	8080-8081	χ	_	
19-149	8081-8082	(	_	
19-150	8082-8083	2	_	
19-151	8083-8084	)	_	
19-152	8084-8085	2	_	
19-153	8085-8086	 	_	
19-154	8086-8087	=	_	
19-155	8087-8088	 	_	
19-156	8088-8092	1.28	_	
19-157	8092-8093	,	_	
19-158	8094-8095	p	_	
19-159	8095-8096	 	_	
19-160	8096-8097	=	_	
19-161	8097-8098	 	_	
19-162	8098-8101	.53	_	
19-163	8104-8111	Illness	_	
19-164	8112-8120	duration	_	
19-165	8121-8122	(	_	
19-166	8122-8127	years	_	
19-167	8127-8128	)	_	
19-168	8128-8129	b	_	
19-169	8130-8131	–	_	
19-170	8132-8133	–	_	
19-171	8134-8138	5.91	_	
19-172	8139-8140	(	_	
19-173	8140-8144	4.12	_	
19-174	8144-8145	)	_	
19-175	8146-8147	–	_	
19-176	8150-8164	Chlorpromazine	_	
19-177	8165-8171	dosage	_	
19-178	8172-8173	(	_	
19-179	8173-8175	mg	_	
19-180	8175-8176	/	_	
19-181	8176-8179	day	_	
19-182	8179-8180	)	_	
19-183	8181-8182	–	_	
19-184	8183-8184	–	_	
19-185	8185-8188	300	_	
19-186	8189-8190	(	_	
19-187	8190-8193	200	_	
19-188	8193-8194	,	_	
19-189	8195-8198	600	_	
19-190	8198-8199	)	_	
19-191	8200-8201	–	_	
19-192	8204-8209	PANSS	_	
19-193	8210-8215	total	_	
19-194	8216-8217	–	_	
19-195	8218-8219	–	_	
19-196	8220-8225	48.38	_	
19-197	8225-8226	 	_	
19-198	8226-8227	±	_	
19-199	8227-8228	 	_	
19-200	8228-8233	14.89	_	
19-201	8234-8235	–	_	
19-202	8238-8243	PANSS	_	
19-203	8244-8252	positive	_	
19-204	8253-8254	–	_	
19-205	8255-8256	–	_	
19-206	8257-8262	11.58	_	
19-207	8262-8263	 	_	
19-208	8263-8264	±	_	
19-209	8264-8265	 	_	
19-210	8265-8269	5.42	_	
19-211	8270-8271	–	_	
19-212	8274-8279	PANSS	_	
19-213	8280-8288	negative	_	
19-214	8289-8290	–	_	
19-215	8291-8292	–	_	
19-216	8293-8298	12.23	_	
19-217	8298-8299	 	_	
19-218	8299-8300	±	_	
19-219	8300-8301	 	_	
19-220	8301-8305	4.35	_	
19-221	8306-8307	–	_	
19-222	8310-8315	PANSS	_	
19-223	8316-8323	general	_	
19-224	8324-8339	psychopathology	_	
19-225	8340-8341	–	_	
19-226	8342-8343	–	_	
19-227	8344-8349	24.57	_	
19-228	8349-8350	 	_	
19-229	8350-8351	±	_	
19-230	8351-8352	 	_	
19-231	8352-8356	7.05	_	
19-232	8357-8358	–	_	

#Text=Group comparison of continuous variables (Age, IQ) are tested with one-way analysis of variance (ANOVA). Nominal variables (sex, handedness, scanner) were compared using chi-square statistics.
20-1	8362-8367	Group	_	
20-2	8368-8378	comparison	_	
20-3	8379-8381	of	_	
20-4	8382-8392	continuous	_	
20-5	8393-8402	variables	_	
20-6	8403-8404	(	_	
20-7	8404-8407	Age	_	
20-8	8407-8408	,	_	
20-9	8409-8411	IQ	_	
20-10	8411-8412	)	_	
20-11	8413-8416	are	_	
20-12	8417-8423	tested	_	
20-13	8424-8428	with	_	
20-14	8429-8436	one-way	_	
20-15	8437-8445	analysis	_	
20-16	8446-8448	of	_	
20-17	8449-8457	variance	_	
20-18	8458-8459	(	_	
20-19	8459-8464	ANOVA	_	
20-20	8464-8465	)	_	
20-21	8465-8466	.	_	
20-22	8467-8474	Nominal	_	
20-23	8475-8484	variables	_	
20-24	8485-8486	(	_	
20-25	8486-8489	sex	_	
20-26	8489-8490	,	_	
20-27	8491-8501	handedness	_	
20-28	8501-8502	,	_	
20-29	8503-8510	scanner	_	
20-30	8510-8511	)	_	
20-31	8512-8516	were	_	
20-32	8517-8525	compared	_	
20-33	8526-8531	using	_	
20-34	8532-8542	chi-square	_	
20-35	8543-8553	statistics	_	
20-36	8553-8554	.	_	

#Text=Distribution of illness duration and medication is skewed, therefore median and inter-quartile range was reported.
21-1	8555-8567	Distribution	_	
21-2	8568-8570	of	_	
21-3	8571-8578	illness	_	
21-4	8579-8587	duration	_	
21-5	8588-8591	and	_	
21-6	8592-8602	medication	_	
21-7	8603-8605	is	_	
21-8	8606-8612	skewed	_	
21-9	8612-8613	,	_	
21-10	8614-8623	therefore	_	
21-11	8624-8630	median	_	
21-12	8631-8634	and	_	
21-13	8635-8649	inter-quartile	_	
21-14	8650-8655	range	_	
21-15	8656-8659	was	_	
21-16	8660-8668	reported	_	
21-17	8668-8669	.	_	

#Text=Patients and siblings originated from 120 unique families and included 48 patient-sibling pairs or triplets. The control group comprised 63 subjects from 57 families. A family identification code (family ID) was assigned to every subject to keep track of their pedigrees. Siblings and healthy controls were excluded for any current or previous psychotic disorder. In addition, controls were examined with the Family Interview for Genetic Studies, to exclude a family history of psychotic disorders (in first- or second-degree relatives). Exclusion criteria for all participants included a history of head trauma or major medical or neurological illness. All participants were between 18 and 60 years of age at the time of inclusion. Demographics and clinical information are described in Table 1.
22-1	8670-8678	Patients	_	
22-2	8679-8682	and	_	
22-3	8683-8691	siblings	_	
22-4	8692-8702	originated	_	
22-5	8703-8707	from	_	
22-6	8708-8711	120	_	
22-7	8712-8718	unique	_	
22-8	8719-8727	families	_	
22-9	8728-8731	and	_	
22-10	8732-8740	included	_	
22-11	8741-8743	48	_	
22-12	8744-8759	patient-sibling	_	
22-13	8760-8765	pairs	_	
22-14	8766-8768	or	_	
22-15	8769-8777	triplets	_	
22-16	8777-8778	.	_	
22-17	8779-8782	The	_	
22-18	8783-8790	control	_	
22-19	8791-8796	group	_	
22-20	8797-8806	comprised	_	
22-21	8807-8809	63	_	
22-22	8810-8818	subjects	_	
22-23	8819-8823	from	_	
22-24	8824-8826	57	_	
22-25	8827-8835	families	_	
22-26	8835-8836	.	_	
22-27	8837-8838	A	_	
22-28	8839-8845	family	_	
22-29	8846-8860	identification	_	
22-30	8861-8865	code	_	
22-31	8866-8867	(	_	
22-32	8867-8873	family	_	
22-33	8874-8876	ID	_	
22-34	8876-8877	)	_	
22-35	8878-8881	was	_	
22-36	8882-8890	assigned	_	
22-37	8891-8893	to	_	
22-38	8894-8899	every	_	
22-39	8900-8907	subject	_	
22-40	8908-8910	to	_	
22-41	8911-8915	keep	_	
22-42	8916-8921	track	_	
22-43	8922-8924	of	_	
22-44	8925-8930	their	_	
22-45	8931-8940	pedigrees	_	
22-46	8940-8941	.	_	
22-47	8942-8950	Siblings	_	
22-48	8951-8954	and	_	
22-49	8955-8962	healthy	_	
22-50	8963-8971	controls	_	
22-51	8972-8976	were	_	
22-52	8977-8985	excluded	_	
22-53	8986-8989	for	_	
22-54	8990-8993	any	_	
22-55	8994-9001	current	_	
22-56	9002-9004	or	_	
22-57	9005-9013	previous	_	
22-58	9014-9023	psychotic	_	
22-59	9024-9032	disorder	_	
22-60	9032-9033	.	_	
22-61	9034-9036	In	_	
22-62	9037-9045	addition	_	
22-63	9045-9046	,	_	
22-64	9047-9055	controls	_	
22-65	9056-9060	were	_	
22-66	9061-9069	examined	_	
22-67	9070-9074	with	_	
22-68	9075-9078	the	_	
22-69	9079-9085	Family	_	
22-70	9086-9095	Interview	_	
22-71	9096-9099	for	_	
22-72	9100-9107	Genetic	_	
22-73	9108-9115	Studies	_	
22-74	9115-9116	,	_	
22-75	9117-9119	to	_	
22-76	9120-9127	exclude	_	
22-77	9128-9129	a	_	
22-78	9130-9136	family	_	
22-79	9137-9144	history	_	
22-80	9145-9147	of	_	
22-81	9148-9157	psychotic	_	
22-82	9158-9167	disorders	_	
22-83	9168-9169	(	_	
22-84	9169-9171	in	_	
22-85	9172-9177	first	_	
22-86	9177-9178	-	_	
22-87	9179-9181	or	_	
22-88	9182-9195	second-degree	_	
22-89	9196-9205	relatives	_	
22-90	9205-9206	)	_	
22-91	9206-9207	.	_	
22-92	9208-9217	Exclusion	_	
22-93	9218-9226	criteria	_	
22-94	9227-9230	for	_	
22-95	9231-9234	all	_	
22-96	9235-9247	participants	_	
22-97	9248-9256	included	_	
22-98	9257-9258	a	_	
22-99	9259-9266	history	_	
22-100	9267-9269	of	_	
22-101	9270-9274	head	_	
22-102	9275-9281	trauma	_	
22-103	9282-9284	or	_	
22-104	9285-9290	major	_	
22-105	9291-9298	medical	_	
22-106	9299-9301	or	_	
22-107	9302-9314	neurological	_	
22-108	9315-9322	illness	_	
22-109	9322-9323	.	_	
22-110	9324-9327	All	_	
22-111	9328-9340	participants	_	
22-112	9341-9345	were	_	
22-113	9346-9353	between	_	
22-114	9354-9356	18	_	
22-115	9357-9360	and	_	
22-116	9361-9363	60	_	
22-117	9363-9364	 	_	
22-118	9364-9369	years	_	
22-119	9370-9372	of	_	
22-120	9373-9376	age	_	
22-121	9377-9379	at	_	
22-122	9380-9383	the	_	
22-123	9384-9388	time	_	
22-124	9389-9391	of	_	
22-125	9392-9401	inclusion	_	
22-126	9401-9402	.	_	
22-127	9403-9415	Demographics	_	
22-128	9416-9419	and	_	
22-129	9420-9428	clinical	_	
22-130	9429-9440	information	_	
22-131	9441-9444	are	_	
22-132	9445-9454	described	_	
22-133	9455-9457	in	_	
22-134	9458-9463	Table	_	
22-135	9464-9465	1	_	
22-136	9465-9466	.	_	

#Text=Data acquisition
23-1	9467-9471	Data	_	
23-2	9472-9483	acquisition	_	

#Text=MRI scans were acquired on two 1.5 T Philips Achieva scanners at the University Medical Center Utrecht, with the same acquisition protocol. The scanner information was included as a covariate in further group-comparisons. For each subject, resting-state functional magnetic resonance imaging (fMRI) time series were acquired with a three dimensional (3D) echo shifting with a train of observations (PRESTO) acquisition scheme. The PRESTO protocol combines the echo shifting technique with multiple gradient echoes per excitation to allow for a repetition time shorter than echo time. The acquisition parameters were: TR / TE = 21.1 / 31.1 ms; flip angle = 90°; field of view = 256 × 256 mm2, voxel size = 4 × 4 × 4 mm3, 900 time frames, consisting of 32 slices covering whole brain. In addition, a T1-weighted scan was collected as anatomical reference with the following scanning parameters: TR/TE = 30/4.6 ms; flip angle = 30°; field of view = 256 × 256 mm2, voxel size = 1 × 1 × 1.2 mm3.
24-1	9484-9487	MRI	_	
24-2	9488-9493	scans	_	
24-3	9494-9498	were	_	
24-4	9499-9507	acquired	_	
24-5	9508-9510	on	_	
24-6	9511-9514	two	_	
24-7	9515-9518	1.5	_	
24-8	9518-9519	 	_	
24-9	9519-9520	T	_	
24-10	9521-9528	Philips	_	
24-11	9529-9536	Achieva	_	
24-12	9537-9545	scanners	_	
24-13	9546-9548	at	_	
24-14	9549-9552	the	_	
24-15	9553-9563	University	_	
24-16	9564-9571	Medical	_	
24-17	9572-9578	Center	_	
24-18	9579-9586	Utrecht	_	
24-19	9586-9587	,	_	
24-20	9588-9592	with	_	
24-21	9593-9596	the	_	
24-22	9597-9601	same	_	
24-23	9602-9613	acquisition	_	
24-24	9614-9622	protocol	_	
24-25	9622-9623	.	_	
24-26	9624-9627	The	_	
24-27	9628-9635	scanner	_	
24-28	9636-9647	information	_	
24-29	9648-9651	was	_	
24-30	9652-9660	included	_	
24-31	9661-9663	as	_	
24-32	9664-9665	a	_	
24-33	9666-9675	covariate	_	
24-34	9676-9678	in	_	
24-35	9679-9686	further	_	
24-36	9687-9704	group-comparisons	_	
24-37	9704-9705	.	_	
24-38	9706-9709	For	_	
24-39	9710-9714	each	_	
24-40	9715-9722	subject	_	
24-41	9722-9723	,	_	
24-42	9724-9737	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]	
24-43	9738-9748	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]	
24-44	9749-9757	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]	
24-45	9758-9767	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]	
24-46	9768-9775	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]	
24-47	9776-9777	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]	
24-48	9777-9781	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]	
24-49	9781-9782	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]	
24-50	9783-9787	time	_	
24-51	9788-9794	series	_	
24-52	9795-9799	were	_	
24-53	9800-9808	acquired	_	
24-54	9809-9813	with	_	
24-55	9814-9815	a	_	
24-56	9816-9821	three	_	
24-57	9822-9833	dimensional	_	
24-58	9834-9835	(	_	
24-59	9835-9837	3D	_	
24-60	9837-9838	)	_	
24-61	9839-9843	echo	_	
24-62	9844-9852	shifting	_	
24-63	9853-9857	with	_	
24-64	9858-9859	a	_	
24-65	9860-9865	train	_	
24-66	9866-9868	of	_	
24-67	9869-9881	observations	_	
24-68	9882-9883	(	_	
24-69	9883-9889	PRESTO	_	
24-70	9889-9890	)	_	
24-71	9891-9902	acquisition	_	
24-72	9903-9909	scheme	_	
24-73	9909-9910	.	_	
24-74	9911-9914	The	_	
24-75	9915-9921	PRESTO	_	
24-76	9922-9930	protocol	_	
24-77	9931-9939	combines	_	
24-78	9940-9943	the	_	
24-79	9944-9948	echo	_	
24-80	9949-9957	shifting	_	
24-81	9958-9967	technique	_	
24-82	9968-9972	with	_	
24-83	9973-9981	multiple	_	
24-84	9982-9990	gradient	_	
24-85	9991-9997	echoes	_	
24-86	9998-10001	per	_	
24-87	10002-10012	excitation	_	
24-88	10013-10015	to	_	
24-89	10016-10021	allow	_	
24-90	10022-10025	for	_	
24-91	10026-10027	a	_	
24-92	10028-10038	repetition	_	
24-93	10039-10043	time	_	
24-94	10044-10051	shorter	_	
24-95	10052-10056	than	_	
24-96	10057-10061	echo	_	
24-97	10062-10066	time	_	
24-98	10066-10067	.	_	
24-99	10068-10071	The	_	
24-100	10072-10083	acquisition	_	
24-101	10084-10094	parameters	_	
24-102	10095-10099	were	_	
24-103	10099-10100	:	_	
24-104	10101-10103	TR	_	
24-105	10104-10105	/	_	
24-106	10106-10108	TE	_	
24-107	10108-10109	 	_	
24-108	10109-10110	=	_	
24-109	10110-10111	 	_	
24-110	10111-10115	21.1	_	
24-111	10116-10117	/	_	
24-112	10118-10122	31.1	_	
24-113	10122-10123	 	_	
24-114	10123-10125	ms	_	
24-115	10125-10126	;	_	
24-116	10127-10131	flip	_	
24-117	10132-10137	angle	_	
24-118	10137-10138	 	_	
24-119	10138-10139	=	_	
24-120	10139-10140	 	_	
24-121	10140-10142	90	_	
24-122	10142-10143	°	_	
24-123	10143-10144	;	_	
24-124	10145-10150	field	_	
24-125	10151-10153	of	_	
24-126	10154-10158	view	_	
24-127	10158-10159	 	_	
24-128	10159-10160	=	_	
24-129	10160-10161	 	_	
24-130	10161-10164	256	_	
24-131	10164-10165	 	_	
24-132	10165-10166	×	_	
24-133	10166-10167	 	_	
24-134	10167-10170	256	_	
24-135	10170-10171	 	_	
24-136	10171-10174	mm2	_	
24-137	10174-10175	,	_	
24-138	10176-10181	voxel	_	
24-139	10182-10186	size	_	
24-140	10186-10187	 	_	
24-141	10187-10188	=	_	
24-142	10188-10189	 	_	
24-143	10189-10190	4	_	
24-144	10190-10191	 	_	
24-145	10191-10192	×	_	
24-146	10192-10193	 	_	
24-147	10193-10194	4	_	
24-148	10194-10195	 	_	
24-149	10195-10196	×	_	
24-150	10196-10197	 	_	
24-151	10197-10198	4	_	
24-152	10198-10199	 	_	
24-153	10199-10202	mm3	_	
24-154	10202-10203	,	_	
24-155	10204-10207	900	_	
24-156	10208-10212	time	_	
24-157	10213-10219	frames	_	
24-158	10219-10220	,	_	
24-159	10221-10231	consisting	_	
24-160	10232-10234	of	_	
24-161	10235-10237	32	_	
24-162	10238-10244	slices	_	
24-163	10245-10253	covering	_	
24-164	10254-10259	whole	_	
24-165	10260-10265	brain	_	
24-166	10265-10266	.	_	
24-167	10267-10269	In	_	
24-168	10270-10278	addition	_	
24-169	10278-10279	,	_	
24-170	10280-10281	a	_	
24-171	10282-10284	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[5]	
24-172	10284-10285	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[5]	
24-173	10285-10293	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[5]	
24-174	10294-10298	scan	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[5]	
24-175	10299-10302	was	_	
24-176	10303-10312	collected	_	
24-177	10313-10315	as	_	
24-178	10316-10326	anatomical	_	
24-179	10327-10336	reference	_	
24-180	10337-10341	with	_	
24-181	10342-10345	the	_	
24-182	10346-10355	following	_	
24-183	10356-10364	scanning	_	
24-184	10365-10375	parameters	_	
24-185	10375-10376	:	_	
24-186	10377-10379	TR	_	
24-187	10379-10380	/	_	
24-188	10380-10382	TE	_	
24-189	10382-10383	 	_	
24-190	10383-10384	=	_	
24-191	10384-10385	 	_	
24-192	10385-10387	30	_	
24-193	10387-10388	/	_	
24-194	10388-10391	4.6	_	
24-195	10391-10392	 	_	
24-196	10392-10394	ms	_	
24-197	10394-10395	;	_	
24-198	10396-10400	flip	_	
24-199	10401-10406	angle	_	
24-200	10406-10407	 	_	
24-201	10407-10408	=	_	
24-202	10408-10409	 	_	
24-203	10409-10411	30	_	
24-204	10411-10412	°	_	
24-205	10412-10413	;	_	
24-206	10414-10419	field	_	
24-207	10420-10422	of	_	
24-208	10423-10427	view	_	
24-209	10427-10428	 	_	
24-210	10428-10429	=	_	
24-211	10429-10430	 	_	
24-212	10430-10433	256	_	
24-213	10433-10434	 	_	
24-214	10434-10435	×	_	
24-215	10435-10436	 	_	
24-216	10436-10439	256	_	
24-217	10439-10440	 	_	
24-218	10440-10443	mm2	_	
24-219	10443-10444	,	_	
24-220	10445-10450	voxel	_	
24-221	10451-10455	size	_	
24-222	10455-10456	 	_	
24-223	10456-10457	=	_	
24-224	10457-10458	 	_	
24-225	10458-10459	1	_	
24-226	10459-10460	 	_	
24-227	10460-10461	×	_	
24-228	10461-10462	 	_	
24-229	10462-10463	1	_	
24-230	10463-10464	 	_	
24-231	10464-10465	×	_	
24-232	10465-10466	 	_	
24-233	10466-10469	1.2	_	
24-234	10469-10470	 	_	
24-235	10470-10473	mm3	_	
24-236	10473-10474	.	_	

#Text=Data preprocessing
25-1	10475-10479	Data	_	
25-2	10480-10493	preprocessing	_	

#Text=Resting-state fMRI data were preprocessed using the Data Processing and Analysis for Brain Imaging (DPABI) toolbox on MATLAB v. R2016a (Mathworks). For every subject, the first 10 functional volumes were removed to allow for signal stabilization. The rest of the functional images were realigned, co-registered with their individual anatomic image, and corrected for nuisance variables (six rigid realignment parameters, signal drift, averaged signal from white matter and cerebrospinal fluid) using a linear regression model. Band-pass filtering (0.01–0.1 Hz) was applied to fMRI time-series to reduce effects of low-frequency drifts and high-frequency noise. Subsequently, the functional scans were spatially normalized to MNI space using a symmetric group-specific T1 template, and resampled to 3 × 3 × 3 mm3 voxels. Spatial smoothing was applied to normalized images with a 4 mm full-width half-maximum (FWHM) Gaussian kernel. In view of recent findings on the influence of in-scanner head motion on fMRI signals, images with excessive movement (frame-wise displacement >0.5 mm) and 1 backward and 2 forward scans relative to the marked frame, were scrubbed. The scrubbing procedure negated group-differences in head motion (before scrubbing χ(2)2 = 6.20, p = .04 and after scrubbing χ(2)2 = 4.09, p = .13, Supplementary Table 1), and did not lead to differences on the number of images rejected among the three subject groups (χ(2)2 = 3.54, p = .17).
26-1	10494-10507	Resting-state	_	
26-2	10508-10512	fMRI	_	
26-3	10513-10517	data	_	
26-4	10518-10522	were	_	
26-5	10523-10535	preprocessed	_	
26-6	10536-10541	using	_	
26-7	10542-10545	the	_	
26-8	10546-10550	Data	_	
26-9	10551-10561	Processing	_	
26-10	10562-10565	and	_	
26-11	10566-10574	Analysis	_	
26-12	10575-10578	for	_	
26-13	10579-10584	Brain	_	
26-14	10585-10592	Imaging	_	
26-15	10593-10594	(	_	
26-16	10594-10599	DPABI	_	
26-17	10599-10600	)	_	
26-18	10601-10608	toolbox	_	
26-19	10609-10611	on	_	
26-20	10612-10618	MATLAB	_	
26-21	10619-10620	v	_	
26-22	10620-10621	.	_	
26-23	10622-10628	R2016a	_	
26-24	10629-10630	(	_	
26-25	10630-10639	Mathworks	_	
26-26	10639-10640	)	_	
26-27	10640-10641	.	_	
26-28	10642-10645	For	_	
26-29	10646-10651	every	_	
26-30	10652-10659	subject	_	
26-31	10659-10660	,	_	
26-32	10661-10664	the	_	
26-33	10665-10670	first	_	
26-34	10671-10673	10	_	
26-35	10674-10684	functional	_	
26-36	10685-10692	volumes	_	
26-37	10693-10697	were	_	
26-38	10698-10705	removed	_	
26-39	10706-10708	to	_	
26-40	10709-10714	allow	_	
26-41	10715-10718	for	_	
26-42	10719-10725	signal	_	
26-43	10726-10739	stabilization	_	
26-44	10739-10740	.	_	
26-45	10741-10744	The	_	
26-46	10745-10749	rest	_	
26-47	10750-10752	of	_	
26-48	10753-10756	the	_	
26-49	10757-10767	functional	_	
26-50	10768-10774	images	_	
26-51	10775-10779	were	_	
26-52	10780-10789	realigned	_	
26-53	10789-10790	,	_	
26-54	10791-10804	co-registered	_	
26-55	10805-10809	with	_	
26-56	10810-10815	their	_	
26-57	10816-10826	individual	_	
26-58	10827-10835	anatomic	_	
26-59	10836-10841	image	_	
26-60	10841-10842	,	_	
26-61	10843-10846	and	_	
26-62	10847-10856	corrected	_	
26-63	10857-10860	for	_	
26-64	10861-10869	nuisance	_	
26-65	10870-10879	variables	_	
26-66	10880-10881	(	_	
26-67	10881-10884	six	_	
26-68	10885-10890	rigid	_	
26-69	10891-10902	realignment	_	
26-70	10903-10913	parameters	_	
26-71	10913-10914	,	_	
26-72	10915-10921	signal	_	
26-73	10922-10927	drift	_	
26-74	10927-10928	,	_	
26-75	10929-10937	averaged	_	
26-76	10938-10944	signal	_	
26-77	10945-10949	from	_	
26-78	10950-10955	white	_	
26-79	10956-10962	matter	_	
26-80	10963-10966	and	_	
26-81	10967-10980	cerebrospinal	_	
26-82	10981-10986	fluid	_	
26-83	10986-10987	)	_	
26-84	10988-10993	using	_	
26-85	10994-10995	a	_	
26-86	10996-11002	linear	_	
26-87	11003-11013	regression	_	
26-88	11014-11019	model	_	
26-89	11019-11020	.	_	
26-90	11021-11030	Band-pass	_	
26-91	11031-11040	filtering	_	
26-92	11041-11042	(	_	
26-93	11042-11046	0.01	_	
26-94	11046-11047	–	_	
26-95	11047-11050	0.1	_	
26-96	11050-11051	 	_	
26-97	11051-11053	Hz	_	
26-98	11053-11054	)	_	
26-99	11055-11058	was	_	
26-100	11059-11066	applied	_	
26-101	11067-11069	to	_	
26-102	11070-11074	fMRI	_	
26-103	11075-11086	time-series	_	
26-104	11087-11089	to	_	
26-105	11090-11096	reduce	_	
26-106	11097-11104	effects	_	
26-107	11105-11107	of	_	
26-108	11108-11121	low-frequency	_	
26-109	11122-11128	drifts	_	
26-110	11129-11132	and	_	
26-111	11133-11147	high-frequency	_	
26-112	11148-11153	noise	_	
26-113	11153-11154	.	_	
26-114	11155-11167	Subsequently	_	
26-115	11167-11168	,	_	
26-116	11169-11172	the	_	
26-117	11173-11183	functional	_	
26-118	11184-11189	scans	_	
26-119	11190-11194	were	_	
26-120	11195-11204	spatially	_	
26-121	11205-11215	normalized	_	
26-122	11216-11218	to	_	
26-123	11219-11222	MNI	_	
26-124	11223-11228	space	_	
26-125	11229-11234	using	_	
26-126	11235-11236	a	_	
26-127	11237-11246	symmetric	_	
26-128	11247-11261	group-specific	_	
26-129	11262-11264	T1	_	
26-130	11265-11273	template	_	
26-131	11273-11274	,	_	
26-132	11275-11278	and	_	
26-133	11279-11288	resampled	_	
26-134	11289-11291	to	_	
26-135	11292-11293	3	_	
26-136	11293-11294	 	_	
26-137	11294-11295	×	_	
26-138	11295-11296	 	_	
26-139	11296-11297	3	_	
26-140	11297-11298	 	_	
26-141	11298-11299	×	_	
26-142	11299-11300	 	_	
26-143	11300-11301	3	_	
26-144	11301-11302	 	_	
26-145	11302-11305	mm3	_	
26-146	11306-11312	voxels	_	
26-147	11312-11313	.	_	
26-148	11314-11321	Spatial	_	
26-149	11322-11331	smoothing	_	
26-150	11332-11335	was	_	
26-151	11336-11343	applied	_	
26-152	11344-11346	to	_	
26-153	11347-11357	normalized	_	
26-154	11358-11364	images	_	
26-155	11365-11369	with	_	
26-156	11370-11371	a	_	
26-157	11372-11373	4	_	
26-158	11373-11374	 	_	
26-159	11374-11376	mm	_	
26-160	11377-11387	full-width	_	
26-161	11388-11400	half-maximum	_	
26-162	11401-11402	(	_	
26-163	11402-11406	FWHM	_	
26-164	11406-11407	)	_	
26-165	11408-11416	Gaussian	_	
26-166	11417-11423	kernel	_	
26-167	11423-11424	.	_	
26-168	11425-11427	In	_	
26-169	11428-11432	view	_	
26-170	11433-11435	of	_	
26-171	11436-11442	recent	_	
26-172	11443-11451	findings	_	
26-173	11452-11454	on	_	
26-174	11455-11458	the	_	
26-175	11459-11468	influence	_	
26-176	11469-11471	of	_	
26-177	11472-11482	in-scanner	_	
26-178	11483-11487	head	_	
26-179	11488-11494	motion	_	
26-180	11495-11497	on	_	
26-181	11498-11502	fMRI	_	
26-182	11503-11510	signals	_	
26-183	11510-11511	,	_	
26-184	11512-11518	images	_	
26-185	11519-11523	with	_	
26-186	11524-11533	excessive	_	
26-187	11534-11542	movement	_	
26-188	11543-11544	(	_	
26-189	11544-11554	frame-wise	_	
26-190	11555-11567	displacement	_	
26-191	11568-11569	>	_	
26-192	11569-11572	0.5	_	
26-193	11572-11573	 	_	
26-194	11573-11575	mm	_	
26-195	11575-11576	)	_	
26-196	11577-11580	and	_	
26-197	11581-11582	1	_	
26-198	11583-11591	backward	_	
26-199	11592-11595	and	_	
26-200	11596-11597	2	_	
26-201	11598-11605	forward	_	
26-202	11606-11611	scans	_	
26-203	11612-11620	relative	_	
26-204	11621-11623	to	_	
26-205	11624-11627	the	_	
26-206	11628-11634	marked	_	
26-207	11635-11640	frame	_	
26-208	11640-11641	,	_	
26-209	11642-11646	were	_	
26-210	11647-11655	scrubbed	_	
26-211	11655-11656	.	_	
26-212	11657-11660	The	_	
26-213	11661-11670	scrubbing	_	
26-214	11671-11680	procedure	_	
26-215	11681-11688	negated	_	
26-216	11689-11706	group-differences	_	
26-217	11707-11709	in	_	
26-218	11710-11714	head	_	
26-219	11715-11721	motion	_	
26-220	11722-11723	(	_	
26-221	11723-11729	before	_	
26-222	11730-11739	scrubbing	_	
26-223	11740-11741	χ	_	
26-224	11741-11742	(	_	
26-225	11742-11743	2	_	
26-226	11743-11744	)	_	
26-227	11744-11745	2	_	
26-228	11745-11746	 	_	
26-229	11746-11747	=	_	
26-230	11747-11748	 	_	
26-231	11748-11752	6.20	_	
26-232	11752-11753	,	_	
26-233	11754-11755	p	_	
26-234	11755-11756	 	_	
26-235	11756-11757	=	_	
26-236	11757-11758	 	_	
26-237	11758-11761	.04	_	
26-238	11762-11765	and	_	
26-239	11766-11771	after	_	
26-240	11772-11781	scrubbing	_	
26-241	11782-11783	χ	_	
26-242	11783-11784	(	_	
26-243	11784-11785	2	_	
26-244	11785-11786	)	_	
26-245	11786-11787	2	_	
26-246	11787-11788	 	_	
26-247	11788-11789	=	_	
26-248	11789-11790	 	_	
26-249	11790-11794	4.09	_	
26-250	11794-11795	,	_	
26-251	11796-11797	p	_	
26-252	11797-11798	 	_	
26-253	11798-11799	=	_	
26-254	11799-11800	 	_	
26-255	11800-11803	.13	_	
26-256	11803-11804	,	_	
26-257	11805-11818	Supplementary	_	
26-258	11819-11824	Table	_	
26-259	11825-11826	1	_	
26-260	11826-11827	)	_	
26-261	11827-11828	,	_	
26-262	11829-11832	and	_	
26-263	11833-11836	did	_	
26-264	11837-11840	not	_	
26-265	11841-11845	lead	_	
26-266	11846-11848	to	_	
26-267	11849-11860	differences	_	
26-268	11861-11863	on	_	
26-269	11864-11867	the	_	
26-270	11868-11874	number	_	
26-271	11875-11877	of	_	
26-272	11878-11884	images	_	
26-273	11885-11893	rejected	_	
26-274	11894-11899	among	_	
26-275	11900-11903	the	_	
26-276	11904-11909	three	_	
26-277	11910-11917	subject	_	
26-278	11918-11924	groups	_	
26-279	11925-11926	(	_	
26-280	11926-11927	χ	_	
26-281	11927-11928	(	_	
26-282	11928-11929	2	_	
26-283	11929-11930	)	_	
26-284	11930-11931	2	_	
26-285	11931-11932	 	_	
26-286	11932-11933	=	_	
26-287	11933-11934	 	_	
26-288	11934-11938	3.54	_	
26-289	11938-11939	,	_	
26-290	11940-11941	p	_	
26-291	11941-11942	 	_	
26-292	11942-11943	=	_	
26-293	11943-11944	 	_	
26-294	11944-11947	.17	_	
26-295	11947-11948	)	_	
26-296	11948-11949	.	_	

#Text=The Harvard-Oxford atlas was applied to whole-brain functional data in order to parcellate the brain into 112 bilateral regions (48 cortical and 8 subcortical regions per hemisphere). Region names, abbreviations, anatomic classification (frontal, temporal, parietal, occipital lobe, cingulate cortex and subcortical regions) and functional hierarchy (primary sensorimotor regions, unimodal, heteromodal association areas, (para)limbic and subcortical regions) are referenced in Supplementary Table 2. The functional hierarchy subdivision scheme is based on previous studies. Regional time-series were averaged across voxels, and cross-correlated for each pair of brain regions using Pearson's correlation. Correlation coefficients were converted to z scores using Fisher's z transformation, serving as a measure of functional connectivity strength between two regions.
27-1	11950-11953	The	_	
27-2	11954-11968	Harvard-Oxford	_	
27-3	11969-11974	atlas	_	
27-4	11975-11978	was	_	
27-5	11979-11986	applied	_	
27-6	11987-11989	to	_	
27-7	11990-12001	whole-brain	_	
27-8	12002-12012	functional	_	
27-9	12013-12017	data	_	
27-10	12018-12020	in	_	
27-11	12021-12026	order	_	
27-12	12027-12029	to	_	
27-13	12030-12040	parcellate	_	
27-14	12041-12044	the	_	
27-15	12045-12050	brain	_	
27-16	12051-12055	into	_	
27-17	12056-12059	112	_	
27-18	12060-12069	bilateral	_	
27-19	12070-12077	regions	_	
27-20	12078-12079	(	_	
27-21	12079-12081	48	_	
27-22	12082-12090	cortical	_	
27-23	12091-12094	and	_	
27-24	12095-12096	8	_	
27-25	12097-12108	subcortical	_	
27-26	12109-12116	regions	_	
27-27	12117-12120	per	_	
27-28	12121-12131	hemisphere	_	
27-29	12131-12132	)	_	
27-30	12132-12133	.	_	
27-31	12134-12140	Region	_	
27-32	12141-12146	names	_	
27-33	12146-12147	,	_	
27-34	12148-12161	abbreviations	_	
27-35	12161-12162	,	_	
27-36	12163-12171	anatomic	_	
27-37	12172-12186	classification	_	
27-38	12187-12188	(	_	
27-39	12188-12195	frontal	_	
27-40	12195-12196	,	_	
27-41	12197-12205	temporal	_	
27-42	12205-12206	,	_	
27-43	12207-12215	parietal	_	
27-44	12215-12216	,	_	
27-45	12217-12226	occipital	_	
27-46	12227-12231	lobe	_	
27-47	12231-12232	,	_	
27-48	12233-12242	cingulate	_	
27-49	12243-12249	cortex	_	
27-50	12250-12253	and	_	
27-51	12254-12265	subcortical	_	
27-52	12266-12273	regions	_	
27-53	12273-12274	)	_	
27-54	12275-12278	and	_	
27-55	12279-12289	functional	_	
27-56	12290-12299	hierarchy	_	
27-57	12300-12301	(	_	
27-58	12301-12308	primary	_	
27-59	12309-12321	sensorimotor	_	
27-60	12322-12329	regions	_	
27-61	12329-12330	,	_	
27-62	12331-12339	unimodal	_	
27-63	12339-12340	,	_	
27-64	12341-12352	heteromodal	_	
27-65	12353-12364	association	_	
27-66	12365-12370	areas	_	
27-67	12370-12371	,	_	
27-68	12372-12373	(	_	
27-69	12373-12377	para	_	
27-70	12377-12378	)	_	
27-71	12378-12384	limbic	_	
27-72	12385-12388	and	_	
27-73	12389-12400	subcortical	_	
27-74	12401-12408	regions	_	
27-75	12408-12409	)	_	
27-76	12410-12413	are	_	
27-77	12414-12424	referenced	_	
27-78	12425-12427	in	_	
27-79	12428-12441	Supplementary	_	
27-80	12442-12447	Table	_	
27-81	12448-12449	2	_	
27-82	12449-12450	.	_	
27-83	12451-12454	The	_	
27-84	12455-12465	functional	_	
27-85	12466-12475	hierarchy	_	
27-86	12476-12487	subdivision	_	
27-87	12488-12494	scheme	_	
27-88	12495-12497	is	_	
27-89	12498-12503	based	_	
27-90	12504-12506	on	_	
27-91	12507-12515	previous	_	
27-92	12516-12523	studies	_	
27-93	12523-12524	.	_	
27-94	12525-12533	Regional	_	
27-95	12534-12545	time-series	_	
27-96	12546-12550	were	_	
27-97	12551-12559	averaged	_	
27-98	12560-12566	across	_	
27-99	12567-12573	voxels	_	
27-100	12573-12574	,	_	
27-101	12575-12578	and	_	
27-102	12579-12595	cross-correlated	_	
27-103	12596-12599	for	_	
27-104	12600-12604	each	_	
27-105	12605-12609	pair	_	
27-106	12610-12612	of	_	
27-107	12613-12618	brain	_	
27-108	12619-12626	regions	_	
27-109	12627-12632	using	_	
27-110	12633-12642	Pearson's	_	
27-111	12643-12654	correlation	_	
27-112	12654-12655	.	_	
27-113	12656-12667	Correlation	_	
27-114	12668-12680	coefficients	_	
27-115	12681-12685	were	_	
27-116	12686-12695	converted	_	
27-117	12696-12698	to	_	
27-118	12699-12700	z	_	
27-119	12701-12707	scores	_	
27-120	12708-12713	using	_	
27-121	12714-12722	Fisher's	_	
27-122	12723-12724	z	_	
27-123	12725-12739	transformation	_	
27-124	12739-12740	,	_	
27-125	12741-12748	serving	_	
27-126	12749-12751	as	_	
27-127	12752-12753	a	_	
27-128	12754-12761	measure	_	
27-129	12762-12764	of	_	
27-130	12765-12775	functional	_	
27-131	12776-12788	connectivity	_	
27-132	12789-12797	strength	_	
27-133	12798-12805	between	_	
27-134	12806-12809	two	_	
27-135	12810-12817	regions	_	
27-136	12817-12818	.	_	

#Text=Interhemispheric connectivity
28-1	12819-12835	Interhemispheric	_	
28-2	12836-12848	connectivity	_	

#Text=The level of functional connectivity between 56 regions in one hemisphere and their corresponding areas in the other hemisphere is used here as the measure of interhemispheric connectivity. Interhemispheric connections between homotopic regions are among the strongest functional associations in cortical-cortical interactions and have reliably been identified in both healthy and clinical populations. As a supplementary analysis, group-differences in heterotopic interhemispheric connectivity and left and right intrahemispheric connectivity were examined in the same manner as homotopic interhemispheric connectivity. Moreover, to assess the consistency of interhemispheric connectivity measurements between studies, we performed an additional analysis examining the correlation in regional interhemispheric connectivity in controls between this study and the study of.
29-1	12849-12852	The	_	
29-2	12853-12858	level	_	
29-3	12859-12861	of	_	
29-4	12862-12872	functional	_	
29-5	12873-12885	connectivity	_	
29-6	12886-12893	between	_	
29-7	12894-12896	56	_	
29-8	12897-12904	regions	_	
29-9	12905-12907	in	_	
29-10	12908-12911	one	_	
29-11	12912-12922	hemisphere	_	
29-12	12923-12926	and	_	
29-13	12927-12932	their	_	
29-14	12933-12946	corresponding	_	
29-15	12947-12952	areas	_	
29-16	12953-12955	in	_	
29-17	12956-12959	the	_	
29-18	12960-12965	other	_	
29-19	12966-12976	hemisphere	_	
29-20	12977-12979	is	_	
29-21	12980-12984	used	_	
29-22	12985-12989	here	_	
29-23	12990-12992	as	_	
29-24	12993-12996	the	_	
29-25	12997-13004	measure	_	
29-26	13005-13007	of	_	
29-27	13008-13024	interhemispheric	_	
29-28	13025-13037	connectivity	_	
29-29	13037-13038	.	_	
29-30	13039-13055	Interhemispheric	_	
29-31	13056-13067	connections	_	
29-32	13068-13075	between	_	
29-33	13076-13085	homotopic	_	
29-34	13086-13093	regions	_	
29-35	13094-13097	are	_	
29-36	13098-13103	among	_	
29-37	13104-13107	the	_	
29-38	13108-13117	strongest	_	
29-39	13118-13128	functional	_	
29-40	13129-13141	associations	_	
29-41	13142-13144	in	_	
29-42	13145-13162	cortical-cortical	_	
29-43	13163-13175	interactions	_	
29-44	13176-13179	and	_	
29-45	13180-13184	have	_	
29-46	13185-13193	reliably	_	
29-47	13194-13198	been	_	
29-48	13199-13209	identified	_	
29-49	13210-13212	in	_	
29-50	13213-13217	both	_	
29-51	13218-13225	healthy	_	
29-52	13226-13229	and	_	
29-53	13230-13238	clinical	_	
29-54	13239-13250	populations	_	
29-55	13250-13251	.	_	
29-56	13252-13254	As	_	
29-57	13255-13256	a	_	
29-58	13257-13270	supplementary	_	
29-59	13271-13279	analysis	_	
29-60	13279-13280	,	_	
29-61	13281-13298	group-differences	_	
29-62	13299-13301	in	_	
29-63	13302-13313	heterotopic	_	
29-64	13314-13330	interhemispheric	_	
29-65	13331-13343	connectivity	_	
29-66	13344-13347	and	_	
29-67	13348-13352	left	_	
29-68	13353-13356	and	_	
29-69	13357-13362	right	_	
29-70	13363-13379	intrahemispheric	_	
29-71	13380-13392	connectivity	_	
29-72	13393-13397	were	_	
29-73	13398-13406	examined	_	
29-74	13407-13409	in	_	
29-75	13410-13413	the	_	
29-76	13414-13418	same	_	
29-77	13419-13425	manner	_	
29-78	13426-13428	as	_	
29-79	13429-13438	homotopic	_	
29-80	13439-13455	interhemispheric	_	
29-81	13456-13468	connectivity	_	
29-82	13468-13469	.	_	
29-83	13470-13478	Moreover	_	
29-84	13478-13479	,	_	
29-85	13480-13482	to	_	
29-86	13483-13489	assess	_	
29-87	13490-13493	the	_	
29-88	13494-13505	consistency	_	
29-89	13506-13508	of	_	
29-90	13509-13525	interhemispheric	_	
29-91	13526-13538	connectivity	_	
29-92	13539-13551	measurements	_	
29-93	13552-13559	between	_	
29-94	13560-13567	studies	_	
29-95	13567-13568	,	_	
29-96	13569-13571	we	_	
29-97	13572-13581	performed	_	
29-98	13582-13584	an	_	
29-99	13585-13595	additional	_	
29-100	13596-13604	analysis	_	
29-101	13605-13614	examining	_	
29-102	13615-13618	the	_	
29-103	13619-13630	correlation	_	
29-104	13631-13633	in	_	
29-105	13634-13642	regional	_	
29-106	13643-13659	interhemispheric	_	
29-107	13660-13672	connectivity	_	
29-108	13673-13675	in	_	
29-109	13676-13684	controls	_	
29-110	13685-13692	between	_	
29-111	13693-13697	this	_	
29-112	13698-13703	study	_	
29-113	13704-13707	and	_	
29-114	13708-13711	the	_	
29-115	13712-13717	study	_	
29-116	13718-13720	of	_	
29-117	13720-13721	.	_	

#Text=Hemispheric specialization
30-1	13722-13733	Hemispheric	_	
30-2	13734-13748	specialization	_	

#Text=Hemispheric specialization is calculated here as the difference in connectivity strength between intrahemispheric and heterotopic interhemispheric connections of each brain region. Homotopic interhemispheric connections were not used in the calculation of hemispheric specialization so that we could examine relationship between hemispheric specialization and interhemispheric connectivity in the following analysis. A positive value of hemispheric specialization indicates that a region or hemisphere is preferentially connected to other regions within its own hemisphere, whereas a negative value suggests that a region or hemisphere is more strongly connected to regions in the contralateral hemisphere. The method used to compute hemispheric specialization using intrinsic functional connectivity has been described in previous studies using a voxel-based analysis.
31-1	13749-13760	Hemispheric	_	
31-2	13761-13775	specialization	_	
31-3	13776-13778	is	_	
31-4	13779-13789	calculated	_	
31-5	13790-13794	here	_	
31-6	13795-13797	as	_	
31-7	13798-13801	the	_	
31-8	13802-13812	difference	_	
31-9	13813-13815	in	_	
31-10	13816-13828	connectivity	_	
31-11	13829-13837	strength	_	
31-12	13838-13845	between	_	
31-13	13846-13862	intrahemispheric	_	
31-14	13863-13866	and	_	
31-15	13867-13878	heterotopic	_	
31-16	13879-13895	interhemispheric	_	
31-17	13896-13907	connections	_	
31-18	13908-13910	of	_	
31-19	13911-13915	each	_	
31-20	13916-13921	brain	_	
31-21	13922-13928	region	_	
31-22	13928-13929	.	_	
31-23	13930-13939	Homotopic	_	
31-24	13940-13956	interhemispheric	_	
31-25	13957-13968	connections	_	
31-26	13969-13973	were	_	
31-27	13974-13977	not	_	
31-28	13978-13982	used	_	
31-29	13983-13985	in	_	
31-30	13986-13989	the	_	
31-31	13990-14001	calculation	_	
31-32	14002-14004	of	_	
31-33	14005-14016	hemispheric	_	
31-34	14017-14031	specialization	_	
31-35	14032-14034	so	_	
31-36	14035-14039	that	_	
31-37	14040-14042	we	_	
31-38	14043-14048	could	_	
31-39	14049-14056	examine	_	
31-40	14057-14069	relationship	_	
31-41	14070-14077	between	_	
31-42	14078-14089	hemispheric	_	
31-43	14090-14104	specialization	_	
31-44	14105-14108	and	_	
31-45	14109-14125	interhemispheric	_	
31-46	14126-14138	connectivity	_	
31-47	14139-14141	in	_	
31-48	14142-14145	the	_	
31-49	14146-14155	following	_	
31-50	14156-14164	analysis	_	
31-51	14164-14165	.	_	
31-52	14166-14167	A	_	
31-53	14168-14176	positive	_	
31-54	14177-14182	value	_	
31-55	14183-14185	of	_	
31-56	14186-14197	hemispheric	_	
31-57	14198-14212	specialization	_	
31-58	14213-14222	indicates	_	
31-59	14223-14227	that	_	
31-60	14228-14229	a	_	
31-61	14230-14236	region	_	
31-62	14237-14239	or	_	
31-63	14240-14250	hemisphere	_	
31-64	14251-14253	is	_	
31-65	14254-14268	preferentially	_	
31-66	14269-14278	connected	_	
31-67	14279-14281	to	_	
31-68	14282-14287	other	_	
31-69	14288-14295	regions	_	
31-70	14296-14302	within	_	
31-71	14303-14306	its	_	
31-72	14307-14310	own	_	
31-73	14311-14321	hemisphere	_	
31-74	14321-14322	,	_	
31-75	14323-14330	whereas	_	
31-76	14331-14332	a	_	
31-77	14333-14341	negative	_	
31-78	14342-14347	value	_	
31-79	14348-14356	suggests	_	
31-80	14357-14361	that	_	
31-81	14362-14363	a	_	
31-82	14364-14370	region	_	
31-83	14371-14373	or	_	
31-84	14374-14384	hemisphere	_	
31-85	14385-14387	is	_	
31-86	14388-14392	more	_	
31-87	14393-14401	strongly	_	
31-88	14402-14411	connected	_	
31-89	14412-14414	to	_	
31-90	14415-14422	regions	_	
31-91	14423-14425	in	_	
31-92	14426-14429	the	_	
31-93	14430-14443	contralateral	_	
31-94	14444-14454	hemisphere	_	
31-95	14454-14455	.	_	
31-96	14456-14459	The	_	
31-97	14460-14466	method	_	
31-98	14467-14471	used	_	
31-99	14472-14474	to	_	
31-100	14475-14482	compute	_	
31-101	14483-14494	hemispheric	_	
31-102	14495-14509	specialization	_	
31-103	14510-14515	using	_	
31-104	14516-14525	intrinsic	_	
31-105	14526-14536	functional	_	
31-106	14537-14549	connectivity	_	
31-107	14550-14553	has	_	
31-108	14554-14558	been	_	
31-109	14559-14568	described	_	
31-110	14569-14571	in	_	
31-111	14572-14580	previous	_	
31-112	14581-14588	studies	_	
31-113	14589-14594	using	_	
31-114	14595-14596	a	_	
31-115	14597-14608	voxel-based	_	
31-116	14609-14617	analysis	_	
31-117	14617-14618	.	_	

#Text=Statistical analysis
32-1	14619-14630	Statistical	_	
32-2	14631-14639	analysis	_	

#Text=Effects of group and covariates on interhemispheric connectivity and hemispheric specialization were assessed using linear-mixed effect models. For interhemispheric connectivity, fixed-effects include: group status (controls, siblings, patients), age, sex, handedness (right / left / mixed), scanner (#1 / #2) and head motion. To control for potential group-differences in global connectivity, mean connectivity strength of all non-homotopic connections (i.e., all intrahemispheric and heterotopic interhemispheric connections) was included as a fixed-effect term (global FC). Family ID, encoding the subjects' pedigree information, was included as random-effect term to control for family ties between subjects (Eq. (1)). The model has 237 observations (number of subjects with complete information), and 10 fixed term predictors (constant, group_sibling, group_patient, age, gender_female, handedness_left, handedness_mixed, scanner_#2, motion, global FC), leaving = 237–10 = 227 residual degrees of freedom.
33-1	14640-14647	Effects	_	
33-2	14648-14650	of	_	
33-3	14651-14656	group	_	
33-4	14657-14660	and	_	
33-5	14661-14671	covariates	_	
33-6	14672-14674	on	_	
33-7	14675-14691	interhemispheric	_	
33-8	14692-14704	connectivity	_	
33-9	14705-14708	and	_	
33-10	14709-14720	hemispheric	_	
33-11	14721-14735	specialization	_	
33-12	14736-14740	were	_	
33-13	14741-14749	assessed	_	
33-14	14750-14755	using	_	
33-15	14756-14768	linear-mixed	_	
33-16	14769-14775	effect	_	
33-17	14776-14782	models	_	
33-18	14782-14783	.	_	
33-19	14784-14787	For	_	
33-20	14788-14804	interhemispheric	_	
33-21	14805-14817	connectivity	_	
33-22	14817-14818	,	_	
33-23	14819-14832	fixed-effects	_	
33-24	14833-14840	include	_	
33-25	14840-14841	:	_	
33-26	14842-14847	group	_	
33-27	14848-14854	status	_	
33-28	14855-14856	(	_	
33-29	14856-14864	controls	_	
33-30	14864-14865	,	_	
33-31	14866-14874	siblings	_	
33-32	14874-14875	,	_	
33-33	14876-14884	patients	_	
33-34	14884-14885	)	_	
33-35	14885-14886	,	_	
33-36	14887-14890	age	_	
33-37	14890-14891	,	_	
33-38	14892-14895	sex	_	
33-39	14895-14896	,	_	
33-40	14897-14907	handedness	_	
33-41	14908-14909	(	_	
33-42	14909-14914	right	_	
33-43	14915-14916	/	_	
33-44	14917-14921	left	_	
33-45	14922-14923	/	_	
33-46	14924-14929	mixed	_	
33-47	14929-14930	)	_	
33-48	14930-14931	,	_	
33-49	14932-14939	scanner	_	
33-50	14940-14941	(	_	
33-51	14941-14943	#1	_	
33-52	14944-14945	/	_	
33-53	14946-14948	#2	_	
33-54	14948-14949	)	_	
33-55	14950-14953	and	_	
33-56	14954-14958	head	_	
33-57	14959-14965	motion	_	
33-58	14965-14966	.	_	
33-59	14967-14969	To	_	
33-60	14970-14977	control	_	
33-61	14978-14981	for	_	
33-62	14982-14991	potential	_	
33-63	14992-15009	group-differences	_	
33-64	15010-15012	in	_	
33-65	15013-15019	global	_	
33-66	15020-15032	connectivity	_	
33-67	15032-15033	,	_	
33-68	15034-15038	mean	_	
33-69	15039-15051	connectivity	_	
33-70	15052-15060	strength	_	
33-71	15061-15063	of	_	
33-72	15064-15067	all	_	
33-73	15068-15081	non-homotopic	_	
33-74	15082-15093	connections	_	
33-75	15094-15095	(	_	
33-76	15095-15098	i.e	_	
33-77	15098-15099	.	_	
33-78	15099-15100	,	_	
33-79	15101-15104	all	_	
33-80	15105-15121	intrahemispheric	_	
33-81	15122-15125	and	_	
33-82	15126-15137	heterotopic	_	
33-83	15138-15154	interhemispheric	_	
33-84	15155-15166	connections	_	
33-85	15166-15167	)	_	
33-86	15168-15171	was	_	
33-87	15172-15180	included	_	
33-88	15181-15183	as	_	
33-89	15184-15185	a	_	
33-90	15186-15198	fixed-effect	_	
33-91	15199-15203	term	_	
33-92	15204-15205	(	_	
33-93	15205-15211	global	_	
33-94	15212-15214	FC	_	
33-95	15214-15215	)	_	
33-96	15215-15216	.	_	
33-97	15217-15223	Family	_	
33-98	15224-15226	ID	_	
33-99	15226-15227	,	_	
33-100	15228-15236	encoding	_	
33-101	15237-15240	the	_	
33-102	15241-15249	subjects	_	
33-103	15249-15250	'	_	
33-104	15251-15259	pedigree	_	
33-105	15260-15271	information	_	
33-106	15271-15272	,	_	
33-107	15273-15276	was	_	
33-108	15277-15285	included	_	
33-109	15286-15288	as	_	
33-110	15289-15302	random-effect	_	
33-111	15303-15307	term	_	
33-112	15308-15310	to	_	
33-113	15311-15318	control	_	
33-114	15319-15322	for	_	
33-115	15323-15329	family	_	
33-116	15330-15334	ties	_	
33-117	15335-15342	between	_	
33-118	15343-15351	subjects	_	
33-119	15352-15353	(	_	
33-120	15353-15355	Eq	_	
33-121	15355-15356	.	_	
33-122	15357-15358	(	_	
33-123	15358-15359	1	_	
33-124	15359-15360	)	_	
33-125	15360-15361	)	_	
33-126	15361-15362	.	_	
33-127	15363-15366	The	_	
33-128	15367-15372	model	_	
33-129	15373-15376	has	_	
33-130	15377-15380	237	_	
33-131	15381-15393	observations	_	
33-132	15394-15395	(	_	
33-133	15395-15401	number	_	
33-134	15402-15404	of	_	
33-135	15405-15413	subjects	_	
33-136	15414-15418	with	_	
33-137	15419-15427	complete	_	
33-138	15428-15439	information	_	
33-139	15439-15440	)	_	
33-140	15440-15441	,	_	
33-141	15442-15445	and	_	
33-142	15446-15448	10	_	
33-143	15449-15454	fixed	_	
33-144	15455-15459	term	_	
33-145	15460-15470	predictors	_	
33-146	15471-15472	(	_	
33-147	15472-15480	constant	_	
33-148	15480-15481	,	_	
33-149	15482-15495	group_sibling	_	
33-150	15495-15496	,	_	
33-151	15497-15510	group_patient	_	
33-152	15510-15511	,	_	
33-153	15512-15515	age	_	
33-154	15515-15516	,	_	
33-155	15517-15530	gender_female	_	
33-156	15530-15531	,	_	
33-157	15532-15547	handedness_left	_	
33-158	15547-15548	,	_	
33-159	15549-15565	handedness_mixed	_	
33-160	15565-15566	,	_	
33-161	15567-15574	scanner	_	
33-162	15574-15575	_	_	
33-163	15575-15577	#2	_	
33-164	15577-15578	,	_	
33-165	15579-15585	motion	_	
33-166	15585-15586	,	_	
33-167	15587-15593	global	_	
33-168	15594-15596	FC	_	
33-169	15596-15597	)	_	
33-170	15597-15598	,	_	
33-171	15599-15606	leaving	_	
33-172	15606-15607	 	_	
33-173	15607-15608	=	_	
33-174	15608-15609	 	_	
33-175	15609-15612	237	_	
33-176	15612-15613	–	_	
33-177	15613-15615	10	_	
33-178	15615-15616	 	_	
33-179	15616-15617	=	_	
33-180	15617-15618	 	_	
33-181	15618-15621	227	_	
33-182	15622-15630	residual	_	
33-183	15631-15638	degrees	_	
33-184	15639-15641	of	_	
33-185	15642-15649	freedom	_	
33-186	15649-15650	.	_	

#Text=Equation 1:
34-1	15651-15659	Equation	_	
34-2	15660-15661	1	_	
34-3	15661-15662	:	_	

#Text=For hemispheric specialization, group status, age, sex, handedness, scanner and head motion were again included as fixed-effect terms. Additionally, we included hemisphere as a fixed factor to examine potential differences in connectivity patterns between the two hemispheres. Random effect terms include family ID and subject ID nested within family ID. The number of fixed term predictors is 10 (constant, group_sibling, group_patient, age, gender_female, handedness_left, handedness_mixed, scanner_#2, motion, hemisphere_RH), and residual degrees of freedom is 237 × 2 (hemisphere) – 10 = 464.
35-1	15663-15666	For	_	
35-2	15667-15678	hemispheric	_	
35-3	15679-15693	specialization	_	
35-4	15693-15694	,	_	
35-5	15695-15700	group	_	
35-6	15701-15707	status	_	
35-7	15707-15708	,	_	
35-8	15709-15712	age	_	
35-9	15712-15713	,	_	
35-10	15714-15717	sex	_	
35-11	15717-15718	,	_	
35-12	15719-15729	handedness	_	
35-13	15729-15730	,	_	
35-14	15731-15738	scanner	_	
35-15	15739-15742	and	_	
35-16	15743-15747	head	_	
35-17	15748-15754	motion	_	
35-18	15755-15759	were	_	
35-19	15760-15765	again	_	
35-20	15766-15774	included	_	
35-21	15775-15777	as	_	
35-22	15778-15790	fixed-effect	_	
35-23	15791-15796	terms	_	
35-24	15796-15797	.	_	
35-25	15798-15810	Additionally	_	
35-26	15810-15811	,	_	
35-27	15812-15814	we	_	
35-28	15815-15823	included	_	
35-29	15824-15834	hemisphere	_	
35-30	15835-15837	as	_	
35-31	15838-15839	a	_	
35-32	15840-15845	fixed	_	
35-33	15846-15852	factor	_	
35-34	15853-15855	to	_	
35-35	15856-15863	examine	_	
35-36	15864-15873	potential	_	
35-37	15874-15885	differences	_	
35-38	15886-15888	in	_	
35-39	15889-15901	connectivity	_	
35-40	15902-15910	patterns	_	
35-41	15911-15918	between	_	
35-42	15919-15922	the	_	
35-43	15923-15926	two	_	
35-44	15927-15938	hemispheres	_	
35-45	15938-15939	.	_	
35-46	15940-15946	Random	_	
35-47	15947-15953	effect	_	
35-48	15954-15959	terms	_	
35-49	15960-15967	include	_	
35-50	15968-15974	family	_	
35-51	15975-15977	ID	_	
35-52	15978-15981	and	_	
35-53	15982-15989	subject	_	
35-54	15990-15992	ID	_	
35-55	15993-15999	nested	_	
35-56	16000-16006	within	_	
35-57	16007-16013	family	_	
35-58	16014-16016	ID	_	
35-59	16016-16017	.	_	
35-60	16018-16021	The	_	
35-61	16022-16028	number	_	
35-62	16029-16031	of	_	
35-63	16032-16037	fixed	_	
35-64	16038-16042	term	_	
35-65	16043-16053	predictors	_	
35-66	16054-16056	is	_	
35-67	16057-16059	10	_	
35-68	16060-16061	(	_	
35-69	16061-16069	constant	_	
35-70	16069-16070	,	_	
35-71	16071-16084	group_sibling	_	
35-72	16084-16085	,	_	
35-73	16086-16099	group_patient	_	
35-74	16099-16100	,	_	
35-75	16101-16104	age	_	
35-76	16104-16105	,	_	
35-77	16106-16119	gender_female	_	
35-78	16119-16120	,	_	
35-79	16121-16136	handedness_left	_	
35-80	16136-16137	,	_	
35-81	16138-16154	handedness_mixed	_	
35-82	16154-16155	,	_	
35-83	16156-16163	scanner	_	
35-84	16163-16164	_	_	
35-85	16164-16166	#2	_	
35-86	16166-16167	,	_	
35-87	16168-16174	motion	_	
35-88	16174-16175	,	_	
35-89	16176-16189	hemisphere_RH	_	
35-90	16189-16190	)	_	
35-91	16190-16191	,	_	
35-92	16192-16195	and	_	
35-93	16196-16204	residual	_	
35-94	16205-16212	degrees	_	
35-95	16213-16215	of	_	
35-96	16216-16223	freedom	_	
35-97	16224-16226	is	_	
35-98	16227-16230	237	_	
35-99	16230-16231	 	_	
35-100	16231-16232	×	_	
35-101	16232-16233	 	_	
35-102	16233-16234	2	_	
35-103	16235-16236	(	_	
35-104	16236-16246	hemisphere	_	
35-105	16246-16247	)	_	
35-106	16248-16249	–	_	
35-107	16250-16252	10	_	
35-108	16252-16253	 	_	
35-109	16253-16254	=	_	
35-110	16254-16255	 	_	
35-111	16255-16258	464	_	
35-112	16258-16259	.	_	

#Text=Equation 2:
36-1	16260-16268	Equation	_	
36-2	16269-16270	2	_	
36-3	16270-16271	:	_	

#Text=Linear-mixed effects analysis was first applied to overall interhemispheric connectivity and hemispheric specialization (p < .05), and then to each of 56 regional measurements, controlling for multiple comparisons (p < .05, Bonferroni corrected). Overall and regional measurements with significant group effects were subjected to post-hoc bivariate comparisons between each pair of subject groups (p < .05).
37-1	16272-16284	Linear-mixed	_	
37-2	16285-16292	effects	_	
37-3	16293-16301	analysis	_	
37-4	16302-16305	was	_	
37-5	16306-16311	first	_	
37-6	16312-16319	applied	_	
37-7	16320-16322	to	_	
37-8	16323-16330	overall	_	
37-9	16331-16347	interhemispheric	_	
37-10	16348-16360	connectivity	_	
37-11	16361-16364	and	_	
37-12	16365-16376	hemispheric	_	
37-13	16377-16391	specialization	_	
37-14	16392-16393	(	_	
37-15	16393-16394	p	_	
37-16	16394-16395	 	_	
37-17	16395-16396	<	_	
37-18	16396-16397	 	_	
37-19	16397-16400	.05	_	
37-20	16400-16401	)	_	
37-21	16401-16402	,	_	
37-22	16403-16406	and	_	
37-23	16407-16411	then	_	
37-24	16412-16414	to	_	
37-25	16415-16419	each	_	
37-26	16420-16422	of	_	
37-27	16423-16425	56	_	
37-28	16426-16434	regional	_	
37-29	16435-16447	measurements	_	
37-30	16447-16448	,	_	
37-31	16449-16460	controlling	_	
37-32	16461-16464	for	_	
37-33	16465-16473	multiple	_	
37-34	16474-16485	comparisons	_	
37-35	16486-16487	(	_	
37-36	16487-16488	p	_	
37-37	16488-16489	 	_	
37-38	16489-16490	<	_	
37-39	16490-16491	 	_	
37-40	16491-16494	.05	_	
37-41	16494-16495	,	_	
37-42	16496-16506	Bonferroni	_	
37-43	16507-16516	corrected	_	
37-44	16516-16517	)	_	
37-45	16517-16518	.	_	
37-46	16519-16526	Overall	_	
37-47	16527-16530	and	_	
37-48	16531-16539	regional	_	
37-49	16540-16552	measurements	_	
37-50	16553-16557	with	_	
37-51	16558-16569	significant	_	
37-52	16570-16575	group	_	
37-53	16576-16583	effects	_	
37-54	16584-16588	were	_	
37-55	16589-16598	subjected	_	
37-56	16599-16601	to	_	
37-57	16602-16610	post-hoc	_	
37-58	16611-16620	bivariate	_	
37-59	16621-16632	comparisons	_	
37-60	16633-16640	between	_	
37-61	16641-16645	each	_	
37-62	16646-16650	pair	_	
37-63	16651-16653	of	_	
37-64	16654-16661	subject	_	
37-65	16662-16668	groups	_	
37-66	16669-16670	(	_	
37-67	16670-16671	p	_	
37-68	16671-16672	 	_	
37-69	16672-16673	<	_	
37-70	16673-16674	 	_	
37-71	16674-16677	.05	_	
37-72	16677-16678	)	_	
37-73	16678-16679	.	_	

#Text=Relationship between interhemispheric connectivity and hemispheric specialization
38-1	16680-16692	Relationship	_	
38-2	16693-16700	between	_	
38-3	16701-16717	interhemispheric	_	
38-4	16718-16730	connectivity	_	
38-5	16731-16734	and	_	
38-6	16735-16746	hemispheric	_	
38-7	16747-16761	specialization	_	

#Text=To test whether schizophrenia-related changes in interhemispheric connectivity co-vary with alterations in hemispheric specialization, we calculated the mean difference between controls and patients on both measurements for each brain region. Pearson's correlation analysis was performed on group-differences of interhemispheric connectivity and hemispheric specialization across regions (p < .05). The same analysis was performed for siblings as compared to patients, and for controls compared to siblings.
39-1	16762-16764	To	_	
39-2	16765-16769	test	_	
39-3	16770-16777	whether	_	
39-4	16778-16799	schizophrenia-related	_	
39-5	16800-16807	changes	_	
39-6	16808-16810	in	_	
39-7	16811-16827	interhemispheric	_	
39-8	16828-16840	connectivity	_	
39-9	16841-16848	co-vary	_	
39-10	16849-16853	with	_	
39-11	16854-16865	alterations	_	
39-12	16866-16868	in	_	
39-13	16869-16880	hemispheric	_	
39-14	16881-16895	specialization	_	
39-15	16895-16896	,	_	
39-16	16897-16899	we	_	
39-17	16900-16910	calculated	_	
39-18	16911-16914	the	_	
39-19	16915-16919	mean	_	
39-20	16920-16930	difference	_	
39-21	16931-16938	between	_	
39-22	16939-16947	controls	_	
39-23	16948-16951	and	_	
39-24	16952-16960	patients	_	
39-25	16961-16963	on	_	
39-26	16964-16968	both	_	
39-27	16969-16981	measurements	_	
39-28	16982-16985	for	_	
39-29	16986-16990	each	_	
39-30	16991-16996	brain	_	
39-31	16997-17003	region	_	
39-32	17003-17004	.	_	
39-33	17005-17014	Pearson's	_	
39-34	17015-17026	correlation	_	
39-35	17027-17035	analysis	_	
39-36	17036-17039	was	_	
39-37	17040-17049	performed	_	
39-38	17050-17052	on	_	
39-39	17053-17070	group-differences	_	
39-40	17071-17073	of	_	
39-41	17074-17090	interhemispheric	_	
39-42	17091-17103	connectivity	_	
39-43	17104-17107	and	_	
39-44	17108-17119	hemispheric	_	
39-45	17120-17134	specialization	_	
39-46	17135-17141	across	_	
39-47	17142-17149	regions	_	
39-48	17150-17151	(	_	
39-49	17151-17152	p	_	
39-50	17152-17153	 	_	
39-51	17153-17154	<	_	
39-52	17154-17155	 	_	
39-53	17155-17158	.05	_	
39-54	17158-17159	)	_	
39-55	17159-17160	.	_	
39-56	17161-17164	The	_	
39-57	17165-17169	same	_	
39-58	17170-17178	analysis	_	
39-59	17179-17182	was	_	
39-60	17183-17192	performed	_	
39-61	17193-17196	for	_	
39-62	17197-17205	siblings	_	
39-63	17206-17208	as	_	
39-64	17209-17217	compared	_	
39-65	17218-17220	to	_	
39-66	17221-17229	patients	_	
39-67	17229-17230	,	_	
39-68	17231-17234	and	_	
39-69	17235-17238	for	_	
39-70	17239-17247	controls	_	
39-71	17248-17256	compared	_	
39-72	17257-17259	to	_	
39-73	17260-17268	siblings	_	
39-74	17268-17269	.	_	

#Text=Correlation between connectivity alteration and clinical factors
40-1	17270-17281	Correlation	_	
40-2	17282-17289	between	_	
40-3	17290-17302	connectivity	_	
40-4	17303-17313	alteration	_	
40-5	17314-17317	and	_	
40-6	17318-17326	clinical	_	
40-7	17327-17334	factors	_	

#Text=To examine the potential clinical relevance of connectivity changes in patients, the level of interhemispheric connectivity and hemispheric specialization were correlated with illness duration and PANSS total scores in patients (p < .05). Moreover, antipsychotic medication was examined as a potential confounder of functional connectivity measurements by correlating daily medication in chlorpromazine equivalent dose with interhemispheric connectivity and hemispheric specialization.
41-1	17335-17337	To	_	
41-2	17338-17345	examine	_	
41-3	17346-17349	the	_	
41-4	17350-17359	potential	_	
41-5	17360-17368	clinical	_	
41-6	17369-17378	relevance	_	
41-7	17379-17381	of	_	
41-8	17382-17394	connectivity	_	
41-9	17395-17402	changes	_	
41-10	17403-17405	in	_	
41-11	17406-17414	patients	_	
41-12	17414-17415	,	_	
41-13	17416-17419	the	_	
41-14	17420-17425	level	_	
41-15	17426-17428	of	_	
41-16	17429-17445	interhemispheric	_	
41-17	17446-17458	connectivity	_	
41-18	17459-17462	and	_	
41-19	17463-17474	hemispheric	_	
41-20	17475-17489	specialization	_	
41-21	17490-17494	were	_	
41-22	17495-17505	correlated	_	
41-23	17506-17510	with	_	
41-24	17511-17518	illness	_	
41-25	17519-17527	duration	_	
41-26	17528-17531	and	_	
41-27	17532-17537	PANSS	_	
41-28	17538-17543	total	_	
41-29	17544-17550	scores	_	
41-30	17551-17553	in	_	
41-31	17554-17562	patients	_	
41-32	17563-17564	(	_	
41-33	17564-17565	p	_	
41-34	17565-17566	 	_	
41-35	17566-17567	<	_	
41-36	17567-17568	 	_	
41-37	17568-17571	.05	_	
41-38	17571-17572	)	_	
41-39	17572-17573	.	_	
41-40	17574-17582	Moreover	_	
41-41	17582-17583	,	_	
41-42	17584-17597	antipsychotic	_	
41-43	17598-17608	medication	_	
41-44	17609-17612	was	_	
41-45	17613-17621	examined	_	
41-46	17622-17624	as	_	
41-47	17625-17626	a	_	
41-48	17627-17636	potential	_	
41-49	17637-17647	confounder	_	
41-50	17648-17650	of	_	
41-51	17651-17661	functional	_	
41-52	17662-17674	connectivity	_	
41-53	17675-17687	measurements	_	
41-54	17688-17690	by	_	
41-55	17691-17702	correlating	_	
41-56	17703-17708	daily	_	
41-57	17709-17719	medication	_	
41-58	17720-17722	in	_	
41-59	17723-17737	chlorpromazine	_	
41-60	17738-17748	equivalent	_	
41-61	17749-17753	dose	_	
41-62	17754-17758	with	_	
41-63	17759-17775	interhemispheric	_	
41-64	17776-17788	connectivity	_	
41-65	17789-17792	and	_	
41-66	17793-17804	hemispheric	_	
41-67	17805-17819	specialization	_	
41-68	17819-17820	.	_	

#Text=Results
42-1	17821-17828	Results	_	

#Text=Interhemispheric connectivity
43-1	17829-17845	Interhemispheric	_	
43-2	17846-17858	connectivity	_	

#Text=Group mean homotopic interhemispheric connectivity strength was plotted on a brain surface for each subject group (Fig. 1). Regional variation in interhemispheric connectivity indicated higher bilateral synchrony in primary sensorimotor, auditory cortex and midline regions as compared to heteromodal association cortex. Regional interhemispheric connectivity in healthy controls correlated with values reported in a previous study in healthy subjects (r = 0.41, p = .002, Supplementary Fig. 1).
44-1	17859-17864	Group	_	
44-2	17865-17869	mean	_	
44-3	17870-17879	homotopic	_	
44-4	17880-17896	interhemispheric	_	
44-5	17897-17909	connectivity	_	
44-6	17910-17918	strength	_	
44-7	17919-17922	was	_	
44-8	17923-17930	plotted	_	
44-9	17931-17933	on	_	
44-10	17934-17935	a	_	
44-11	17936-17941	brain	_	
44-12	17942-17949	surface	_	
44-13	17950-17953	for	_	
44-14	17954-17958	each	_	
44-15	17959-17966	subject	_	
44-16	17967-17972	group	_	
44-17	17973-17974	(	_	
44-18	17974-17977	Fig	_	
44-19	17977-17978	.	_	
44-20	17979-17980	1	_	
44-21	17980-17981	)	_	
44-22	17981-17982	.	_	
44-23	17983-17991	Regional	_	
44-24	17992-18001	variation	_	
44-25	18002-18004	in	_	
44-26	18005-18021	interhemispheric	_	
44-27	18022-18034	connectivity	_	
44-28	18035-18044	indicated	_	
44-29	18045-18051	higher	_	
44-30	18052-18061	bilateral	_	
44-31	18062-18071	synchrony	_	
44-32	18072-18074	in	_	
44-33	18075-18082	primary	_	
44-34	18083-18095	sensorimotor	_	
44-35	18095-18096	,	_	
44-36	18097-18105	auditory	_	
44-37	18106-18112	cortex	_	
44-38	18113-18116	and	_	
44-39	18117-18124	midline	_	
44-40	18125-18132	regions	_	
44-41	18133-18135	as	_	
44-42	18136-18144	compared	_	
44-43	18145-18147	to	_	
44-44	18148-18159	heteromodal	_	
44-45	18160-18171	association	_	
44-46	18172-18178	cortex	_	
44-47	18178-18179	.	_	
44-48	18180-18188	Regional	_	
44-49	18189-18205	interhemispheric	_	
44-50	18206-18218	connectivity	_	
44-51	18219-18221	in	_	
44-52	18222-18229	healthy	_	
44-53	18230-18238	controls	_	
44-54	18239-18249	correlated	_	
44-55	18250-18254	with	_	
44-56	18255-18261	values	_	
44-57	18262-18270	reported	_	
44-58	18271-18273	in	_	
44-59	18274-18275	a	_	
44-60	18276-18284	previous	_	
44-61	18285-18290	study	_	
44-62	18291-18293	in	_	
44-63	18294-18301	healthy	_	
44-64	18302-18310	subjects	_	
44-65	18311-18312	(	_	
44-66	18312-18313	r	_	
44-67	18313-18314	 	_	
44-68	18314-18315	=	_	
44-69	18315-18316	 	_	
44-70	18316-18320	0.41	_	
44-71	18320-18321	,	_	
44-72	18322-18323	p	_	
44-73	18323-18324	 	_	
44-74	18324-18325	=	_	
44-75	18325-18326	 	_	
44-76	18326-18330	.002	_	
44-77	18330-18331	,	_	
44-78	18332-18345	Supplementary	_	
44-79	18346-18349	Fig	_	
44-80	18349-18350	.	_	
44-81	18351-18352	1	_	
44-82	18352-18353	)	_	
44-83	18353-18354	.	_	

#Text=Linear mixed-effects analysis showed a significant main effect of group on homotopic interhemispheric connectivity (F(2,227) = 4.31, p = .01, Fig. 1), such that interhemispheric connectivity was lower in patients as compared to both controls (t(227) = 2.03, p = .04) and siblings (t(227) = 2.90, p = .004). Group-differences for heterotopic interhemispheric connectivity or left and right intra-hemispheric functional connectivity was not significant after controlling for global connectivity differences (F(2,227) = 0.61, 0.11, 0.14, p = .54, 0.89, 0.87 respectively, Supplementary Fig. 2).
45-1	18355-18361	Linear	_	
45-2	18362-18375	mixed-effects	_	
45-3	18376-18384	analysis	_	
45-4	18385-18391	showed	_	
45-5	18392-18393	a	_	
45-6	18394-18405	significant	_	
45-7	18406-18410	main	_	
45-8	18411-18417	effect	_	
45-9	18418-18420	of	_	
45-10	18421-18426	group	_	
45-11	18427-18429	on	_	
45-12	18430-18439	homotopic	_	
45-13	18440-18456	interhemispheric	_	
45-14	18457-18469	connectivity	_	
45-15	18470-18471	(	_	
45-16	18471-18472	F	_	
45-17	18472-18473	(	_	
45-18	18473-18478	2,227	_	
45-19	18478-18479	)	_	
45-20	18479-18480	 	_	
45-21	18480-18481	=	_	
45-22	18481-18482	 	_	
45-23	18482-18486	4.31	_	
45-24	18486-18487	,	_	
45-25	18488-18489	p	_	
45-26	18489-18490	 	_	
45-27	18490-18491	=	_	
45-28	18491-18492	 	_	
45-29	18492-18495	.01	_	
45-30	18495-18496	,	_	
45-31	18497-18500	Fig	_	
45-32	18500-18501	.	_	
45-33	18502-18503	1	_	
45-34	18503-18504	)	_	
45-35	18504-18505	,	_	
45-36	18506-18510	such	_	
45-37	18511-18515	that	_	
45-38	18516-18532	interhemispheric	_	
45-39	18533-18545	connectivity	_	
45-40	18546-18549	was	_	
45-41	18550-18555	lower	_	
45-42	18556-18558	in	_	
45-43	18559-18567	patients	_	
45-44	18568-18570	as	_	
45-45	18571-18579	compared	_	
45-46	18580-18582	to	_	
45-47	18583-18587	both	_	
45-48	18588-18596	controls	_	
45-49	18597-18598	(	_	
45-50	18598-18599	t	_	
45-51	18599-18600	(	_	
45-52	18600-18603	227	_	
45-53	18603-18604	)	_	
45-54	18604-18605	 	_	
45-55	18605-18606	=	_	
45-56	18606-18607	 	_	
45-57	18607-18611	2.03	_	
45-58	18611-18612	,	_	
45-59	18613-18614	p	_	
45-60	18614-18615	 	_	
45-61	18615-18616	=	_	
45-62	18616-18617	 	_	
45-63	18617-18620	.04	_	
45-64	18620-18621	)	_	
45-65	18622-18625	and	_	
45-66	18626-18634	siblings	_	
45-67	18635-18636	(	_	
45-68	18636-18637	t	_	
45-69	18637-18638	(	_	
45-70	18638-18641	227	_	
45-71	18641-18642	)	_	
45-72	18642-18643	 	_	
45-73	18643-18644	=	_	
45-74	18644-18645	 	_	
45-75	18645-18649	2.90	_	
45-76	18649-18650	,	_	
45-77	18651-18652	p	_	
45-78	18652-18653	 	_	
45-79	18653-18654	=	_	
45-80	18654-18655	 	_	
45-81	18655-18659	.004	_	
45-82	18659-18660	)	_	
45-83	18660-18661	.	_	
45-84	18662-18679	Group-differences	_	
45-85	18680-18683	for	_	
45-86	18684-18695	heterotopic	_	
45-87	18696-18712	interhemispheric	_	
45-88	18713-18725	connectivity	_	
45-89	18726-18728	or	_	
45-90	18729-18733	left	_	
45-91	18734-18737	and	_	
45-92	18738-18743	right	_	
45-93	18744-18761	intra-hemispheric	_	
45-94	18762-18772	functional	_	
45-95	18773-18785	connectivity	_	
45-96	18786-18789	was	_	
45-97	18790-18793	not	_	
45-98	18794-18805	significant	_	
45-99	18806-18811	after	_	
45-100	18812-18823	controlling	_	
45-101	18824-18827	for	_	
45-102	18828-18834	global	_	
45-103	18835-18847	connectivity	_	
45-104	18848-18859	differences	_	
45-105	18860-18861	(	_	
45-106	18861-18862	F	_	
45-107	18862-18863	(	_	
45-108	18863-18868	2,227	_	
45-109	18868-18869	)	_	
45-110	18869-18870	 	_	
45-111	18870-18871	=	_	
45-112	18871-18872	 	_	
45-113	18872-18876	0.61	_	
45-114	18876-18877	,	_	
45-115	18878-18882	0.11	_	
45-116	18882-18883	,	_	
45-117	18884-18888	0.14	_	
45-118	18888-18889	,	_	
45-119	18890-18891	p	_	
45-120	18891-18892	 	_	
45-121	18892-18893	=	_	
45-122	18893-18894	 	_	
45-123	18894-18897	.54	_	
45-124	18897-18898	,	_	
45-125	18899-18903	0.89	_	
45-126	18903-18904	,	_	
45-127	18905-18909	0.87	_	
45-128	18910-18922	respectively	_	
45-129	18922-18923	,	_	
45-130	18924-18937	Supplementary	_	
45-131	18938-18941	Fig	_	
45-132	18941-18942	.	_	
45-133	18943-18944	2	_	
45-134	18944-18945	)	_	
45-135	18945-18946	.	_	

#Text=Regional homotopic interhemispheric connectivity strength (z score) were plotted on brain volume for the three subject groups. The lower right boxplot depicts global interhemispheric connectivity for every subject. Patients had lower interhemispheric connectivity strength than controls (p = .04) and siblings (p = .004).
46-1	18947-18955	Regional	_	
46-2	18956-18965	homotopic	_	
46-3	18966-18982	interhemispheric	_	
46-4	18983-18995	connectivity	_	
46-5	18996-19004	strength	_	
46-6	19005-19006	(	_	
46-7	19006-19007	z	_	
46-8	19008-19013	score	_	
46-9	19013-19014	)	_	
46-10	19015-19019	were	_	
46-11	19020-19027	plotted	_	
46-12	19028-19030	on	_	
46-13	19031-19036	brain	_	
46-14	19037-19043	volume	_	
46-15	19044-19047	for	_	
46-16	19048-19051	the	_	
46-17	19052-19057	three	_	
46-18	19058-19065	subject	_	
46-19	19066-19072	groups	_	
46-20	19072-19073	.	_	
46-21	19074-19077	The	_	
46-22	19078-19083	lower	_	
46-23	19084-19089	right	_	
46-24	19090-19097	boxplot	_	
46-25	19098-19105	depicts	_	
46-26	19106-19112	global	_	
46-27	19113-19129	interhemispheric	_	
46-28	19130-19142	connectivity	_	
46-29	19143-19146	for	_	
46-30	19147-19152	every	_	
46-31	19153-19160	subject	_	
46-32	19160-19161	.	_	
46-33	19162-19170	Patients	_	
46-34	19171-19174	had	_	
46-35	19175-19180	lower	_	
46-36	19181-19197	interhemispheric	_	
46-37	19198-19210	connectivity	_	
46-38	19211-19219	strength	_	
46-39	19220-19224	than	_	
46-40	19225-19233	controls	_	
46-41	19234-19235	(	_	
46-42	19235-19236	p	_	
46-43	19236-19237	 	_	
46-44	19237-19238	=	_	
46-45	19238-19239	 	_	
46-46	19239-19242	.04	_	
46-47	19242-19243	)	_	
46-48	19244-19247	and	_	
46-49	19248-19256	siblings	_	
46-50	19257-19258	(	_	
46-51	19258-19259	p	_	
46-52	19259-19260	 	_	
46-53	19260-19261	=	_	
46-54	19261-19262	 	_	
46-55	19262-19266	.004	_	
46-56	19266-19267	)	_	
46-57	19267-19268	.	_	

#Text=Fig. 1
47-1	19269-19272	Fig	_	
47-2	19272-19273	.	_	
47-3	19274-19275	1	_	

#Text=Regions showing a significant group effect on interhemispheric connectivity (p < .05, Bonferroni corrected). Post-hoc analyses revealed significant reductions in interhemispheric connectivity in patients relative to both controls and siblings for all these regions (p < .05, detailed statistics were provided in the Supplementary Table 3). Abbreviation: CON, healthy controls; SIB, unaffected siblings; PAT, schizophrenia patients.
48-1	19276-19283	Regions	_	
48-2	19284-19291	showing	_	
48-3	19292-19293	a	_	
48-4	19294-19305	significant	_	
48-5	19306-19311	group	_	
48-6	19312-19318	effect	_	
48-7	19319-19321	on	_	
48-8	19322-19338	interhemispheric	_	
48-9	19339-19351	connectivity	_	
48-10	19352-19353	(	_	
48-11	19353-19354	p	_	
48-12	19354-19355	 	_	
48-13	19355-19356	<	_	
48-14	19356-19357	 	_	
48-15	19357-19360	.05	_	
48-16	19360-19361	,	_	
48-17	19362-19372	Bonferroni	_	
48-18	19373-19382	corrected	_	
48-19	19382-19383	)	_	
48-20	19383-19384	.	_	
48-21	19385-19393	Post-hoc	_	
48-22	19394-19402	analyses	_	
48-23	19403-19411	revealed	_	
48-24	19412-19423	significant	_	
48-25	19424-19434	reductions	_	
48-26	19435-19437	in	_	
48-27	19438-19454	interhemispheric	_	
48-28	19455-19467	connectivity	_	
48-29	19468-19470	in	_	
48-30	19471-19479	patients	_	
48-31	19480-19488	relative	_	
48-32	19489-19491	to	_	
48-33	19492-19496	both	_	
48-34	19497-19505	controls	_	
48-35	19506-19509	and	_	
48-36	19510-19518	siblings	_	
48-37	19519-19522	for	_	
48-38	19523-19526	all	_	
48-39	19527-19532	these	_	
48-40	19533-19540	regions	_	
48-41	19541-19542	(	_	
48-42	19542-19543	p	_	
48-43	19543-19544	 	_	
48-44	19544-19545	<	_	
48-45	19545-19546	 	_	
48-46	19546-19549	.05	_	
48-47	19549-19550	,	_	
48-48	19551-19559	detailed	_	
48-49	19560-19570	statistics	_	
48-50	19571-19575	were	_	
48-51	19576-19584	provided	_	
48-52	19585-19587	in	_	
48-53	19588-19591	the	_	
48-54	19592-19605	Supplementary	_	
48-55	19606-19611	Table	_	
48-56	19612-19613	3	_	
48-57	19613-19614	)	_	
48-58	19614-19615	.	_	
48-59	19616-19628	Abbreviation	_	
48-60	19628-19629	:	_	
48-61	19630-19633	CON	_	
48-62	19633-19634	,	_	
48-63	19635-19642	healthy	_	
48-64	19643-19651	controls	_	
48-65	19651-19652	;	_	
48-66	19653-19656	SIB	_	
48-67	19656-19657	,	_	
48-68	19658-19668	unaffected	_	
48-69	19669-19677	siblings	_	
48-70	19677-19678	;	_	
48-71	19679-19682	PAT	_	
48-72	19682-19683	,	_	
48-73	19684-19697	schizophrenia	_	
48-74	19698-19706	patients	_	
48-75	19706-19707	.	_	

#Text=Fig. 2
49-1	19708-19711	Fig	_	
49-2	19711-19712	.	_	
49-3	19713-19714	2	_	

#Text=Regional homotopic interhemispheric connectivity showed a significant group-effect in pre- and postcentral gyrus, subcallosal cortex and anterior supramarginal gyrus (p < .05, Bonferroni corrected, Fig. 2). Post-hoc analyses revealed significant reductions in interhemispheric connectivity in patients relative to both controls and siblings for all these regions (p < .05, detailed statistics are provided in the Supplementary Table 3). There were no significant group-differences in regional interhemispheric connectivity between controls and siblings.
50-1	19715-19723	Regional	_	
50-2	19724-19733	homotopic	_	
50-3	19734-19750	interhemispheric	_	
50-4	19751-19763	connectivity	_	
50-5	19764-19770	showed	_	
50-6	19771-19772	a	_	
50-7	19773-19784	significant	_	
50-8	19785-19797	group-effect	_	
50-9	19798-19800	in	_	
50-10	19801-19804	pre	_	
50-11	19804-19805	-	_	
50-12	19806-19809	and	_	
50-13	19810-19821	postcentral	_	
50-14	19822-19827	gyrus	_	
50-15	19827-19828	,	_	
50-16	19829-19840	subcallosal	_	
50-17	19841-19847	cortex	_	
50-18	19848-19851	and	_	
50-19	19852-19860	anterior	_	
50-20	19861-19874	supramarginal	_	
50-21	19875-19880	gyrus	_	
50-22	19881-19882	(	_	
50-23	19882-19883	p	_	
50-24	19883-19884	 	_	
50-25	19884-19885	<	_	
50-26	19885-19886	 	_	
50-27	19886-19889	.05	_	
50-28	19889-19890	,	_	
50-29	19891-19901	Bonferroni	_	
50-30	19902-19911	corrected	_	
50-31	19911-19912	,	_	
50-32	19913-19916	Fig	_	
50-33	19916-19917	.	_	
50-34	19918-19919	2	_	
50-35	19919-19920	)	_	
50-36	19920-19921	.	_	
50-37	19922-19930	Post-hoc	_	
50-38	19931-19939	analyses	_	
50-39	19940-19948	revealed	_	
50-40	19949-19960	significant	_	
50-41	19961-19971	reductions	_	
50-42	19972-19974	in	_	
50-43	19975-19991	interhemispheric	_	
50-44	19992-20004	connectivity	_	
50-45	20005-20007	in	_	
50-46	20008-20016	patients	_	
50-47	20017-20025	relative	_	
50-48	20026-20028	to	_	
50-49	20029-20033	both	_	
50-50	20034-20042	controls	_	
50-51	20043-20046	and	_	
50-52	20047-20055	siblings	_	
50-53	20056-20059	for	_	
50-54	20060-20063	all	_	
50-55	20064-20069	these	_	
50-56	20070-20077	regions	_	
50-57	20078-20079	(	_	
50-58	20079-20080	p	_	
50-59	20080-20081	 	_	
50-60	20081-20082	<	_	
50-61	20082-20083	 	_	
50-62	20083-20086	.05	_	
50-63	20086-20087	,	_	
50-64	20088-20096	detailed	_	
50-65	20097-20107	statistics	_	
50-66	20108-20111	are	_	
50-67	20112-20120	provided	_	
50-68	20121-20123	in	_	
50-69	20124-20127	the	_	
50-70	20128-20141	Supplementary	_	
50-71	20142-20147	Table	_	
50-72	20148-20149	3	_	
50-73	20149-20150	)	_	
50-74	20150-20151	.	_	
50-75	20152-20157	There	_	
50-76	20158-20162	were	_	
50-77	20163-20165	no	_	
50-78	20166-20177	significant	_	
50-79	20178-20195	group-differences	_	
50-80	20196-20198	in	_	
50-81	20199-20207	regional	_	
50-82	20208-20224	interhemispheric	_	
50-83	20225-20237	connectivity	_	
50-84	20238-20245	between	_	
50-85	20246-20254	controls	_	
50-86	20255-20258	and	_	
50-87	20259-20267	siblings	_	
50-88	20267-20268	.	_	

#Text=Hemispheric specialization: group effects
51-1	20269-20280	Hemispheric	_	
51-2	20281-20295	specialization	_	
51-3	20295-20296	:	_	
51-4	20297-20302	group	_	
51-5	20303-20310	effects	_	

#Text=The color of brain volume represents regional hemispheric specialization (z score) in the three subject groups. The boxplot shows individual global hemispheric specialization. Patients with schizophrenia had higher global hemispheric specialization than siblings (p = .01).
52-1	20311-20314	The	_	
52-2	20315-20320	color	_	
52-3	20321-20323	of	_	
52-4	20324-20329	brain	_	
52-5	20330-20336	volume	_	
52-6	20337-20347	represents	_	
52-7	20348-20356	regional	_	
52-8	20357-20368	hemispheric	_	
52-9	20369-20383	specialization	_	
52-10	20384-20385	(	_	
52-11	20385-20386	z	_	
52-12	20387-20392	score	_	
52-13	20392-20393	)	_	
52-14	20394-20396	in	_	
52-15	20397-20400	the	_	
52-16	20401-20406	three	_	
52-17	20407-20414	subject	_	
52-18	20415-20421	groups	_	
52-19	20421-20422	.	_	
52-20	20423-20426	The	_	
52-21	20427-20434	boxplot	_	
52-22	20435-20440	shows	_	
52-23	20441-20451	individual	_	
52-24	20452-20458	global	_	
52-25	20459-20470	hemispheric	_	
52-26	20471-20485	specialization	_	
52-27	20485-20486	.	_	
52-28	20487-20495	Patients	_	
52-29	20496-20500	with	_	
52-30	20501-20514	schizophrenia	_	
52-31	20515-20518	had	_	
52-32	20519-20525	higher	_	
52-33	20526-20532	global	_	
52-34	20533-20544	hemispheric	_	
52-35	20545-20559	specialization	_	
52-36	20560-20564	than	_	
52-37	20565-20573	siblings	_	
52-38	20574-20575	(	_	
52-39	20575-20576	p	_	
52-40	20576-20577	 	_	
52-41	20577-20578	=	_	
52-42	20578-20579	 	_	
52-43	20579-20582	.01	_	
52-44	20582-20583	)	_	
52-45	20583-20584	.	_	

#Text=Fig. 3
53-1	20585-20588	Fig	_	
53-2	20588-20589	.	_	
53-3	20590-20591	3	_	

#Text=Regional variation of hemispheric specialization showed a distinct pattern from interhemispheric connectivity (Fig. 3). Heteromodal regions showed higher levels of hemispheric specialization than primary sensorimotor areas, indicating a tendency of heteromodal regions to interact preferentially with ipsilateral brain areas.
54-1	20592-20600	Regional	_	
54-2	20601-20610	variation	_	
54-3	20611-20613	of	_	
54-4	20614-20625	hemispheric	_	
54-5	20626-20640	specialization	_	
54-6	20641-20647	showed	_	
54-7	20648-20649	a	_	
54-8	20650-20658	distinct	_	
54-9	20659-20666	pattern	_	
54-10	20667-20671	from	_	
54-11	20672-20688	interhemispheric	_	
54-12	20689-20701	connectivity	_	
54-13	20702-20703	(	_	
54-14	20703-20706	Fig	_	
54-15	20706-20707	.	_	
54-16	20708-20709	3	_	
54-17	20709-20710	)	_	
54-18	20710-20711	.	_	
54-19	20712-20723	Heteromodal	_	
54-20	20724-20731	regions	_	
54-21	20732-20738	showed	_	
54-22	20739-20745	higher	_	
54-23	20746-20752	levels	_	
54-24	20753-20755	of	_	
54-25	20756-20767	hemispheric	_	
54-26	20768-20782	specialization	_	
54-27	20783-20787	than	_	
54-28	20788-20795	primary	_	
54-29	20796-20808	sensorimotor	_	
54-30	20809-20814	areas	_	
54-31	20814-20815	,	_	
54-32	20816-20826	indicating	_	
54-33	20827-20828	a	_	
54-34	20829-20837	tendency	_	
54-35	20838-20840	of	_	
54-36	20841-20852	heteromodal	_	
54-37	20853-20860	regions	_	
54-38	20861-20863	to	_	
54-39	20864-20872	interact	_	
54-40	20873-20887	preferentially	_	
54-41	20888-20892	with	_	
54-42	20893-20904	ipsilateral	_	
54-43	20905-20910	brain	_	
54-44	20911-20916	areas	_	
54-45	20916-20917	.	_	

#Text=There was a significant main effect of group on global hemispheric specialization (F(2,464) = 3.73, p = .02). Post-hoc comparisons showed that hemispheric specialization is higher in patients as compared to siblings (t(464) = 2.73, p = .01), indicating that functional connectivity in schizophrenia patients is more confined within their own hemispheres.
55-1	20918-20923	There	_	
55-2	20924-20927	was	_	
55-3	20928-20929	a	_	
55-4	20930-20941	significant	_	
55-5	20942-20946	main	_	
55-6	20947-20953	effect	_	
55-7	20954-20956	of	_	
55-8	20957-20962	group	_	
55-9	20963-20965	on	_	
55-10	20966-20972	global	_	
55-11	20973-20984	hemispheric	_	
55-12	20985-20999	specialization	_	
55-13	21000-21001	(	_	
55-14	21001-21002	F	_	
55-15	21002-21003	(	_	
55-16	21003-21008	2,464	_	
55-17	21008-21009	)	_	
55-18	21009-21010	 	_	
55-19	21010-21011	=	_	
55-20	21011-21012	 	_	
55-21	21012-21016	3.73	_	
55-22	21016-21017	,	_	
55-23	21018-21019	p	_	
55-24	21019-21020	 	_	
55-25	21020-21021	=	_	
55-26	21021-21022	 	_	
55-27	21022-21025	.02	_	
55-28	21025-21026	)	_	
55-29	21026-21027	.	_	
55-30	21028-21036	Post-hoc	_	
55-31	21037-21048	comparisons	_	
55-32	21049-21055	showed	_	
55-33	21056-21060	that	_	
55-34	21061-21072	hemispheric	_	
55-35	21073-21087	specialization	_	
55-36	21088-21090	is	_	
55-37	21091-21097	higher	_	
55-38	21098-21100	in	_	
55-39	21101-21109	patients	_	
55-40	21110-21112	as	_	
55-41	21113-21121	compared	_	
55-42	21122-21124	to	_	
55-43	21125-21133	siblings	_	
55-44	21134-21135	(	_	
55-45	21135-21136	t	_	
55-46	21136-21137	(	_	
55-47	21137-21140	464	_	
55-48	21140-21141	)	_	
55-49	21141-21142	 	_	
55-50	21142-21143	=	_	
55-51	21143-21144	 	_	
55-52	21144-21148	2.73	_	
55-53	21148-21149	,	_	
55-54	21150-21151	p	_	
55-55	21151-21152	 	_	
55-56	21152-21153	=	_	
55-57	21153-21154	 	_	
55-58	21154-21157	.01	_	
55-59	21157-21158	)	_	
55-60	21158-21159	,	_	
55-61	21160-21170	indicating	_	
55-62	21171-21175	that	_	
55-63	21176-21186	functional	_	
55-64	21187-21199	connectivity	_	
55-65	21200-21202	in	_	
55-66	21203-21216	schizophrenia	_	
55-67	21217-21225	patients	_	
55-68	21226-21228	is	_	
55-69	21229-21233	more	_	
55-70	21234-21242	confined	_	
55-71	21243-21249	within	_	
55-72	21250-21255	their	_	
55-73	21256-21259	own	_	
55-74	21260-21271	hemispheres	_	
55-75	21271-21272	.	_	

#Text=Regional hemispheric specialization showing significant (A) group differences; (B) hemispheric effects (p < .05, Bonferroni corrected, Supplementary Tables 4, 5). For group effects (A), patients exhibited increased hemispheric specialization in unimodal and heteromodal association cortices, sensorimotor cortices and limbic areas. The hemispheric effects (B) indicate higher specialization in frontal and temporal regions and subcortical structures in the left hemisphere, whereas higher specialization was observed in the right hemisphere for parietal, occipital, auditory, subcortical and anterior cingulate cortex. For illustration purpose, regional hemispheric specialization values were averaged over the two hemispheres (A) and over the three groups (B). Abbreviation: LH, left hemisphere; RH, right hemisphere; brain regional abbreviation and classification please refer to Supplementary Table 2.
56-1	21273-21281	Regional	_	
56-2	21282-21293	hemispheric	_	
56-3	21294-21308	specialization	_	
56-4	21309-21316	showing	_	
56-5	21317-21328	significant	_	
56-6	21329-21330	(	_	
56-7	21330-21331	A	_	
56-8	21331-21332	)	_	
56-9	21333-21338	group	_	
56-10	21339-21350	differences	_	
56-11	21350-21351	;	_	
56-12	21352-21353	(	_	
56-13	21353-21354	B	_	
56-14	21354-21355	)	_	
56-15	21356-21367	hemispheric	_	
56-16	21368-21375	effects	_	
56-17	21376-21377	(	_	
56-18	21377-21378	p	_	
56-19	21378-21379	 	_	
56-20	21379-21380	<	_	
56-21	21380-21381	 	_	
56-22	21381-21384	.05	_	
56-23	21384-21385	,	_	
56-24	21386-21396	Bonferroni	_	
56-25	21397-21406	corrected	_	
56-26	21406-21407	,	_	
56-27	21408-21421	Supplementary	_	
56-28	21422-21428	Tables	_	
56-29	21429-21430	4	_	
56-30	21430-21431	,	_	
56-31	21432-21433	5	_	
56-32	21433-21434	)	_	
56-33	21434-21435	.	_	
56-34	21436-21439	For	_	
56-35	21440-21445	group	_	
56-36	21446-21453	effects	_	
56-37	21454-21455	(	_	
56-38	21455-21456	A	_	
56-39	21456-21457	)	_	
56-40	21457-21458	,	_	
56-41	21459-21467	patients	_	
56-42	21468-21477	exhibited	_	
56-43	21478-21487	increased	_	
56-44	21488-21499	hemispheric	_	
56-45	21500-21514	specialization	_	
56-46	21515-21517	in	_	
56-47	21518-21526	unimodal	_	
56-48	21527-21530	and	_	
56-49	21531-21542	heteromodal	_	
56-50	21543-21554	association	_	
56-51	21555-21563	cortices	_	
56-52	21563-21564	,	_	
56-53	21565-21577	sensorimotor	_	
56-54	21578-21586	cortices	_	
56-55	21587-21590	and	_	
56-56	21591-21597	limbic	_	
56-57	21598-21603	areas	_	
56-58	21603-21604	.	_	
56-59	21605-21608	The	_	
56-60	21609-21620	hemispheric	_	
56-61	21621-21628	effects	_	
56-62	21629-21630	(	_	
56-63	21630-21631	B	_	
56-64	21631-21632	)	_	
56-65	21633-21641	indicate	_	
56-66	21642-21648	higher	_	
56-67	21649-21663	specialization	_	
56-68	21664-21666	in	_	
56-69	21667-21674	frontal	_	
56-70	21675-21678	and	_	
56-71	21679-21687	temporal	_	
56-72	21688-21695	regions	_	
56-73	21696-21699	and	_	
56-74	21700-21711	subcortical	_	
56-75	21712-21722	structures	_	
56-76	21723-21725	in	_	
56-77	21726-21729	the	_	
56-78	21730-21734	left	_	
56-79	21735-21745	hemisphere	_	
56-80	21745-21746	,	_	
56-81	21747-21754	whereas	_	
56-82	21755-21761	higher	_	
56-83	21762-21776	specialization	_	
56-84	21777-21780	was	_	
56-85	21781-21789	observed	_	
56-86	21790-21792	in	_	
56-87	21793-21796	the	_	
56-88	21797-21802	right	_	
56-89	21803-21813	hemisphere	_	
56-90	21814-21817	for	_	
56-91	21818-21826	parietal	_	
56-92	21826-21827	,	_	
56-93	21828-21837	occipital	_	
56-94	21837-21838	,	_	
56-95	21839-21847	auditory	_	
56-96	21847-21848	,	_	
56-97	21849-21860	subcortical	_	
56-98	21861-21864	and	_	
56-99	21865-21873	anterior	_	
56-100	21874-21883	cingulate	_	
56-101	21884-21890	cortex	_	
56-102	21890-21891	.	_	
56-103	21892-21895	For	_	
56-104	21896-21908	illustration	_	
56-105	21909-21916	purpose	_	
56-106	21916-21917	,	_	
56-107	21918-21926	regional	_	
56-108	21927-21938	hemispheric	_	
56-109	21939-21953	specialization	_	
56-110	21954-21960	values	_	
56-111	21961-21965	were	_	
56-112	21966-21974	averaged	_	
56-113	21975-21979	over	_	
56-114	21980-21983	the	_	
56-115	21984-21987	two	_	
56-116	21988-21999	hemispheres	_	
56-117	22000-22001	(	_	
56-118	22001-22002	A	_	
56-119	22002-22003	)	_	
56-120	22004-22007	and	_	
56-121	22008-22012	over	_	
56-122	22013-22016	the	_	
56-123	22017-22022	three	_	
56-124	22023-22029	groups	_	
56-125	22030-22031	(	_	
56-126	22031-22032	B	_	
56-127	22032-22033	)	_	
56-128	22033-22034	.	_	
56-129	22035-22047	Abbreviation	_	
56-130	22047-22048	:	_	
56-131	22049-22051	LH	_	
56-132	22051-22052	,	_	
56-133	22053-22057	left	_	
56-134	22058-22068	hemisphere	_	
56-135	22068-22069	;	_	
56-136	22070-22072	RH	_	
56-137	22072-22073	,	_	
56-138	22074-22079	right	_	
56-139	22080-22090	hemisphere	_	
56-140	22090-22091	;	_	
56-141	22092-22097	brain	_	
56-142	22098-22106	regional	_	
56-143	22107-22119	abbreviation	_	
56-144	22120-22123	and	_	
56-145	22124-22138	classification	_	
56-146	22139-22145	please	_	
56-147	22146-22151	refer	_	
56-148	22152-22154	to	_	
56-149	22155-22168	Supplementary	_	
56-150	22169-22174	Table	_	
56-151	22175-22176	2	_	
56-152	22176-22177	.	_	

#Text=Fig. 4
57-1	22178-22181	Fig	_	
57-2	22181-22182	.	_	
57-3	22183-22184	4	_	

#Text=Ten out of 56 whole-brain areas showed significant group effects of regional hemispheric specialization (p < .05, Bonferroni corrected), including parietal, temporal and occipital association cortices, sensorimotor regions and limbic areas, mainly belonging to unimodal and heteromodal association cortices (Fig. 4A). In these regions, hemispheric specialization was increased in patients as compared to both controls and siblings (p < .05, Supplementary Table 4). The only exception was the posterior supramarginal gyrus which showed marginally higher hemispheric specialization in patients relative to controls (t(464) = 1.90, p = .058), but lower hemispheric specialization in siblings relative to controls (t(464) = −1.73, p = .084). There were no significant group-differences between siblings and controls in hemispheric specialization.
58-1	22185-22188	Ten	_	
58-2	22189-22192	out	_	
58-3	22193-22195	of	_	
58-4	22196-22198	56	_	
58-5	22199-22210	whole-brain	_	
58-6	22211-22216	areas	_	
58-7	22217-22223	showed	_	
58-8	22224-22235	significant	_	
58-9	22236-22241	group	_	
58-10	22242-22249	effects	_	
58-11	22250-22252	of	_	
58-12	22253-22261	regional	_	
58-13	22262-22273	hemispheric	_	
58-14	22274-22288	specialization	_	
58-15	22289-22290	(	_	
58-16	22290-22291	p	_	
58-17	22291-22292	 	_	
58-18	22292-22293	<	_	
58-19	22293-22294	 	_	
58-20	22294-22297	.05	_	
58-21	22297-22298	,	_	
58-22	22299-22309	Bonferroni	_	
58-23	22310-22319	corrected	_	
58-24	22319-22320	)	_	
58-25	22320-22321	,	_	
58-26	22322-22331	including	_	
58-27	22332-22340	parietal	_	
58-28	22340-22341	,	_	
58-29	22342-22350	temporal	_	
58-30	22351-22354	and	_	
58-31	22355-22364	occipital	_	
58-32	22365-22376	association	_	
58-33	22377-22385	cortices	_	
58-34	22385-22386	,	_	
58-35	22387-22399	sensorimotor	_	
58-36	22400-22407	regions	_	
58-37	22408-22411	and	_	
58-38	22412-22418	limbic	_	
58-39	22419-22424	areas	_	
58-40	22424-22425	,	_	
58-41	22426-22432	mainly	_	
58-42	22433-22442	belonging	_	
58-43	22443-22445	to	_	
58-44	22446-22454	unimodal	_	
58-45	22455-22458	and	_	
58-46	22459-22470	heteromodal	_	
58-47	22471-22482	association	_	
58-48	22483-22491	cortices	_	
58-49	22492-22493	(	_	
58-50	22493-22496	Fig	_	
58-51	22496-22497	.	_	
58-52	22498-22500	4A	_	
58-53	22500-22501	)	_	
58-54	22501-22502	.	_	
58-55	22503-22505	In	_	
58-56	22506-22511	these	_	
58-57	22512-22519	regions	_	
58-58	22519-22520	,	_	
58-59	22521-22532	hemispheric	_	
58-60	22533-22547	specialization	_	
58-61	22548-22551	was	_	
58-62	22552-22561	increased	_	
58-63	22562-22564	in	_	
58-64	22565-22573	patients	_	
58-65	22574-22576	as	_	
58-66	22577-22585	compared	_	
58-67	22586-22588	to	_	
58-68	22589-22593	both	_	
58-69	22594-22602	controls	_	
58-70	22603-22606	and	_	
58-71	22607-22615	siblings	_	
58-72	22616-22617	(	_	
58-73	22617-22618	p	_	
58-74	22618-22619	 	_	
58-75	22619-22620	<	_	
58-76	22620-22621	 	_	
58-77	22621-22624	.05	_	
58-78	22624-22625	,	_	
58-79	22626-22639	Supplementary	_	
58-80	22640-22645	Table	_	
58-81	22646-22647	4	_	
58-82	22647-22648	)	_	
58-83	22648-22649	.	_	
58-84	22650-22653	The	_	
58-85	22654-22658	only	_	
58-86	22659-22668	exception	_	
58-87	22669-22672	was	_	
58-88	22673-22676	the	_	
58-89	22677-22686	posterior	_	
58-90	22687-22700	supramarginal	_	
58-91	22701-22706	gyrus	_	
58-92	22707-22712	which	_	
58-93	22713-22719	showed	_	
58-94	22720-22730	marginally	_	
58-95	22731-22737	higher	_	
58-96	22738-22749	hemispheric	_	
58-97	22750-22764	specialization	_	
58-98	22765-22767	in	_	
58-99	22768-22776	patients	_	
58-100	22777-22785	relative	_	
58-101	22786-22788	to	_	
58-102	22789-22797	controls	_	
58-103	22798-22799	(	_	
58-104	22799-22800	t	_	
58-105	22800-22801	(	_	
58-106	22801-22804	464	_	
58-107	22804-22805	)	_	
58-108	22805-22806	 	_	
58-109	22806-22807	=	_	
58-110	22807-22808	 	_	
58-111	22808-22812	1.90	_	
58-112	22812-22813	,	_	
58-113	22814-22815	p	_	
58-114	22815-22816	 	_	
58-115	22816-22817	=	_	
58-116	22817-22818	 	_	
58-117	22818-22822	.058	_	
58-118	22822-22823	)	_	
58-119	22823-22824	,	_	
58-120	22825-22828	but	_	
58-121	22829-22834	lower	_	
58-122	22835-22846	hemispheric	_	
58-123	22847-22861	specialization	_	
58-124	22862-22864	in	_	
58-125	22865-22873	siblings	_	
58-126	22874-22882	relative	_	
58-127	22883-22885	to	_	
58-128	22886-22894	controls	_	
58-129	22895-22896	(	_	
58-130	22896-22897	t	_	
58-131	22897-22898	(	_	
58-132	22898-22901	464	_	
58-133	22901-22902	)	_	
58-134	22902-22903	 	_	
58-135	22903-22904	=	_	
58-136	22904-22905	 	_	
58-137	22905-22906	−	_	
58-138	22906-22910	1.73	_	
58-139	22910-22911	,	_	
58-140	22912-22913	p	_	
58-141	22913-22914	 	_	
58-142	22914-22915	=	_	
58-143	22915-22916	 	_	
58-144	22916-22920	.084	_	
58-145	22920-22921	)	_	
58-146	22921-22922	.	_	
58-147	22923-22928	There	_	
58-148	22929-22933	were	_	
58-149	22934-22936	no	_	
58-150	22937-22948	significant	_	
58-151	22949-22966	group-differences	_	
58-152	22967-22974	between	_	
58-153	22975-22983	siblings	_	
58-154	22984-22987	and	_	
58-155	22988-22996	controls	_	
58-156	22997-22999	in	_	
58-157	23000-23011	hemispheric	_	
58-158	23012-23026	specialization	_	
58-159	23026-23027	.	_	

#Text=Hemispheric specialization: hemispheric effects
59-1	23028-23039	Hemispheric	_	
59-2	23040-23054	specialization	_	
59-3	23054-23055	:	_	
59-4	23056-23067	hemispheric	_	
59-5	23068-23075	effects	_	

#Text=There were no significant hemispheric effects of global hemispheric specialization (F(1,464) = 0.02, p = .89). On the regional level, significant main effects of hemisphere were observed for a range of cortical and subcortical brain (p < .05, Bonferroni corrected, Fig. 4B). Higher left-hemispheric specialization was found predominantly in superior/inferior frontal and inferior/middle temporal gyrus, as well as subcortical regions and posterior cingulate cortex. Regions with higher right-hemispheric specialization included parietal and occipital areas, central opercular cortex, heschls gyrus, planum temporale, caudate nucleus and accumbens, anterior and paracingulate gyrus (Supplementary Table 5).
60-1	23076-23081	There	_	
60-2	23082-23086	were	_	
60-3	23087-23089	no	_	
60-4	23090-23101	significant	_	
60-5	23102-23113	hemispheric	_	
60-6	23114-23121	effects	_	
60-7	23122-23124	of	_	
60-8	23125-23131	global	_	
60-9	23132-23143	hemispheric	_	
60-10	23144-23158	specialization	_	
60-11	23159-23160	(	_	
60-12	23160-23161	F	_	
60-13	23161-23162	(	_	
60-14	23162-23167	1,464	_	
60-15	23167-23168	)	_	
60-16	23168-23169	 	_	
60-17	23169-23170	=	_	
60-18	23170-23171	 	_	
60-19	23171-23175	0.02	_	
60-20	23175-23176	,	_	
60-21	23177-23178	p	_	
60-22	23178-23179	 	_	
60-23	23179-23180	=	_	
60-24	23180-23181	 	_	
60-25	23181-23184	.89	_	
60-26	23184-23185	)	_	
60-27	23185-23186	.	_	
60-28	23187-23189	On	_	
60-29	23190-23193	the	_	
60-30	23194-23202	regional	_	
60-31	23203-23208	level	_	
60-32	23208-23209	,	_	
60-33	23210-23221	significant	_	
60-34	23222-23226	main	_	
60-35	23227-23234	effects	_	
60-36	23235-23237	of	_	
60-37	23238-23248	hemisphere	_	
60-38	23249-23253	were	_	
60-39	23254-23262	observed	_	
60-40	23263-23266	for	_	
60-41	23267-23268	a	_	
60-42	23269-23274	range	_	
60-43	23275-23277	of	_	
60-44	23278-23286	cortical	_	
60-45	23287-23290	and	_	
60-46	23291-23302	subcortical	_	
60-47	23303-23308	brain	_	
60-48	23309-23310	(	_	
60-49	23310-23311	p	_	
60-50	23311-23312	 	_	
60-51	23312-23313	<	_	
60-52	23313-23314	 	_	
60-53	23314-23317	.05	_	
60-54	23317-23318	,	_	
60-55	23319-23329	Bonferroni	_	
60-56	23330-23339	corrected	_	
60-57	23339-23340	,	_	
60-58	23341-23344	Fig	_	
60-59	23344-23345	.	_	
60-60	23346-23348	4B	_	
60-61	23348-23349	)	_	
60-62	23349-23350	.	_	
60-63	23351-23357	Higher	_	
60-64	23358-23374	left-hemispheric	_	
60-65	23375-23389	specialization	_	
60-66	23390-23393	was	_	
60-67	23394-23399	found	_	
60-68	23400-23413	predominantly	_	
60-69	23414-23416	in	_	
60-70	23417-23425	superior	_	
60-71	23425-23426	/	_	
60-72	23426-23434	inferior	_	
60-73	23435-23442	frontal	_	
60-74	23443-23446	and	_	
60-75	23447-23455	inferior	_	
60-76	23455-23456	/	_	
60-77	23456-23462	middle	_	
60-78	23463-23471	temporal	_	
60-79	23472-23477	gyrus	_	
60-80	23477-23478	,	_	
60-81	23479-23481	as	_	
60-82	23482-23486	well	_	
60-83	23487-23489	as	_	
60-84	23490-23501	subcortical	_	
60-85	23502-23509	regions	_	
60-86	23510-23513	and	_	
60-87	23514-23523	posterior	_	
60-88	23524-23533	cingulate	_	
60-89	23534-23540	cortex	_	
60-90	23540-23541	.	_	
60-91	23542-23549	Regions	_	
60-92	23550-23554	with	_	
60-93	23555-23561	higher	_	
60-94	23562-23579	right-hemispheric	_	
60-95	23580-23594	specialization	_	
60-96	23595-23603	included	_	
60-97	23604-23612	parietal	_	
60-98	23613-23616	and	_	
60-99	23617-23626	occipital	_	
60-100	23627-23632	areas	_	
60-101	23632-23633	,	_	
60-102	23634-23641	central	_	
60-103	23642-23651	opercular	_	
60-104	23652-23658	cortex	_	
60-105	23658-23659	,	_	
60-106	23660-23667	heschls	_	
60-107	23668-23673	gyrus	_	
60-108	23673-23674	,	_	
60-109	23675-23681	planum	_	
60-110	23682-23691	temporale	_	
60-111	23691-23692	,	_	
60-112	23693-23700	caudate	_	
60-113	23701-23708	nucleus	_	
60-114	23709-23712	and	_	
60-115	23713-23722	accumbens	_	
60-116	23722-23723	,	_	
60-117	23724-23732	anterior	_	
60-118	23733-23736	and	_	
60-119	23737-23750	paracingulate	_	
60-120	23751-23756	gyrus	_	
60-121	23757-23758	(	_	
60-122	23758-23771	Supplementary	_	
60-123	23772-23777	Table	_	
60-124	23778-23779	5	_	
60-125	23779-23780	)	_	
60-126	23780-23781	.	_	

#Text=Relationship between interhemispheric connectivity and hemispheric specialization
61-1	23782-23794	Relationship	_	
61-2	23795-23802	between	_	
61-3	23803-23819	interhemispheric	_	
61-4	23820-23832	connectivity	_	
61-5	23833-23836	and	_	
61-6	23837-23848	hemispheric	_	
61-7	23849-23863	specialization	_	

#Text=Correlation between group-differences in homotopic interhemispheric connectivity and differences in hemispheric specialization. Decreased regional interhemispheric connectivity is negatively correlated with increased hemispheric specialization in patients as compared to controls (r = −0.54, p < .001) and siblings (r = −0.54, p < .001). For the control-sibling comparison, co-variation of group-differences in the two connectivity measurements is marginally significant (r = −0.26, p = .053).
62-1	23864-23875	Correlation	_	
62-2	23876-23883	between	_	
62-3	23884-23901	group-differences	_	
62-4	23902-23904	in	_	
62-5	23905-23914	homotopic	_	
62-6	23915-23931	interhemispheric	_	
62-7	23932-23944	connectivity	_	
62-8	23945-23948	and	_	
62-9	23949-23960	differences	_	
62-10	23961-23963	in	_	
62-11	23964-23975	hemispheric	_	
62-12	23976-23990	specialization	_	
62-13	23990-23991	.	_	
62-14	23992-24001	Decreased	_	
62-15	24002-24010	regional	_	
62-16	24011-24027	interhemispheric	_	
62-17	24028-24040	connectivity	_	
62-18	24041-24043	is	_	
62-19	24044-24054	negatively	_	
62-20	24055-24065	correlated	_	
62-21	24066-24070	with	_	
62-22	24071-24080	increased	_	
62-23	24081-24092	hemispheric	_	
62-24	24093-24107	specialization	_	
62-25	24108-24110	in	_	
62-26	24111-24119	patients	_	
62-27	24120-24122	as	_	
62-28	24123-24131	compared	_	
62-29	24132-24134	to	_	
62-30	24135-24143	controls	_	
62-31	24144-24145	(	_	
62-32	24145-24146	r	_	
62-33	24146-24147	 	_	
62-34	24147-24148	=	_	
62-35	24148-24149	 	_	
62-36	24149-24150	−	_	
62-37	24150-24154	0.54	_	
62-38	24154-24155	,	_	
62-39	24156-24157	p	_	
62-40	24157-24158	 	_	
62-41	24158-24159	<	_	
62-42	24159-24160	 	_	
62-43	24160-24164	.001	_	
62-44	24164-24165	)	_	
62-45	24166-24169	and	_	
62-46	24170-24178	siblings	_	
62-47	24179-24180	(	_	
62-48	24180-24181	r	_	
62-49	24181-24182	 	_	
62-50	24182-24183	=	_	
62-51	24183-24184	 	_	
62-52	24184-24185	−	_	
62-53	24185-24189	0.54	_	
62-54	24189-24190	,	_	
62-55	24191-24192	p	_	
62-56	24192-24193	 	_	
62-57	24193-24194	<	_	
62-58	24194-24195	 	_	
62-59	24195-24199	.001	_	
62-60	24199-24200	)	_	
62-61	24200-24201	.	_	
62-62	24202-24205	For	_	
62-63	24206-24209	the	_	
62-64	24210-24225	control-sibling	_	
62-65	24226-24236	comparison	_	
62-66	24236-24237	,	_	
62-67	24238-24250	co-variation	_	
62-68	24251-24253	of	_	
62-69	24254-24271	group-differences	_	
62-70	24272-24274	in	_	
62-71	24275-24278	the	_	
62-72	24279-24282	two	_	
62-73	24283-24295	connectivity	_	
62-74	24296-24308	measurements	_	
62-75	24309-24311	is	_	
62-76	24312-24322	marginally	_	
62-77	24323-24334	significant	_	
62-78	24335-24336	(	_	
62-79	24336-24337	r	_	
62-80	24337-24338	 	_	
62-81	24338-24339	=	_	
62-82	24339-24340	 	_	
62-83	24340-24341	−	_	
62-84	24341-24345	0.26	_	
62-85	24345-24346	,	_	
62-86	24347-24348	p	_	
62-87	24348-24349	 	_	
62-88	24349-24350	=	_	
62-89	24350-24351	 	_	
62-90	24351-24355	.053	_	
62-91	24355-24356	)	_	
62-92	24356-24357	.	_	

#Text=Fig. 5
63-1	24358-24361	Fig	_	
63-2	24361-24362	.	_	
63-3	24363-24364	5	_	

#Text=Comparing patients to controls, group-differences in regional interhemispheric connectivity correlated with changes of regional hemispheric specialization averaged for the left and right hemisphere (r = −0.54, p < .001, Fig. 5). Co-variation of group-differences in the two measurements was also significant for the sibling-patient comparison (r = −0.54, p < .001), and marginally significant for the control-sibling comparison (r = −0.26, p = .053). These correlations indicate that regions showing a larger decrease in interhemispheric connectivity in patients as compared to controls or siblings show higher level of hemispheric specialization, indicating that they are preferentially collaborating with regions within the same hemisphere.
64-1	24365-24374	Comparing	_	
64-2	24375-24383	patients	_	
64-3	24384-24386	to	_	
64-4	24387-24395	controls	_	
64-5	24395-24396	,	_	
64-6	24397-24414	group-differences	_	
64-7	24415-24417	in	_	
64-8	24418-24426	regional	_	
64-9	24427-24443	interhemispheric	_	
64-10	24444-24456	connectivity	_	
64-11	24457-24467	correlated	_	
64-12	24468-24472	with	_	
64-13	24473-24480	changes	_	
64-14	24481-24483	of	_	
64-15	24484-24492	regional	_	
64-16	24493-24504	hemispheric	_	
64-17	24505-24519	specialization	_	
64-18	24520-24528	averaged	_	
64-19	24529-24532	for	_	
64-20	24533-24536	the	_	
64-21	24537-24541	left	_	
64-22	24542-24545	and	_	
64-23	24546-24551	right	_	
64-24	24552-24562	hemisphere	_	
64-25	24563-24564	(	_	
64-26	24564-24565	r	_	
64-27	24565-24566	 	_	
64-28	24566-24567	=	_	
64-29	24567-24568	 	_	
64-30	24568-24569	−	_	
64-31	24569-24573	0.54	_	
64-32	24573-24574	,	_	
64-33	24575-24576	p	_	
64-34	24576-24577	 	_	
64-35	24577-24578	<	_	
64-36	24578-24579	 	_	
64-37	24579-24583	.001	_	
64-38	24583-24584	,	_	
64-39	24585-24588	Fig	_	
64-40	24588-24589	.	_	
64-41	24590-24591	5	_	
64-42	24591-24592	)	_	
64-43	24592-24593	.	_	
64-44	24594-24606	Co-variation	_	
64-45	24607-24609	of	_	
64-46	24610-24627	group-differences	_	
64-47	24628-24630	in	_	
64-48	24631-24634	the	_	
64-49	24635-24638	two	_	
64-50	24639-24651	measurements	_	
64-51	24652-24655	was	_	
64-52	24656-24660	also	_	
64-53	24661-24672	significant	_	
64-54	24673-24676	for	_	
64-55	24677-24680	the	_	
64-56	24681-24696	sibling-patient	_	
64-57	24697-24707	comparison	_	
64-58	24708-24709	(	_	
64-59	24709-24710	r	_	
64-60	24710-24711	 	_	
64-61	24711-24712	=	_	
64-62	24712-24713	 	_	
64-63	24713-24714	−	_	
64-64	24714-24718	0.54	_	
64-65	24718-24719	,	_	
64-66	24720-24721	p	_	
64-67	24721-24722	 	_	
64-68	24722-24723	<	_	
64-69	24723-24724	 	_	
64-70	24724-24728	.001	_	
64-71	24728-24729	)	_	
64-72	24729-24730	,	_	
64-73	24731-24734	and	_	
64-74	24735-24745	marginally	_	
64-75	24746-24757	significant	_	
64-76	24758-24761	for	_	
64-77	24762-24765	the	_	
64-78	24766-24781	control-sibling	_	
64-79	24782-24792	comparison	_	
64-80	24793-24794	(	_	
64-81	24794-24795	r	_	
64-82	24795-24796	 	_	
64-83	24796-24797	=	_	
64-84	24797-24798	 	_	
64-85	24798-24799	−	_	
64-86	24799-24803	0.26	_	
64-87	24803-24804	,	_	
64-88	24805-24806	p	_	
64-89	24806-24807	 	_	
64-90	24807-24808	=	_	
64-91	24808-24809	 	_	
64-92	24809-24813	.053	_	
64-93	24813-24814	)	_	
64-94	24814-24815	.	_	
64-95	24816-24821	These	_	
64-96	24822-24834	correlations	_	
64-97	24835-24843	indicate	_	
64-98	24844-24848	that	_	
64-99	24849-24856	regions	_	
64-100	24857-24864	showing	_	
64-101	24865-24866	a	_	
64-102	24867-24873	larger	_	
64-103	24874-24882	decrease	_	
64-104	24883-24885	in	_	
64-105	24886-24902	interhemispheric	_	
64-106	24903-24915	connectivity	_	
64-107	24916-24918	in	_	
64-108	24919-24927	patients	_	
64-109	24928-24930	as	_	
64-110	24931-24939	compared	_	
64-111	24940-24942	to	_	
64-112	24943-24951	controls	_	
64-113	24952-24954	or	_	
64-114	24955-24963	siblings	_	
64-115	24964-24968	show	_	
64-116	24969-24975	higher	_	
64-117	24976-24981	level	_	
64-118	24982-24984	of	_	
64-119	24985-24996	hemispheric	_	
64-120	24997-25011	specialization	_	
64-121	25011-25012	,	_	
64-122	25013-25023	indicating	_	
64-123	25024-25028	that	_	
64-124	25029-25033	they	_	
64-125	25034-25037	are	_	
64-126	25038-25052	preferentially	_	
64-127	25053-25066	collaborating	_	
64-128	25067-25071	with	_	
64-129	25072-25079	regions	_	
64-130	25080-25086	within	_	
64-131	25087-25090	the	_	
64-132	25091-25095	same	_	
64-133	25096-25106	hemisphere	_	
64-134	25106-25107	.	_	

#Text=Correlation between connectivity alterations and clinical factors
65-1	25108-25119	Correlation	_	
65-2	25120-25127	between	_	
65-3	25128-25140	connectivity	_	
65-4	25141-25152	alterations	_	
65-5	25153-25156	and	_	
65-6	25157-25165	clinical	_	
65-7	25166-25173	factors	_	

#Text=Duration of illness is negatively correlated with global homotopic connectivity (r = −0.26, p = .03) and marginally associated with hemispheric specialization (r = 0.24, p = .049) in the patient group.
66-1	25174-25182	Duration	_	
66-2	25183-25185	of	_	
66-3	25186-25193	illness	_	
66-4	25194-25196	is	_	
66-5	25197-25207	negatively	_	
66-6	25208-25218	correlated	_	
66-7	25219-25223	with	_	
66-8	25224-25230	global	_	
66-9	25231-25240	homotopic	_	
66-10	25241-25253	connectivity	_	
66-11	25254-25255	(	_	
66-12	25255-25256	r	_	
66-13	25256-25257	 	_	
66-14	25257-25258	=	_	
66-15	25258-25259	 	_	
66-16	25259-25260	−	_	
66-17	25260-25264	0.26	_	
66-18	25264-25265	,	_	
66-19	25266-25267	p	_	
66-20	25267-25268	 	_	
66-21	25268-25269	=	_	
66-22	25269-25270	 	_	
66-23	25270-25273	.03	_	
66-24	25273-25274	)	_	
66-25	25275-25278	and	_	
66-26	25279-25289	marginally	_	
66-27	25290-25300	associated	_	
66-28	25301-25305	with	_	
66-29	25306-25317	hemispheric	_	
66-30	25318-25332	specialization	_	
66-31	25333-25334	(	_	
66-32	25334-25335	r	_	
66-33	25335-25336	 	_	
66-34	25336-25337	=	_	
66-35	25337-25338	 	_	
66-36	25338-25342	0.24	_	
66-37	25342-25343	,	_	
66-38	25344-25345	p	_	
66-39	25345-25346	 	_	
66-40	25346-25347	=	_	
66-41	25347-25348	 	_	
66-42	25348-25352	.049	_	
66-43	25352-25353	)	_	
66-44	25354-25356	in	_	
66-45	25357-25360	the	_	
66-46	25361-25368	patient	_	
66-47	25369-25374	group	_	
66-48	25374-25375	.	_	

#Text=Fig. 6
67-1	25376-25379	Fig	_	
67-2	25379-25380	.	_	
67-3	25381-25382	6	_	

#Text=Duration of illness was negatively correlated with interhemispheric connectivity (r = −0.26, p = .03), and marginally associated with hemispheric specialization (r = 0.24, p = .049) in patients (Fig. 6). With longer course of illness, patients have more reduced interhemispheric connectivity and a higher level of segregation between the hemispheres. These connectivity alterations are not likely to be attributable to age, as for controls and siblings, we found no correlations between age and interhemispheric connectivity (controls: r = −0.05, p = .69, siblings: r = −0.07, p = .50) or between age and hemispheric specialization (controls: r = −0.03, p = .84, siblings: r = 0.04, p = .70). We found no correlations between PANSS total scores and connectivity measurements in patients (interhemispheric connectivity: r = 0.12, p = .34, hemispheric specialization r = −0.07, p = .60). Dosage of antipsychotic medication did not show significant associations with interhemispheric connectivity (r = −0.05, p = .70) or hemispheric specialization (r = 0.09, p = .49).
68-1	25383-25391	Duration	_	
68-2	25392-25394	of	_	
68-3	25395-25402	illness	_	
68-4	25403-25406	was	_	
68-5	25407-25417	negatively	_	
68-6	25418-25428	correlated	_	
68-7	25429-25433	with	_	
68-8	25434-25450	interhemispheric	_	
68-9	25451-25463	connectivity	_	
68-10	25464-25465	(	_	
68-11	25465-25466	r	_	
68-12	25466-25467	 	_	
68-13	25467-25468	=	_	
68-14	25468-25469	 	_	
68-15	25469-25470	−	_	
68-16	25470-25474	0.26	_	
68-17	25474-25475	,	_	
68-18	25476-25477	p	_	
68-19	25477-25478	 	_	
68-20	25478-25479	=	_	
68-21	25479-25480	 	_	
68-22	25480-25483	.03	_	
68-23	25483-25484	)	_	
68-24	25484-25485	,	_	
68-25	25486-25489	and	_	
68-26	25490-25500	marginally	_	
68-27	25501-25511	associated	_	
68-28	25512-25516	with	_	
68-29	25517-25528	hemispheric	_	
68-30	25529-25543	specialization	_	
68-31	25544-25545	(	_	
68-32	25545-25546	r	_	
68-33	25546-25547	 	_	
68-34	25547-25548	=	_	
68-35	25548-25549	 	_	
68-36	25549-25553	0.24	_	
68-37	25553-25554	,	_	
68-38	25555-25556	p	_	
68-39	25556-25557	 	_	
68-40	25557-25558	=	_	
68-41	25558-25559	 	_	
68-42	25559-25563	.049	_	
68-43	25563-25564	)	_	
68-44	25565-25567	in	_	
68-45	25568-25576	patients	_	
68-46	25577-25578	(	_	
68-47	25578-25581	Fig	_	
68-48	25581-25582	.	_	
68-49	25583-25584	6	_	
68-50	25584-25585	)	_	
68-51	25585-25586	.	_	
68-52	25587-25591	With	_	
68-53	25592-25598	longer	_	
68-54	25599-25605	course	_	
68-55	25606-25608	of	_	
68-56	25609-25616	illness	_	
68-57	25616-25617	,	_	
68-58	25618-25626	patients	_	
68-59	25627-25631	have	_	
68-60	25632-25636	more	_	
68-61	25637-25644	reduced	_	
68-62	25645-25661	interhemispheric	_	
68-63	25662-25674	connectivity	_	
68-64	25675-25678	and	_	
68-65	25679-25680	a	_	
68-66	25681-25687	higher	_	
68-67	25688-25693	level	_	
68-68	25694-25696	of	_	
68-69	25697-25708	segregation	_	
68-70	25709-25716	between	_	
68-71	25717-25720	the	_	
68-72	25721-25732	hemispheres	_	
68-73	25732-25733	.	_	
68-74	25734-25739	These	_	
68-75	25740-25752	connectivity	_	
68-76	25753-25764	alterations	_	
68-77	25765-25768	are	_	
68-78	25769-25772	not	_	
68-79	25773-25779	likely	_	
68-80	25780-25782	to	_	
68-81	25783-25785	be	_	
68-82	25786-25798	attributable	_	
68-83	25799-25801	to	_	
68-84	25802-25805	age	_	
68-85	25805-25806	,	_	
68-86	25807-25809	as	_	
68-87	25810-25813	for	_	
68-88	25814-25822	controls	_	
68-89	25823-25826	and	_	
68-90	25827-25835	siblings	_	
68-91	25835-25836	,	_	
68-92	25837-25839	we	_	
68-93	25840-25845	found	_	
68-94	25846-25848	no	_	
68-95	25849-25861	correlations	_	
68-96	25862-25869	between	_	
68-97	25870-25873	age	_	
68-98	25874-25877	and	_	
68-99	25878-25894	interhemispheric	_	
68-100	25895-25907	connectivity	_	
68-101	25908-25909	(	_	
68-102	25909-25917	controls	_	
68-103	25917-25918	:	_	
68-104	25919-25920	r	_	
68-105	25920-25921	 	_	
68-106	25921-25922	=	_	
68-107	25922-25923	 	_	
68-108	25923-25924	−	_	
68-109	25924-25928	0.05	_	
68-110	25928-25929	,	_	
68-111	25930-25931	p	_	
68-112	25931-25932	 	_	
68-113	25932-25933	=	_	
68-114	25933-25934	 	_	
68-115	25934-25937	.69	_	
68-116	25937-25938	,	_	
68-117	25939-25947	siblings	_	
68-118	25947-25948	:	_	
68-119	25949-25950	r	_	
68-120	25950-25951	 	_	
68-121	25951-25952	=	_	
68-122	25952-25953	 	_	
68-123	25953-25954	−	_	
68-124	25954-25958	0.07	_	
68-125	25958-25959	,	_	
68-126	25960-25961	p	_	
68-127	25961-25962	 	_	
68-128	25962-25963	=	_	
68-129	25963-25964	 	_	
68-130	25964-25967	.50	_	
68-131	25967-25968	)	_	
68-132	25969-25971	or	_	
68-133	25972-25979	between	_	
68-134	25980-25983	age	_	
68-135	25984-25987	and	_	
68-136	25988-25999	hemispheric	_	
68-137	26000-26014	specialization	_	
68-138	26015-26016	(	_	
68-139	26016-26024	controls	_	
68-140	26024-26025	:	_	
68-141	26026-26027	r	_	
68-142	26027-26028	 	_	
68-143	26028-26029	=	_	
68-144	26029-26030	 	_	
68-145	26030-26031	−	_	
68-146	26031-26035	0.03	_	
68-147	26035-26036	,	_	
68-148	26037-26038	p	_	
68-149	26038-26039	 	_	
68-150	26039-26040	=	_	
68-151	26040-26041	 	_	
68-152	26041-26044	.84	_	
68-153	26044-26045	,	_	
68-154	26046-26054	siblings	_	
68-155	26054-26055	:	_	
68-156	26056-26057	r	_	
68-157	26057-26058	 	_	
68-158	26058-26059	=	_	
68-159	26059-26060	 	_	
68-160	26060-26064	0.04	_	
68-161	26064-26065	,	_	
68-162	26066-26067	p	_	
68-163	26067-26068	 	_	
68-164	26068-26069	=	_	
68-165	26069-26070	 	_	
68-166	26070-26073	.70	_	
68-167	26073-26074	)	_	
68-168	26074-26075	.	_	
68-169	26076-26078	We	_	
68-170	26079-26084	found	_	
68-171	26085-26087	no	_	
68-172	26088-26100	correlations	_	
68-173	26101-26108	between	_	
68-174	26109-26114	PANSS	_	
68-175	26115-26120	total	_	
68-176	26121-26127	scores	_	
68-177	26128-26131	and	_	
68-178	26132-26144	connectivity	_	
68-179	26145-26157	measurements	_	
68-180	26158-26160	in	_	
68-181	26161-26169	patients	_	
68-182	26170-26171	(	_	
68-183	26171-26187	interhemispheric	_	
68-184	26188-26200	connectivity	_	
68-185	26200-26201	:	_	
68-186	26202-26203	r	_	
68-187	26203-26204	 	_	
68-188	26204-26205	=	_	
68-189	26205-26206	 	_	
68-190	26206-26210	0.12	_	
68-191	26210-26211	,	_	
68-192	26212-26213	p	_	
68-193	26213-26214	 	_	
68-194	26214-26215	=	_	
68-195	26215-26216	 	_	
68-196	26216-26219	.34	_	
68-197	26219-26220	,	_	
68-198	26221-26232	hemispheric	_	
68-199	26233-26247	specialization	_	
68-200	26248-26249	r	_	
68-201	26249-26250	 	_	
68-202	26250-26251	=	_	
68-203	26251-26252	 	_	
68-204	26252-26253	−	_	
68-205	26253-26257	0.07	_	
68-206	26257-26258	,	_	
68-207	26259-26260	p	_	
68-208	26260-26261	 	_	
68-209	26261-26262	=	_	
68-210	26262-26263	 	_	
68-211	26263-26266	.60	_	
68-212	26266-26267	)	_	
68-213	26267-26268	.	_	
68-214	26269-26275	Dosage	_	
68-215	26276-26278	of	_	
68-216	26279-26292	antipsychotic	_	
68-217	26293-26303	medication	_	
68-218	26304-26307	did	_	
68-219	26308-26311	not	_	
68-220	26312-26316	show	_	
68-221	26317-26328	significant	_	
68-222	26329-26341	associations	_	
68-223	26342-26346	with	_	
68-224	26347-26363	interhemispheric	_	
68-225	26364-26376	connectivity	_	
68-226	26377-26378	(	_	
68-227	26378-26379	r	_	
68-228	26379-26380	 	_	
68-229	26380-26381	=	_	
68-230	26381-26382	 	_	
68-231	26382-26383	−	_	
68-232	26383-26387	0.05	_	
68-233	26387-26388	,	_	
68-234	26389-26390	p	_	
68-235	26390-26391	 	_	
68-236	26391-26392	=	_	
68-237	26392-26393	 	_	
68-238	26393-26396	.70	_	
68-239	26396-26397	)	_	
68-240	26398-26400	or	_	
68-241	26401-26412	hemispheric	_	
68-242	26413-26427	specialization	_	
68-243	26428-26429	(	_	
68-244	26429-26430	r	_	
68-245	26430-26431	 	_	
68-246	26431-26432	=	_	
68-247	26432-26433	 	_	
68-248	26433-26437	0.09	_	
68-249	26437-26438	,	_	
68-250	26439-26440	p	_	
68-251	26440-26441	 	_	
68-252	26441-26442	=	_	
68-253	26442-26443	 	_	
68-254	26443-26446	.49	_	
68-255	26446-26447	)	_	
68-256	26447-26448	.	_	

#Text=Discussion
69-1	26449-26459	Discussion	_	

#Text=The current study examined interhemispheric connectivity and hemispheric specialization in a large cohort of schizophrenia patients, their unaffected siblings, and healthy controls. Compared to controls and siblings, patients showed marked decreases in interhemispheric connectivity, as well as increased hemispheric specialization on a global and regional level. No major deficits in interhemispheric connectivity or hemispheric specialization were found in unaffected siblings of patients. Moreover, interhemispheric connectivity and hemispheric specialization were found to correlate with duration of illness in patients. Taken together, our study shows impaired interhemispheric connectivity and a more segregated hemispheric connectivity profile in schizophrenia patients and suggests that these abnormalities are likely to be characteristics of established disease, rather than an expression of preexistent risk for the disorder.
70-1	26460-26463	The	_	
70-2	26464-26471	current	_	
70-3	26472-26477	study	_	
70-4	26478-26486	examined	_	
70-5	26487-26503	interhemispheric	_	
70-6	26504-26516	connectivity	_	
70-7	26517-26520	and	_	
70-8	26521-26532	hemispheric	_	
70-9	26533-26547	specialization	_	
70-10	26548-26550	in	_	
70-11	26551-26552	a	_	
70-12	26553-26558	large	_	
70-13	26559-26565	cohort	_	
70-14	26566-26568	of	_	
70-15	26569-26582	schizophrenia	_	
70-16	26583-26591	patients	_	
70-17	26591-26592	,	_	
70-18	26593-26598	their	_	
70-19	26599-26609	unaffected	_	
70-20	26610-26618	siblings	_	
70-21	26618-26619	,	_	
70-22	26620-26623	and	_	
70-23	26624-26631	healthy	_	
70-24	26632-26640	controls	_	
70-25	26640-26641	.	_	
70-26	26642-26650	Compared	_	
70-27	26651-26653	to	_	
70-28	26654-26662	controls	_	
70-29	26663-26666	and	_	
70-30	26667-26675	siblings	_	
70-31	26675-26676	,	_	
70-32	26677-26685	patients	_	
70-33	26686-26692	showed	_	
70-34	26693-26699	marked	_	
70-35	26700-26709	decreases	_	
70-36	26710-26712	in	_	
70-37	26713-26729	interhemispheric	_	
70-38	26730-26742	connectivity	_	
70-39	26742-26743	,	_	
70-40	26744-26746	as	_	
70-41	26747-26751	well	_	
70-42	26752-26754	as	_	
70-43	26755-26764	increased	_	
70-44	26765-26776	hemispheric	_	
70-45	26777-26791	specialization	_	
70-46	26792-26794	on	_	
70-47	26795-26796	a	_	
70-48	26797-26803	global	_	
70-49	26804-26807	and	_	
70-50	26808-26816	regional	_	
70-51	26817-26822	level	_	
70-52	26822-26823	.	_	
70-53	26824-26826	No	_	
70-54	26827-26832	major	_	
70-55	26833-26841	deficits	_	
70-56	26842-26844	in	_	
70-57	26845-26861	interhemispheric	_	
70-58	26862-26874	connectivity	_	
70-59	26875-26877	or	_	
70-60	26878-26889	hemispheric	_	
70-61	26890-26904	specialization	_	
70-62	26905-26909	were	_	
70-63	26910-26915	found	_	
70-64	26916-26918	in	_	
70-65	26919-26929	unaffected	_	
70-66	26930-26938	siblings	_	
70-67	26939-26941	of	_	
70-68	26942-26950	patients	_	
70-69	26950-26951	.	_	
70-70	26952-26960	Moreover	_	
70-71	26960-26961	,	_	
70-72	26962-26978	interhemispheric	_	
70-73	26979-26991	connectivity	_	
70-74	26992-26995	and	_	
70-75	26996-27007	hemispheric	_	
70-76	27008-27022	specialization	_	
70-77	27023-27027	were	_	
70-78	27028-27033	found	_	
70-79	27034-27036	to	_	
70-80	27037-27046	correlate	_	
70-81	27047-27051	with	_	
70-82	27052-27060	duration	_	
70-83	27061-27063	of	_	
70-84	27064-27071	illness	_	
70-85	27072-27074	in	_	
70-86	27075-27083	patients	_	
70-87	27083-27084	.	_	
70-88	27085-27090	Taken	_	
70-89	27091-27099	together	_	
70-90	27099-27100	,	_	
70-91	27101-27104	our	_	
70-92	27105-27110	study	_	
70-93	27111-27116	shows	_	
70-94	27117-27125	impaired	_	
70-95	27126-27142	interhemispheric	_	
70-96	27143-27155	connectivity	_	
70-97	27156-27159	and	_	
70-98	27160-27161	a	_	
70-99	27162-27166	more	_	
70-100	27167-27177	segregated	_	
70-101	27178-27189	hemispheric	_	
70-102	27190-27202	connectivity	_	
70-103	27203-27210	profile	_	
70-104	27211-27213	in	_	
70-105	27214-27227	schizophrenia	_	
70-106	27228-27236	patients	_	
70-107	27237-27240	and	_	
70-108	27241-27249	suggests	_	
70-109	27250-27254	that	_	
70-110	27255-27260	these	_	
70-111	27261-27274	abnormalities	_	
70-112	27275-27278	are	_	
70-113	27279-27285	likely	_	
70-114	27286-27288	to	_	
70-115	27289-27291	be	_	
70-116	27292-27307	characteristics	_	
70-117	27308-27310	of	_	
70-118	27311-27322	established	_	
70-119	27323-27330	disease	_	
70-120	27330-27331	,	_	
70-121	27332-27338	rather	_	
70-122	27339-27343	than	_	
70-123	27344-27346	an	_	
70-124	27347-27357	expression	_	
70-125	27358-27360	of	_	
70-126	27361-27372	preexistent	_	
70-127	27373-27377	risk	_	
70-128	27378-27381	for	_	
70-129	27382-27385	the	_	
70-130	27386-27394	disorder	_	
70-131	27394-27395	.	_	

#Text=The first question we set out to answer is whether impairments in interhemispheric connectivity are present in patients with schizophrenia and, if so, whether these impairments relate to preexistent familial risk for the illness. To answer this question, we examined a group of unaffected siblings of schizophrenia patients, who share 50% of their genetic information with affected probands on average. In contrast to a previous study reporting a subtle decline of regional interhemispheric connectivity strength in siblings as compared to controls, our current study does not find significant reductions in interhemispheric connectivity in unaffected siblings, suggesting that interhemispheric connectivity impairments may be an overt clinical phenotype of schizophrenia. Alternatively, interhemispheric connectivity impairments may be present from a young age in patients and siblings, but normalize with development in unaffected siblings due to a compensatory mechanism, as has been shown for siblings of childhood-onset schizophrenia patients.
71-1	27396-27399	The	_	
71-2	27400-27405	first	_	
71-3	27406-27414	question	_	
71-4	27415-27417	we	_	
71-5	27418-27421	set	_	
71-6	27422-27425	out	_	
71-7	27426-27428	to	_	
71-8	27429-27435	answer	_	
71-9	27436-27438	is	_	
71-10	27439-27446	whether	_	
71-11	27447-27458	impairments	_	
71-12	27459-27461	in	_	
71-13	27462-27478	interhemispheric	_	
71-14	27479-27491	connectivity	_	
71-15	27492-27495	are	_	
71-16	27496-27503	present	_	
71-17	27504-27506	in	_	
71-18	27507-27515	patients	_	
71-19	27516-27520	with	_	
71-20	27521-27534	schizophrenia	_	
71-21	27535-27538	and	_	
71-22	27538-27539	,	_	
71-23	27540-27542	if	_	
71-24	27543-27545	so	_	
71-25	27545-27546	,	_	
71-26	27547-27554	whether	_	
71-27	27555-27560	these	_	
71-28	27561-27572	impairments	_	
71-29	27573-27579	relate	_	
71-30	27580-27582	to	_	
71-31	27583-27594	preexistent	_	
71-32	27595-27603	familial	_	
71-33	27604-27608	risk	_	
71-34	27609-27612	for	_	
71-35	27613-27616	the	_	
71-36	27617-27624	illness	_	
71-37	27624-27625	.	_	
71-38	27626-27628	To	_	
71-39	27629-27635	answer	_	
71-40	27636-27640	this	_	
71-41	27641-27649	question	_	
71-42	27649-27650	,	_	
71-43	27651-27653	we	_	
71-44	27654-27662	examined	_	
71-45	27663-27664	a	_	
71-46	27665-27670	group	_	
71-47	27671-27673	of	_	
71-48	27674-27684	unaffected	_	
71-49	27685-27693	siblings	_	
71-50	27694-27696	of	_	
71-51	27697-27710	schizophrenia	_	
71-52	27711-27719	patients	_	
71-53	27719-27720	,	_	
71-54	27721-27724	who	_	
71-55	27725-27730	share	_	
71-56	27731-27734	50%	_	
71-57	27735-27737	of	_	
71-58	27738-27743	their	_	
71-59	27744-27751	genetic	_	
71-60	27752-27763	information	_	
71-61	27764-27768	with	_	
71-62	27769-27777	affected	_	
71-63	27778-27786	probands	_	
71-64	27787-27789	on	_	
71-65	27790-27797	average	_	
71-66	27797-27798	.	_	
71-67	27799-27801	In	_	
71-68	27802-27810	contrast	_	
71-69	27811-27813	to	_	
71-70	27814-27815	a	_	
71-71	27816-27824	previous	_	
71-72	27825-27830	study	_	
71-73	27831-27840	reporting	_	
71-74	27841-27842	a	_	
71-75	27843-27849	subtle	_	
71-76	27850-27857	decline	_	
71-77	27858-27860	of	_	
71-78	27861-27869	regional	_	
71-79	27870-27886	interhemispheric	_	
71-80	27887-27899	connectivity	_	
71-81	27900-27908	strength	_	
71-82	27909-27911	in	_	
71-83	27912-27920	siblings	_	
71-84	27921-27923	as	_	
71-85	27924-27932	compared	_	
71-86	27933-27935	to	_	
71-87	27936-27944	controls	_	
71-88	27944-27945	,	_	
71-89	27946-27949	our	_	
71-90	27950-27957	current	_	
71-91	27958-27963	study	_	
71-92	27964-27968	does	_	
71-93	27969-27972	not	_	
71-94	27973-27977	find	_	
71-95	27978-27989	significant	_	
71-96	27990-28000	reductions	_	
71-97	28001-28003	in	_	
71-98	28004-28020	interhemispheric	_	
71-99	28021-28033	connectivity	_	
71-100	28034-28036	in	_	
71-101	28037-28047	unaffected	_	
71-102	28048-28056	siblings	_	
71-103	28056-28057	,	_	
71-104	28058-28068	suggesting	_	
71-105	28069-28073	that	_	
71-106	28074-28090	interhemispheric	_	
71-107	28091-28103	connectivity	_	
71-108	28104-28115	impairments	_	
71-109	28116-28119	may	_	
71-110	28120-28122	be	_	
71-111	28123-28125	an	_	
71-112	28126-28131	overt	_	
71-113	28132-28140	clinical	_	
71-114	28141-28150	phenotype	_	
71-115	28151-28153	of	_	
71-116	28154-28167	schizophrenia	_	
71-117	28167-28168	.	_	
71-118	28169-28182	Alternatively	_	
71-119	28182-28183	,	_	
71-120	28184-28200	interhemispheric	_	
71-121	28201-28213	connectivity	_	
71-122	28214-28225	impairments	_	
71-123	28226-28229	may	_	
71-124	28230-28232	be	_	
71-125	28233-28240	present	_	
71-126	28241-28245	from	_	
71-127	28246-28247	a	_	
71-128	28248-28253	young	_	
71-129	28254-28257	age	_	
71-130	28258-28260	in	_	
71-131	28261-28269	patients	_	
71-132	28270-28273	and	_	
71-133	28274-28282	siblings	_	
71-134	28282-28283	,	_	
71-135	28284-28287	but	_	
71-136	28288-28297	normalize	_	
71-137	28298-28302	with	_	
71-138	28303-28314	development	_	
71-139	28315-28317	in	_	
71-140	28318-28328	unaffected	_	
71-141	28329-28337	siblings	_	
71-142	28338-28341	due	_	
71-143	28342-28344	to	_	
71-144	28345-28346	a	_	
71-145	28347-28359	compensatory	_	
71-146	28360-28369	mechanism	_	
71-147	28369-28370	,	_	
71-148	28371-28373	as	_	
71-149	28374-28377	has	_	
71-150	28378-28382	been	_	
71-151	28383-28388	shown	_	
71-152	28389-28392	for	_	
71-153	28393-28401	siblings	_	
71-154	28402-28404	of	_	
71-155	28405-28420	childhood-onset	_	
71-156	28421-28434	schizophrenia	_	
71-157	28435-28443	patients	_	
71-158	28443-28444	.	_	

#Text=Another interest of the current study was to examine disturbances of interhemispheric connectivity in relation to putative abnormalities in hemispheric specialization. We find that schizophrenia patients exhibit increased hemispheric specialization in several unimodal and heteromodal association regions, as well as sensorimotor cortex and limbic areas (Fig. 4A), indicating an excessive reduction in cross-hemisphere connectivity relative to within-hemisphere connectivity in these brain regions. The unimodal and heteromodal association cortices have reciprocal connectivity with lower level brain regions, and are involved in the integration of sensory information from multiple modalities. Previous studies have shown that the cortical network of multimodal brain regions is disproportionately affected in schizophrenia and abnormalities in association cortices such as reduced cortical thickness and fiber integrity have been found in schizophrenia patients. Extending previous findings, we suggest that unimodal and heteromodal areas more preferentially connected to ipsilateral brain areas in schizophrenia, at the expense of facilitating cross-hemisphere interactions with a broader range of brain regions.
72-1	28445-28452	Another	_	
72-2	28453-28461	interest	_	
72-3	28462-28464	of	_	
72-4	28465-28468	the	_	
72-5	28469-28476	current	_	
72-6	28477-28482	study	_	
72-7	28483-28486	was	_	
72-8	28487-28489	to	_	
72-9	28490-28497	examine	_	
72-10	28498-28510	disturbances	_	
72-11	28511-28513	of	_	
72-12	28514-28530	interhemispheric	_	
72-13	28531-28543	connectivity	_	
72-14	28544-28546	in	_	
72-15	28547-28555	relation	_	
72-16	28556-28558	to	_	
72-17	28559-28567	putative	_	
72-18	28568-28581	abnormalities	_	
72-19	28582-28584	in	_	
72-20	28585-28596	hemispheric	_	
72-21	28597-28611	specialization	_	
72-22	28611-28612	.	_	
72-23	28613-28615	We	_	
72-24	28616-28620	find	_	
72-25	28621-28625	that	_	
72-26	28626-28639	schizophrenia	_	
72-27	28640-28648	patients	_	
72-28	28649-28656	exhibit	_	
72-29	28657-28666	increased	_	
72-30	28667-28678	hemispheric	_	
72-31	28679-28693	specialization	_	
72-32	28694-28696	in	_	
72-33	28697-28704	several	_	
72-34	28705-28713	unimodal	_	
72-35	28714-28717	and	_	
72-36	28718-28729	heteromodal	_	
72-37	28730-28741	association	_	
72-38	28742-28749	regions	_	
72-39	28749-28750	,	_	
72-40	28751-28753	as	_	
72-41	28754-28758	well	_	
72-42	28759-28761	as	_	
72-43	28762-28774	sensorimotor	_	
72-44	28775-28781	cortex	_	
72-45	28782-28785	and	_	
72-46	28786-28792	limbic	_	
72-47	28793-28798	areas	_	
72-48	28799-28800	(	_	
72-49	28800-28803	Fig	_	
72-50	28803-28804	.	_	
72-51	28805-28807	4A	_	
72-52	28807-28808	)	_	
72-53	28808-28809	,	_	
72-54	28810-28820	indicating	_	
72-55	28821-28823	an	_	
72-56	28824-28833	excessive	_	
72-57	28834-28843	reduction	_	
72-58	28844-28846	in	_	
72-59	28847-28863	cross-hemisphere	_	
72-60	28864-28876	connectivity	_	
72-61	28877-28885	relative	_	
72-62	28886-28888	to	_	
72-63	28889-28906	within-hemisphere	_	
72-64	28907-28919	connectivity	_	
72-65	28920-28922	in	_	
72-66	28923-28928	these	_	
72-67	28929-28934	brain	_	
72-68	28935-28942	regions	_	
72-69	28942-28943	.	_	
72-70	28944-28947	The	_	
72-71	28948-28956	unimodal	_	
72-72	28957-28960	and	_	
72-73	28961-28972	heteromodal	_	
72-74	28973-28984	association	_	
72-75	28985-28993	cortices	_	
72-76	28994-28998	have	_	
72-77	28999-29009	reciprocal	_	
72-78	29010-29022	connectivity	_	
72-79	29023-29027	with	_	
72-80	29028-29033	lower	_	
72-81	29034-29039	level	_	
72-82	29040-29045	brain	_	
72-83	29046-29053	regions	_	
72-84	29053-29054	,	_	
72-85	29055-29058	and	_	
72-86	29059-29062	are	_	
72-87	29063-29071	involved	_	
72-88	29072-29074	in	_	
72-89	29075-29078	the	_	
72-90	29079-29090	integration	_	
72-91	29091-29093	of	_	
72-92	29094-29101	sensory	_	
72-93	29102-29113	information	_	
72-94	29114-29118	from	_	
72-95	29119-29127	multiple	_	
72-96	29128-29138	modalities	_	
72-97	29138-29139	.	_	
72-98	29140-29148	Previous	_	
72-99	29149-29156	studies	_	
72-100	29157-29161	have	_	
72-101	29162-29167	shown	_	
72-102	29168-29172	that	_	
72-103	29173-29176	the	_	
72-104	29177-29185	cortical	_	
72-105	29186-29193	network	_	
72-106	29194-29196	of	_	
72-107	29197-29207	multimodal	_	
72-108	29208-29213	brain	_	
72-109	29214-29221	regions	_	
72-110	29222-29224	is	_	
72-111	29225-29243	disproportionately	_	
72-112	29244-29252	affected	_	
72-113	29253-29255	in	_	
72-114	29256-29269	schizophrenia	_	
72-115	29270-29273	and	_	
72-116	29274-29287	abnormalities	_	
72-117	29288-29290	in	_	
72-118	29291-29302	association	_	
72-119	29303-29311	cortices	_	
72-120	29312-29316	such	_	
72-121	29317-29319	as	_	
72-122	29320-29327	reduced	_	
72-123	29328-29336	cortical	_	
72-124	29337-29346	thickness	_	
72-125	29347-29350	and	_	
72-126	29351-29356	fiber	_	
72-127	29357-29366	integrity	_	
72-128	29367-29371	have	_	
72-129	29372-29376	been	_	
72-130	29377-29382	found	_	
72-131	29383-29385	in	_	
72-132	29386-29399	schizophrenia	_	
72-133	29400-29408	patients	_	
72-134	29408-29409	.	_	
72-135	29410-29419	Extending	_	
72-136	29420-29428	previous	_	
72-137	29429-29437	findings	_	
72-138	29437-29438	,	_	
72-139	29439-29441	we	_	
72-140	29442-29449	suggest	_	
72-141	29450-29454	that	_	
72-142	29455-29463	unimodal	_	
72-143	29464-29467	and	_	
72-144	29468-29479	heteromodal	_	
72-145	29480-29485	areas	_	
72-146	29486-29490	more	_	
72-147	29491-29505	preferentially	_	
72-148	29506-29515	connected	_	
72-149	29516-29518	to	_	
72-150	29519-29530	ipsilateral	_	
72-151	29531-29536	brain	_	
72-152	29537-29542	areas	_	
72-153	29543-29545	in	_	
72-154	29546-29559	schizophrenia	_	
72-155	29559-29560	,	_	
72-156	29561-29563	at	_	
72-157	29564-29567	the	_	
72-158	29568-29575	expense	_	
72-159	29576-29578	of	_	
72-160	29579-29591	facilitating	_	
72-161	29592-29608	cross-hemisphere	_	
72-162	29609-29621	interactions	_	
72-163	29622-29626	with	_	
72-164	29627-29628	a	_	
72-165	29629-29636	broader	_	
72-166	29637-29642	range	_	
72-167	29643-29645	of	_	
72-168	29646-29651	brain	_	
72-169	29652-29659	regions	_	
72-170	29659-29660	.	_	

#Text=In terms of the relationship between interhemispheric connectivity and hemispheric specialization, we find a significant correlation between lower interhemispheric connectivity and higher hemispheric specialization index in patients as compared to both controls and siblings (Fig. 5). These connectivity abnormalities may relate to reduced lateralization in schizophrenia. Previous studies have found that schizophrenia patients exhibit a loss of asymmetry in the auditory cortex in task-induced activation, and its functional connectivity with other regions. In addition, reduced asymmetry in brain morphology and white matter connectivity have also been reported (for review and meta-analysis please refer to). The identified abnormalities of intrinsic interhemispheric connectivity and hemispheric specialization suggest impairments of synchronization between the two hemispheres, and a preference of intra- versus inter-hemispheric connectivity in patients, which is consistent with a lack of efficient lateralized processing in the dominant hemisphere during tasks.
73-1	29661-29663	In	_	
73-2	29664-29669	terms	_	
73-3	29670-29672	of	_	
73-4	29673-29676	the	_	
73-5	29677-29689	relationship	_	
73-6	29690-29697	between	_	
73-7	29698-29714	interhemispheric	_	
73-8	29715-29727	connectivity	_	
73-9	29728-29731	and	_	
73-10	29732-29743	hemispheric	_	
73-11	29744-29758	specialization	_	
73-12	29758-29759	,	_	
73-13	29760-29762	we	_	
73-14	29763-29767	find	_	
73-15	29768-29769	a	_	
73-16	29770-29781	significant	_	
73-17	29782-29793	correlation	_	
73-18	29794-29801	between	_	
73-19	29802-29807	lower	_	
73-20	29808-29824	interhemispheric	_	
73-21	29825-29837	connectivity	_	
73-22	29838-29841	and	_	
73-23	29842-29848	higher	_	
73-24	29849-29860	hemispheric	_	
73-25	29861-29875	specialization	_	
73-26	29876-29881	index	_	
73-27	29882-29884	in	_	
73-28	29885-29893	patients	_	
73-29	29894-29896	as	_	
73-30	29897-29905	compared	_	
73-31	29906-29908	to	_	
73-32	29909-29913	both	_	
73-33	29914-29922	controls	_	
73-34	29923-29926	and	_	
73-35	29927-29935	siblings	_	
73-36	29936-29937	(	_	
73-37	29937-29940	Fig	_	
73-38	29940-29941	.	_	
73-39	29942-29943	5	_	
73-40	29943-29944	)	_	
73-41	29944-29945	.	_	
73-42	29946-29951	These	_	
73-43	29952-29964	connectivity	_	
73-44	29965-29978	abnormalities	_	
73-45	29979-29982	may	_	
73-46	29983-29989	relate	_	
73-47	29990-29992	to	_	
73-48	29993-30000	reduced	_	
73-49	30001-30015	lateralization	_	
73-50	30016-30018	in	_	
73-51	30019-30032	schizophrenia	_	
73-52	30032-30033	.	_	
73-53	30034-30042	Previous	_	
73-54	30043-30050	studies	_	
73-55	30051-30055	have	_	
73-56	30056-30061	found	_	
73-57	30062-30066	that	_	
73-58	30067-30080	schizophrenia	_	
73-59	30081-30089	patients	_	
73-60	30090-30097	exhibit	_	
73-61	30098-30099	a	_	
73-62	30100-30104	loss	_	
73-63	30105-30107	of	_	
73-64	30108-30117	asymmetry	_	
73-65	30118-30120	in	_	
73-66	30121-30124	the	_	
73-67	30125-30133	auditory	_	
73-68	30134-30140	cortex	_	
73-69	30141-30143	in	_	
73-70	30144-30156	task-induced	_	
73-71	30157-30167	activation	_	
73-72	30167-30168	,	_	
73-73	30169-30172	and	_	
73-74	30173-30176	its	_	
73-75	30177-30187	functional	_	
73-76	30188-30200	connectivity	_	
73-77	30201-30205	with	_	
73-78	30206-30211	other	_	
73-79	30212-30219	regions	_	
73-80	30219-30220	.	_	
73-81	30221-30223	In	_	
73-82	30224-30232	addition	_	
73-83	30232-30233	,	_	
73-84	30234-30241	reduced	_	
73-85	30242-30251	asymmetry	_	
73-86	30252-30254	in	_	
73-87	30255-30260	brain	_	
73-88	30261-30271	morphology	_	
73-89	30272-30275	and	_	
73-90	30276-30281	white	_	
73-91	30282-30288	matter	_	
73-92	30289-30301	connectivity	_	
73-93	30302-30306	have	_	
73-94	30307-30311	also	_	
73-95	30312-30316	been	_	
73-96	30317-30325	reported	_	
73-97	30326-30327	(	_	
73-98	30327-30330	for	_	
73-99	30331-30337	review	_	
73-100	30338-30341	and	_	
73-101	30342-30355	meta-analysis	_	
73-102	30356-30362	please	_	
73-103	30363-30368	refer	_	
73-104	30369-30371	to	_	
73-105	30371-30372	)	_	
73-106	30372-30373	.	_	
73-107	30374-30377	The	_	
73-108	30378-30388	identified	_	
73-109	30389-30402	abnormalities	_	
73-110	30403-30405	of	_	
73-111	30406-30415	intrinsic	_	
73-112	30416-30432	interhemispheric	_	
73-113	30433-30445	connectivity	_	
73-114	30446-30449	and	_	
73-115	30450-30461	hemispheric	_	
73-116	30462-30476	specialization	_	
73-117	30477-30484	suggest	_	
73-118	30485-30496	impairments	_	
73-119	30497-30499	of	_	
73-120	30500-30515	synchronization	_	
73-121	30516-30523	between	_	
73-122	30524-30527	the	_	
73-123	30528-30531	two	_	
73-124	30532-30543	hemispheres	_	
73-125	30543-30544	,	_	
73-126	30545-30548	and	_	
73-127	30549-30550	a	_	
73-128	30551-30561	preference	_	
73-129	30562-30564	of	_	
73-130	30565-30570	intra	_	
73-131	30570-30571	-	_	
73-132	30572-30578	versus	_	
73-133	30579-30596	inter-hemispheric	_	
73-134	30597-30609	connectivity	_	
73-135	30610-30612	in	_	
73-136	30613-30621	patients	_	
73-137	30621-30622	,	_	
73-138	30623-30628	which	_	
73-139	30629-30631	is	_	
73-140	30632-30642	consistent	_	
73-141	30643-30647	with	_	
73-142	30648-30649	a	_	
73-143	30650-30654	lack	_	
73-144	30655-30657	of	_	
73-145	30658-30667	efficient	_	
73-146	30668-30679	lateralized	_	
73-147	30680-30690	processing	_	
73-148	30691-30693	in	_	
73-149	30694-30697	the	_	
73-150	30698-30706	dominant	_	
73-151	30707-30717	hemisphere	_	
73-152	30718-30724	during	_	
73-153	30725-30730	tasks	_	
73-154	30730-30731	.	_	

#Text=A strong main effect of hemisphere was found for hemispheric autonomy of many cortical and subcortical regions (Fig. 4B). Higher hemispheric specialization in the left hemisphere was found predominately in language-related regions, as well as subcortical regions and posterior cingulate cortex. Regions with higher autonomy in the right hemisphere mainly included parietal and occipital areas, as well as a few frontal, temporal, cingulate, and subcortical regions. This lateralization pattern is consistent with previous findings of a dissociation between left hemisphere specialization in language areas and a right hemisphere dominance in visuospatial and attentional areas. Interestingly, we found that the hemispheric specialization of Heschl's gyrus and the temporal plane is lower in the left than the right hemispheric regions, indicating that in these primary auditory cortices, left hemispheric regions are more bilaterally connected (low hemispheric specialization), whereas right-sided regions are more ipsilaterally connected (high hemispheric specialization). This connectivity profile may indicate a more important role of the left primary auditory cortex in integration and processing of auditory information. Connectivity of the caudate nucleus tends to be more ipsilateral in the right hemisphere as compared to the left hemisphere, which is different from the results of a previous study, but is consistent with a right-over-left dopamine receptor availability in this region in healthy subjects. Other subcortical regions such as thalamus, putamen, pallidum, and amygdala were all found to exhibit higher hemispheric autonomy for the right hemisphere, in line with previous findings of a more bilaterally connected pattern in the right hemisphere.
74-1	30732-30733	A	_	
74-2	30734-30740	strong	_	
74-3	30741-30745	main	_	
74-4	30746-30752	effect	_	
74-5	30753-30755	of	_	
74-6	30756-30766	hemisphere	_	
74-7	30767-30770	was	_	
74-8	30771-30776	found	_	
74-9	30777-30780	for	_	
74-10	30781-30792	hemispheric	_	
74-11	30793-30801	autonomy	_	
74-12	30802-30804	of	_	
74-13	30805-30809	many	_	
74-14	30810-30818	cortical	_	
74-15	30819-30822	and	_	
74-16	30823-30834	subcortical	_	
74-17	30835-30842	regions	_	
74-18	30843-30844	(	_	
74-19	30844-30847	Fig	_	
74-20	30847-30848	.	_	
74-21	30849-30851	4B	_	
74-22	30851-30852	)	_	
74-23	30852-30853	.	_	
74-24	30854-30860	Higher	_	
74-25	30861-30872	hemispheric	_	
74-26	30873-30887	specialization	_	
74-27	30888-30890	in	_	
74-28	30891-30894	the	_	
74-29	30895-30899	left	_	
74-30	30900-30910	hemisphere	_	
74-31	30911-30914	was	_	
74-32	30915-30920	found	_	
74-33	30921-30934	predominately	_	
74-34	30935-30937	in	_	
74-35	30938-30954	language-related	_	
74-36	30955-30962	regions	_	
74-37	30962-30963	,	_	
74-38	30964-30966	as	_	
74-39	30967-30971	well	_	
74-40	30972-30974	as	_	
74-41	30975-30986	subcortical	_	
74-42	30987-30994	regions	_	
74-43	30995-30998	and	_	
74-44	30999-31008	posterior	_	
74-45	31009-31018	cingulate	_	
74-46	31019-31025	cortex	_	
74-47	31025-31026	.	_	
74-48	31027-31034	Regions	_	
74-49	31035-31039	with	_	
74-50	31040-31046	higher	_	
74-51	31047-31055	autonomy	_	
74-52	31056-31058	in	_	
74-53	31059-31062	the	_	
74-54	31063-31068	right	_	
74-55	31069-31079	hemisphere	_	
74-56	31080-31086	mainly	_	
74-57	31087-31095	included	_	
74-58	31096-31104	parietal	_	
74-59	31105-31108	and	_	
74-60	31109-31118	occipital	_	
74-61	31119-31124	areas	_	
74-62	31124-31125	,	_	
74-63	31126-31128	as	_	
74-64	31129-31133	well	_	
74-65	31134-31136	as	_	
74-66	31137-31138	a	_	
74-67	31139-31142	few	_	
74-68	31143-31150	frontal	_	
74-69	31150-31151	,	_	
74-70	31152-31160	temporal	_	
74-71	31160-31161	,	_	
74-72	31162-31171	cingulate	_	
74-73	31171-31172	,	_	
74-74	31173-31176	and	_	
74-75	31177-31188	subcortical	_	
74-76	31189-31196	regions	_	
74-77	31196-31197	.	_	
74-78	31198-31202	This	_	
74-79	31203-31217	lateralization	_	
74-80	31218-31225	pattern	_	
74-81	31226-31228	is	_	
74-82	31229-31239	consistent	_	
74-83	31240-31244	with	_	
74-84	31245-31253	previous	_	
74-85	31254-31262	findings	_	
74-86	31263-31265	of	_	
74-87	31266-31267	a	_	
74-88	31268-31280	dissociation	_	
74-89	31281-31288	between	_	
74-90	31289-31293	left	_	
74-91	31294-31304	hemisphere	_	
74-92	31305-31319	specialization	_	
74-93	31320-31322	in	_	
74-94	31323-31331	language	_	
74-95	31332-31337	areas	_	
74-96	31338-31341	and	_	
74-97	31342-31343	a	_	
74-98	31344-31349	right	_	
74-99	31350-31360	hemisphere	_	
74-100	31361-31370	dominance	_	
74-101	31371-31373	in	_	
74-102	31374-31386	visuospatial	_	
74-103	31387-31390	and	_	
74-104	31391-31402	attentional	_	
74-105	31403-31408	areas	_	
74-106	31408-31409	.	_	
74-107	31410-31423	Interestingly	_	
74-108	31423-31424	,	_	
74-109	31425-31427	we	_	
74-110	31428-31433	found	_	
74-111	31434-31438	that	_	
74-112	31439-31442	the	_	
74-113	31443-31454	hemispheric	_	
74-114	31455-31469	specialization	_	
74-115	31470-31472	of	_	
74-116	31473-31481	Heschl's	_	
74-117	31482-31487	gyrus	_	
74-118	31488-31491	and	_	
74-119	31492-31495	the	_	
74-120	31496-31504	temporal	_	
74-121	31505-31510	plane	_	
74-122	31511-31513	is	_	
74-123	31514-31519	lower	_	
74-124	31520-31522	in	_	
74-125	31523-31526	the	_	
74-126	31527-31531	left	_	
74-127	31532-31536	than	_	
74-128	31537-31540	the	_	
74-129	31541-31546	right	_	
74-130	31547-31558	hemispheric	_	
74-131	31559-31566	regions	_	
74-132	31566-31567	,	_	
74-133	31568-31578	indicating	_	
74-134	31579-31583	that	_	
74-135	31584-31586	in	_	
74-136	31587-31592	these	_	
74-137	31593-31600	primary	_	
74-138	31601-31609	auditory	_	
74-139	31610-31618	cortices	_	
74-140	31618-31619	,	_	
74-141	31620-31624	left	_	
74-142	31625-31636	hemispheric	_	
74-143	31637-31644	regions	_	
74-144	31645-31648	are	_	
74-145	31649-31653	more	_	
74-146	31654-31665	bilaterally	_	
74-147	31666-31675	connected	_	
74-148	31676-31677	(	_	
74-149	31677-31680	low	_	
74-150	31681-31692	hemispheric	_	
74-151	31693-31707	specialization	_	
74-152	31707-31708	)	_	
74-153	31708-31709	,	_	
74-154	31710-31717	whereas	_	
74-155	31718-31729	right-sided	_	
74-156	31730-31737	regions	_	
74-157	31738-31741	are	_	
74-158	31742-31746	more	_	
74-159	31747-31760	ipsilaterally	_	
74-160	31761-31770	connected	_	
74-161	31771-31772	(	_	
74-162	31772-31776	high	_	
74-163	31777-31788	hemispheric	_	
74-164	31789-31803	specialization	_	
74-165	31803-31804	)	_	
74-166	31804-31805	.	_	
74-167	31806-31810	This	_	
74-168	31811-31823	connectivity	_	
74-169	31824-31831	profile	_	
74-170	31832-31835	may	_	
74-171	31836-31844	indicate	_	
74-172	31845-31846	a	_	
74-173	31847-31851	more	_	
74-174	31852-31861	important	_	
74-175	31862-31866	role	_	
74-176	31867-31869	of	_	
74-177	31870-31873	the	_	
74-178	31874-31878	left	_	
74-179	31879-31886	primary	_	
74-180	31887-31895	auditory	_	
74-181	31896-31902	cortex	_	
74-182	31903-31905	in	_	
74-183	31906-31917	integration	_	
74-184	31918-31921	and	_	
74-185	31922-31932	processing	_	
74-186	31933-31935	of	_	
74-187	31936-31944	auditory	_	
74-188	31945-31956	information	_	
74-189	31956-31957	.	_	
74-190	31958-31970	Connectivity	_	
74-191	31971-31973	of	_	
74-192	31974-31977	the	_	
74-193	31978-31985	caudate	_	
74-194	31986-31993	nucleus	_	
74-195	31994-31999	tends	_	
74-196	32000-32002	to	_	
74-197	32003-32005	be	_	
74-198	32006-32010	more	_	
74-199	32011-32022	ipsilateral	_	
74-200	32023-32025	in	_	
74-201	32026-32029	the	_	
74-202	32030-32035	right	_	
74-203	32036-32046	hemisphere	_	
74-204	32047-32049	as	_	
74-205	32050-32058	compared	_	
74-206	32059-32061	to	_	
74-207	32062-32065	the	_	
74-208	32066-32070	left	_	
74-209	32071-32081	hemisphere	_	
74-210	32081-32082	,	_	
74-211	32083-32088	which	_	
74-212	32089-32091	is	_	
74-213	32092-32101	different	_	
74-214	32102-32106	from	_	
74-215	32107-32110	the	_	
74-216	32111-32118	results	_	
74-217	32119-32121	of	_	
74-218	32122-32123	a	_	
74-219	32124-32132	previous	_	
74-220	32133-32138	study	_	
74-221	32138-32139	,	_	
74-222	32140-32143	but	_	
74-223	32144-32146	is	_	
74-224	32147-32157	consistent	_	
74-225	32158-32162	with	_	
74-226	32163-32164	a	_	
74-227	32165-32180	right-over-left	_	
74-228	32181-32189	dopamine	_	
74-229	32190-32198	receptor	_	
74-230	32199-32211	availability	_	
74-231	32212-32214	in	_	
74-232	32215-32219	this	_	
74-233	32220-32226	region	_	
74-234	32227-32229	in	_	
74-235	32230-32237	healthy	_	
74-236	32238-32246	subjects	_	
74-237	32246-32247	.	_	
74-238	32248-32253	Other	_	
74-239	32254-32265	subcortical	_	
74-240	32266-32273	regions	_	
74-241	32274-32278	such	_	
74-242	32279-32281	as	_	
74-243	32282-32290	thalamus	_	
74-244	32290-32291	,	_	
74-245	32292-32299	putamen	_	
74-246	32299-32300	,	_	
74-247	32301-32309	pallidum	_	
74-248	32309-32310	,	_	
74-249	32311-32314	and	_	
74-250	32315-32323	amygdala	_	
74-251	32324-32328	were	_	
74-252	32329-32332	all	_	
74-253	32333-32338	found	_	
74-254	32339-32341	to	_	
74-255	32342-32349	exhibit	_	
74-256	32350-32356	higher	_	
74-257	32357-32368	hemispheric	_	
74-258	32369-32377	autonomy	_	
74-259	32378-32381	for	_	
74-260	32382-32385	the	_	
74-261	32386-32391	right	_	
74-262	32392-32402	hemisphere	_	
74-263	32402-32403	,	_	
74-264	32404-32406	in	_	
74-265	32407-32411	line	_	
74-266	32412-32416	with	_	
74-267	32417-32425	previous	_	
74-268	32426-32434	findings	_	
74-269	32435-32437	of	_	
74-270	32438-32439	a	_	
74-271	32440-32444	more	_	
74-272	32445-32456	bilaterally	_	
74-273	32457-32466	connected	_	
74-274	32467-32474	pattern	_	
74-275	32475-32477	in	_	
74-276	32478-32481	the	_	
74-277	32482-32487	right	_	
74-278	32488-32498	hemisphere	_	
74-279	32498-32499	.	_	

#Text=Several points need to be taken into consideration when interpreting our results. First, we preformed region-based rather than voxel-based analyses of interhemispheric connectivity and hemispheric specialization. Hence, our definition of hemispheric specialization is different from a previous study based on voxel-wise measurements. Region-based and voxel-based approaches each have their benefits and limitations. We adopted a region-based approach for better sensitivity and interpretability of the results, and to allow us to correlate measurements of interhemispheric connectivity and hemispheric specialization across brain regions. Second, the proportion of male and female subjects are not balanced across groups. To address this issue, we included sex as a covariate when performing group-comparisons. Previous studies have produced mixed results in terms of the effects of sex on interhemispheric connectivity strength. Future studies with a balanced sex distribution would be better suited to examine potential sex differences on interhemispheric connectivity and hemispheric specialization in schizophrenia. Third, we did not find a significant correlation between regional interhemispheric disconnectivity and symptom severity in patients as some previous studies have reported. A possible reason for the lack of association may be that the patients recruited in this study were relatively stable at the time of participation (PANSS total scores 48.38 ± 14.89, see Table 1). Therefore, we cannot rule out the possibility that an association exists between disconnectivity and symptoms in patients with more pronounced clinical symptoms.
75-1	32500-32507	Several	_	
75-2	32508-32514	points	_	
75-3	32515-32519	need	_	
75-4	32520-32522	to	_	
75-5	32523-32525	be	_	
75-6	32526-32531	taken	_	
75-7	32532-32536	into	_	
75-8	32537-32550	consideration	_	
75-9	32551-32555	when	_	
75-10	32556-32568	interpreting	_	
75-11	32569-32572	our	_	
75-12	32573-32580	results	_	
75-13	32580-32581	.	_	
75-14	32582-32587	First	_	
75-15	32587-32588	,	_	
75-16	32589-32591	we	_	
75-17	32592-32601	preformed	_	
75-18	32602-32614	region-based	_	
75-19	32615-32621	rather	_	
75-20	32622-32626	than	_	
75-21	32627-32638	voxel-based	_	
75-22	32639-32647	analyses	_	
75-23	32648-32650	of	_	
75-24	32651-32667	interhemispheric	_	
75-25	32668-32680	connectivity	_	
75-26	32681-32684	and	_	
75-27	32685-32696	hemispheric	_	
75-28	32697-32711	specialization	_	
75-29	32711-32712	.	_	
75-30	32713-32718	Hence	_	
75-31	32718-32719	,	_	
75-32	32720-32723	our	_	
75-33	32724-32734	definition	_	
75-34	32735-32737	of	_	
75-35	32738-32749	hemispheric	_	
75-36	32750-32764	specialization	_	
75-37	32765-32767	is	_	
75-38	32768-32777	different	_	
75-39	32778-32782	from	_	
75-40	32783-32784	a	_	
75-41	32785-32793	previous	_	
75-42	32794-32799	study	_	
75-43	32800-32805	based	_	
75-44	32806-32808	on	_	
75-45	32809-32819	voxel-wise	_	
75-46	32820-32832	measurements	_	
75-47	32832-32833	.	_	
75-48	32834-32846	Region-based	_	
75-49	32847-32850	and	_	
75-50	32851-32862	voxel-based	_	
75-51	32863-32873	approaches	_	
75-52	32874-32878	each	_	
75-53	32879-32883	have	_	
75-54	32884-32889	their	_	
75-55	32890-32898	benefits	_	
75-56	32899-32902	and	_	
75-57	32903-32914	limitations	_	
75-58	32914-32915	.	_	
75-59	32916-32918	We	_	
75-60	32919-32926	adopted	_	
75-61	32927-32928	a	_	
75-62	32929-32941	region-based	_	
75-63	32942-32950	approach	_	
75-64	32951-32954	for	_	
75-65	32955-32961	better	_	
75-66	32962-32973	sensitivity	_	
75-67	32974-32977	and	_	
75-68	32978-32994	interpretability	_	
75-69	32995-32997	of	_	
75-70	32998-33001	the	_	
75-71	33002-33009	results	_	
75-72	33009-33010	,	_	
75-73	33011-33014	and	_	
75-74	33015-33017	to	_	
75-75	33018-33023	allow	_	
75-76	33024-33026	us	_	
75-77	33027-33029	to	_	
75-78	33030-33039	correlate	_	
75-79	33040-33052	measurements	_	
75-80	33053-33055	of	_	
75-81	33056-33072	interhemispheric	_	
75-82	33073-33085	connectivity	_	
75-83	33086-33089	and	_	
75-84	33090-33101	hemispheric	_	
75-85	33102-33116	specialization	_	
75-86	33117-33123	across	_	
75-87	33124-33129	brain	_	
75-88	33130-33137	regions	_	
75-89	33137-33138	.	_	
75-90	33139-33145	Second	_	
75-91	33145-33146	,	_	
75-92	33147-33150	the	_	
75-93	33151-33161	proportion	_	
75-94	33162-33164	of	_	
75-95	33165-33169	male	_	
75-96	33170-33173	and	_	
75-97	33174-33180	female	_	
75-98	33181-33189	subjects	_	
75-99	33190-33193	are	_	
75-100	33194-33197	not	_	
75-101	33198-33206	balanced	_	
75-102	33207-33213	across	_	
75-103	33214-33220	groups	_	
75-104	33220-33221	.	_	
75-105	33222-33224	To	_	
75-106	33225-33232	address	_	
75-107	33233-33237	this	_	
75-108	33238-33243	issue	_	
75-109	33243-33244	,	_	
75-110	33245-33247	we	_	
75-111	33248-33256	included	_	
75-112	33257-33260	sex	_	
75-113	33261-33263	as	_	
75-114	33264-33265	a	_	
75-115	33266-33275	covariate	_	
75-116	33276-33280	when	_	
75-117	33281-33291	performing	_	
75-118	33292-33309	group-comparisons	_	
75-119	33309-33310	.	_	
75-120	33311-33319	Previous	_	
75-121	33320-33327	studies	_	
75-122	33328-33332	have	_	
75-123	33333-33341	produced	_	
75-124	33342-33347	mixed	_	
75-125	33348-33355	results	_	
75-126	33356-33358	in	_	
75-127	33359-33364	terms	_	
75-128	33365-33367	of	_	
75-129	33368-33371	the	_	
75-130	33372-33379	effects	_	
75-131	33380-33382	of	_	
75-132	33383-33386	sex	_	
75-133	33387-33389	on	_	
75-134	33390-33406	interhemispheric	_	
75-135	33407-33419	connectivity	_	
75-136	33420-33428	strength	_	
75-137	33428-33429	.	_	
75-138	33430-33436	Future	_	
75-139	33437-33444	studies	_	
75-140	33445-33449	with	_	
75-141	33450-33451	a	_	
75-142	33452-33460	balanced	_	
75-143	33461-33464	sex	_	
75-144	33465-33477	distribution	_	
75-145	33478-33483	would	_	
75-146	33484-33486	be	_	
75-147	33487-33493	better	_	
75-148	33494-33500	suited	_	
75-149	33501-33503	to	_	
75-150	33504-33511	examine	_	
75-151	33512-33521	potential	_	
75-152	33522-33525	sex	_	
75-153	33526-33537	differences	_	
75-154	33538-33540	on	_	
75-155	33541-33557	interhemispheric	_	
75-156	33558-33570	connectivity	_	
75-157	33571-33574	and	_	
75-158	33575-33586	hemispheric	_	
75-159	33587-33601	specialization	_	
75-160	33602-33604	in	_	
75-161	33605-33618	schizophrenia	_	
75-162	33618-33619	.	_	
75-163	33620-33625	Third	_	
75-164	33625-33626	,	_	
75-165	33627-33629	we	_	
75-166	33630-33633	did	_	
75-167	33634-33637	not	_	
75-168	33638-33642	find	_	
75-169	33643-33644	a	_	
75-170	33645-33656	significant	_	
75-171	33657-33668	correlation	_	
75-172	33669-33676	between	_	
75-173	33677-33685	regional	_	
75-174	33686-33702	interhemispheric	_	
75-175	33703-33718	disconnectivity	_	
75-176	33719-33722	and	_	
75-177	33723-33730	symptom	_	
75-178	33731-33739	severity	_	
75-179	33740-33742	in	_	
75-180	33743-33751	patients	_	
75-181	33752-33754	as	_	
75-182	33755-33759	some	_	
75-183	33760-33768	previous	_	
75-184	33769-33776	studies	_	
75-185	33777-33781	have	_	
75-186	33782-33790	reported	_	
75-187	33790-33791	.	_	
75-188	33792-33793	A	_	
75-189	33794-33802	possible	_	
75-190	33803-33809	reason	_	
75-191	33810-33813	for	_	
75-192	33814-33817	the	_	
75-193	33818-33822	lack	_	
75-194	33823-33825	of	_	
75-195	33826-33837	association	_	
75-196	33838-33841	may	_	
75-197	33842-33844	be	_	
75-198	33845-33849	that	_	
75-199	33850-33853	the	_	
75-200	33854-33862	patients	_	
75-201	33863-33872	recruited	_	
75-202	33873-33875	in	_	
75-203	33876-33880	this	_	
75-204	33881-33886	study	_	
75-205	33887-33891	were	_	
75-206	33892-33902	relatively	_	
75-207	33903-33909	stable	_	
75-208	33910-33912	at	_	
75-209	33913-33916	the	_	
75-210	33917-33921	time	_	
75-211	33922-33924	of	_	
75-212	33925-33938	participation	_	
75-213	33939-33940	(	_	
75-214	33940-33945	PANSS	_	
75-215	33946-33951	total	_	
75-216	33952-33958	scores	_	
75-217	33959-33964	48.38	_	
75-218	33964-33965	 	_	
75-219	33965-33966	±	_	
75-220	33966-33967	 	_	
75-221	33967-33972	14.89	_	
75-222	33972-33973	,	_	
75-223	33974-33977	see	_	
75-224	33978-33983	Table	_	
75-225	33984-33985	1	_	
75-226	33985-33986	)	_	
75-227	33986-33987	.	_	
75-228	33988-33997	Therefore	_	
75-229	33997-33998	,	_	
75-230	33999-34001	we	_	
75-231	34002-34008	cannot	_	
75-232	34009-34013	rule	_	
75-233	34014-34017	out	_	
75-234	34018-34021	the	_	
75-235	34022-34033	possibility	_	
75-236	34034-34038	that	_	
75-237	34039-34041	an	_	
75-238	34042-34053	association	_	
75-239	34054-34060	exists	_	
75-240	34061-34068	between	_	
75-241	34069-34084	disconnectivity	_	
75-242	34085-34088	and	_	
75-243	34089-34097	symptoms	_	
75-244	34098-34100	in	_	
75-245	34101-34109	patients	_	
75-246	34110-34114	with	_	
75-247	34115-34119	more	_	
75-248	34120-34130	pronounced	_	
75-249	34131-34139	clinical	_	
75-250	34140-34148	symptoms	_	
75-251	34148-34149	.	_	

#Text=Conclusion
76-1	34150-34160	Conclusion	_	

#Text=This study explored interhemispheric connectivity and hemispheric specialization in a large cohort of schizophrenia patients, their unaffected siblings and healthy controls. Our results indicate that patients exhibit decreased interhemispheric connectivity as compared to both healthy controls and unaffected siblings, and these impairments were found to correlate with increases in the level of hemispheric specialization. These connectivity alterations appear to be primarily related to illness manifestation, as siblings did not show significant changes compared to controls, and connectivity changes in patients correlated with duration of illness. In summary, the current study suggests that decreased interhemispheric connectivity and associated abnormalities in hemispheric specialization are features of established schizophrenia rather than an expression of preexistent risk for the disorder.
77-1	34161-34165	This	_	
77-2	34166-34171	study	_	
77-3	34172-34180	explored	_	
77-4	34181-34197	interhemispheric	_	
77-5	34198-34210	connectivity	_	
77-6	34211-34214	and	_	
77-7	34215-34226	hemispheric	_	
77-8	34227-34241	specialization	_	
77-9	34242-34244	in	_	
77-10	34245-34246	a	_	
77-11	34247-34252	large	_	
77-12	34253-34259	cohort	_	
77-13	34260-34262	of	_	
77-14	34263-34276	schizophrenia	_	
77-15	34277-34285	patients	_	
77-16	34285-34286	,	_	
77-17	34287-34292	their	_	
77-18	34293-34303	unaffected	_	
77-19	34304-34312	siblings	_	
77-20	34313-34316	and	_	
77-21	34317-34324	healthy	_	
77-22	34325-34333	controls	_	
77-23	34333-34334	.	_	
77-24	34335-34338	Our	_	
77-25	34339-34346	results	_	
77-26	34347-34355	indicate	_	
77-27	34356-34360	that	_	
77-28	34361-34369	patients	_	
77-29	34370-34377	exhibit	_	
77-30	34378-34387	decreased	_	
77-31	34388-34404	interhemispheric	_	
77-32	34405-34417	connectivity	_	
77-33	34418-34420	as	_	
77-34	34421-34429	compared	_	
77-35	34430-34432	to	_	
77-36	34433-34437	both	_	
77-37	34438-34445	healthy	_	
77-38	34446-34454	controls	_	
77-39	34455-34458	and	_	
77-40	34459-34469	unaffected	_	
77-41	34470-34478	siblings	_	
77-42	34478-34479	,	_	
77-43	34480-34483	and	_	
77-44	34484-34489	these	_	
77-45	34490-34501	impairments	_	
77-46	34502-34506	were	_	
77-47	34507-34512	found	_	
77-48	34513-34515	to	_	
77-49	34516-34525	correlate	_	
77-50	34526-34530	with	_	
77-51	34531-34540	increases	_	
77-52	34541-34543	in	_	
77-53	34544-34547	the	_	
77-54	34548-34553	level	_	
77-55	34554-34556	of	_	
77-56	34557-34568	hemispheric	_	
77-57	34569-34583	specialization	_	
77-58	34583-34584	.	_	
77-59	34585-34590	These	_	
77-60	34591-34603	connectivity	_	
77-61	34604-34615	alterations	_	
77-62	34616-34622	appear	_	
77-63	34623-34625	to	_	
77-64	34626-34628	be	_	
77-65	34629-34638	primarily	_	
77-66	34639-34646	related	_	
77-67	34647-34649	to	_	
77-68	34650-34657	illness	_	
77-69	34658-34671	manifestation	_	
77-70	34671-34672	,	_	
77-71	34673-34675	as	_	
77-72	34676-34684	siblings	_	
77-73	34685-34688	did	_	
77-74	34689-34692	not	_	
77-75	34693-34697	show	_	
77-76	34698-34709	significant	_	
77-77	34710-34717	changes	_	
77-78	34718-34726	compared	_	
77-79	34727-34729	to	_	
77-80	34730-34738	controls	_	
77-81	34738-34739	,	_	
77-82	34740-34743	and	_	
77-83	34744-34756	connectivity	_	
77-84	34757-34764	changes	_	
77-85	34765-34767	in	_	
77-86	34768-34776	patients	_	
77-87	34777-34787	correlated	_	
77-88	34788-34792	with	_	
77-89	34793-34801	duration	_	
77-90	34802-34804	of	_	
77-91	34805-34812	illness	_	
77-92	34812-34813	.	_	
77-93	34814-34816	In	_	
77-94	34817-34824	summary	_	
77-95	34824-34825	,	_	
77-96	34826-34829	the	_	
77-97	34830-34837	current	_	
77-98	34838-34843	study	_	
77-99	34844-34852	suggests	_	
77-100	34853-34857	that	_	
77-101	34858-34867	decreased	_	
77-102	34868-34884	interhemispheric	_	
77-103	34885-34897	connectivity	_	
77-104	34898-34901	and	_	
77-105	34902-34912	associated	_	
77-106	34913-34926	abnormalities	_	
77-107	34927-34929	in	_	
77-108	34930-34941	hemispheric	_	
77-109	34942-34956	specialization	_	
77-110	34957-34960	are	_	
77-111	34961-34969	features	_	
77-112	34970-34972	of	_	
77-113	34973-34984	established	_	
77-114	34985-34998	schizophrenia	_	
77-115	34999-35005	rather	_	
77-116	35006-35010	than	_	
77-117	35011-35013	an	_	
77-118	35014-35024	expression	_	
77-119	35025-35027	of	_	
77-120	35028-35039	preexistent	_	
77-121	35040-35044	risk	_	
77-122	35045-35048	for	_	
77-123	35049-35052	the	_	
77-124	35053-35061	disorder	_	
77-125	35061-35062	.	_	

#Text=The following are the supplementary data related to this article.
78-1	35063-35066	The	_	
78-2	35067-35076	following	_	
78-3	35077-35080	are	_	
78-4	35081-35084	the	_	
78-5	35085-35098	supplementary	_	
78-6	35099-35103	data	_	
78-7	35104-35111	related	_	
78-8	35112-35114	to	_	
78-9	35115-35119	this	_	
78-10	35120-35127	article	_	
78-11	35127-35128	.	_	

#Text=Funding statement
79-1	35129-35136	Funding	_	
79-2	35137-35146	statement	_	

#Text=The infrastructure for the GROUP study is funded through the Geestkracht programme of the  (Zon-Mw, grant number 10-000-1001), and matching funds from participating pharmaceutical companies (, , , ) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the  and the mental health institutions: , , , , , . Groningen:  Groningen and the mental health institutions: , , , , , ,  and  The Hague. Maastricht:  and the mental health institutions: , , , , , , , , , , , , . Utrecht:  and the mental health institutions , ).
80-1	35147-35150	The	_	
80-2	35151-35165	infrastructure	_	
80-3	35166-35169	for	_	
80-4	35170-35173	the	_	
80-5	35174-35179	GROUP	_	
80-6	35180-35185	study	_	
80-7	35186-35188	is	_	
80-8	35189-35195	funded	_	
80-9	35196-35203	through	_	
80-10	35204-35207	the	_	
80-11	35208-35219	Geestkracht	_	
80-12	35220-35229	programme	_	
80-13	35230-35232	of	_	
80-14	35233-35236	the	_	
80-15	35238-35239	(	_	
80-16	35239-35245	Zon-Mw	_	
80-17	35245-35246	,	_	
80-18	35247-35252	grant	_	
80-19	35253-35259	number	_	
80-20	35260-35262	10	_	
80-21	35262-35263	-	_	
80-22	35263-35266	000	_	
80-23	35266-35267	-	_	
80-24	35267-35271	1001	_	
80-25	35271-35272	)	_	
80-26	35272-35273	,	_	
80-27	35274-35277	and	_	
80-28	35278-35286	matching	_	
80-29	35287-35292	funds	_	
80-30	35293-35297	from	_	
80-31	35298-35311	participating	_	
80-32	35312-35326	pharmaceutical	_	
80-33	35327-35336	companies	_	
80-34	35337-35338	(	_	
80-35	35338-35339	,	_	
80-36	35340-35341	,	_	
80-37	35342-35343	,	_	
80-38	35344-35345	)	_	
80-39	35346-35349	and	_	
80-40	35350-35362	universities	_	
80-41	35363-35366	and	_	
80-42	35367-35373	mental	_	
80-43	35374-35380	health	_	
80-44	35381-35385	care	_	
80-45	35386-35399	organizations	_	
80-46	35400-35401	(	_	
80-47	35401-35410	Amsterdam	_	
80-48	35410-35411	:	_	
80-49	35412-35420	Academic	_	
80-50	35421-35432	Psychiatric	_	
80-51	35433-35439	Centre	_	
80-52	35440-35442	of	_	
80-53	35443-35446	the	_	
80-54	35448-35451	and	_	
80-55	35452-35455	the	_	
80-56	35456-35462	mental	_	
80-57	35463-35469	health	_	
80-58	35470-35482	institutions	_	
80-59	35482-35483	:	_	
80-60	35484-35485	,	_	
80-61	35486-35487	,	_	
80-62	35488-35489	,	_	
80-63	35490-35491	,	_	
80-64	35492-35493	,	_	
80-65	35494-35495	.	_	
80-66	35496-35505	Groningen	_	
80-67	35505-35506	:	_	
80-68	35508-35517	Groningen	_	
80-69	35518-35521	and	_	
80-70	35522-35525	the	_	
80-71	35526-35532	mental	_	
80-72	35533-35539	health	_	
80-73	35540-35552	institutions	_	
80-74	35552-35553	:	_	
80-75	35554-35555	,	_	
80-76	35556-35557	,	_	
80-77	35558-35559	,	_	
80-78	35560-35561	,	_	
80-79	35562-35563	,	_	
80-80	35564-35565	,	_	
80-81	35567-35570	and	_	
80-82	35572-35575	The	_	
80-83	35576-35581	Hague	_	
80-84	35581-35582	.	_	
80-85	35583-35593	Maastricht	_	
80-86	35593-35594	:	_	
80-87	35596-35599	and	_	
80-88	35600-35603	the	_	
80-89	35604-35610	mental	_	
80-90	35611-35617	health	_	
80-91	35618-35630	institutions	_	
80-92	35630-35631	:	_	
80-93	35632-35633	,	_	
80-94	35634-35635	,	_	
80-95	35636-35637	,	_	
80-96	35638-35639	,	_	
80-97	35640-35641	,	_	
80-98	35642-35643	,	_	
80-99	35644-35645	,	_	
80-100	35646-35647	,	_	
80-101	35648-35649	,	_	
80-102	35650-35651	,	_	
80-103	35652-35653	,	_	
80-104	35654-35655	,	_	
80-105	35656-35657	.	_	
80-106	35658-35665	Utrecht	_	
80-107	35665-35666	:	_	
80-108	35668-35671	and	_	
80-109	35672-35675	the	_	
80-110	35676-35682	mental	_	
80-111	35683-35689	health	_	
80-112	35690-35702	institutions	_	
80-113	35703-35704	,	_	
80-114	35705-35706	)	_	
80-115	35706-35707	.	_	

#Text=Conflict of interest
81-1	35708-35716	Conflict	_	
81-2	35717-35719	of	_	
81-3	35720-35728	interest	_	

#Text=All authors declare no conflict of interest.
82-1	35729-35732	All	_	
82-2	35733-35740	authors	_	
82-3	35741-35748	declare	_	
82-4	35749-35751	no	_	
82-5	35752-35760	conflict	_	
82-6	35761-35763	of	_	
82-7	35764-35772	interest	_	
82-8	35772-35773	.	_	

#Text=References
83-1	35774-35784	References	_	

#Text=Decreased interhemispheric functional connectivity in autism
84-1	35785-35794	Decreased	_	
84-2	35795-35811	interhemispheric	_	
84-3	35812-35822	functional	_	
84-4	35823-35835	connectivity	_	
84-5	35836-35838	in	_	
84-6	35839-35845	autism	_	

#Text=The comprehensive assessment of symptoms and history (CASH). An instrument for assessing diagnosis and psychopathology
85-1	35846-35849	The	_	
85-2	35850-35863	comprehensive	_	
85-3	35864-35874	assessment	_	
85-4	35875-35877	of	_	
85-5	35878-35886	symptoms	_	
85-6	35887-35890	and	_	
85-7	35891-35898	history	_	
85-8	35899-35900	(	_	
85-9	35900-35904	CASH	_	
85-10	35904-35905	)	_	
85-11	35905-35906	.	_	
85-12	35907-35909	An	_	
85-13	35910-35920	instrument	_	
85-14	35921-35924	for	_	
85-15	35925-35934	assessing	_	
85-16	35935-35944	diagnosis	_	
85-17	35945-35948	and	_	
85-18	35949-35964	psychopathology	_	

#Text=Lack of asymmetrical transfer for linguistic stimuli in schizophrenia: an ERP study
86-1	35965-35969	Lack	_	
86-2	35970-35972	of	_	
86-3	35973-35985	asymmetrical	_	
86-4	35986-35994	transfer	_	
86-5	35995-35998	for	_	
86-6	35999-36009	linguistic	_	
86-7	36010-36017	stimuli	_	
86-8	36018-36020	in	_	
86-9	36021-36034	schizophrenia	_	
86-10	36034-36035	:	_	
86-11	36036-36038	an	_	
86-12	36039-36042	ERP	_	
86-13	36043-36048	study	_	

#Text=Planum temporale asymmetry reversal in schizophrenia: replication and relationship to gray matter abnormalities
87-1	36049-36055	Planum	_	
87-2	36056-36065	temporale	_	
87-3	36066-36075	asymmetry	_	
87-4	36076-36084	reversal	_	
87-5	36085-36087	in	_	
87-6	36088-36101	schizophrenia	_	
87-7	36101-36102	:	_	
87-8	36103-36114	replication	_	
87-9	36115-36118	and	_	
87-10	36119-36131	relationship	_	
87-11	36132-36134	to	_	
87-12	36135-36139	gray	_	
87-13	36140-36146	matter	_	
87-14	36147-36160	abnormalities	_	

#Text=Hierarchical organization of human cortical networks in health and schizophrenia
88-1	36161-36173	Hierarchical	_	
88-2	36174-36186	organization	_	
88-3	36187-36189	of	_	
88-4	36190-36195	human	_	
88-5	36196-36204	cortical	_	
88-6	36205-36213	networks	_	
88-7	36214-36216	in	_	
88-8	36217-36223	health	_	
88-9	36224-36227	and	_	
88-10	36228-36241	schizophrenia	_	

#Text=Absence of regional hemispheric volume asymmetries in first-episode schizophrenia
89-1	36242-36249	Absence	_	
89-2	36250-36252	of	_	
89-3	36253-36261	regional	_	
89-4	36262-36273	hemispheric	_	
89-5	36274-36280	volume	_	
89-6	36281-36292	asymmetries	_	
89-7	36293-36295	in	_	
89-8	36296-36309	first-episode	_	
89-9	36310-36323	schizophrenia	_	

#Text=Reduced language lateralization in first-episode schizophrenia: an fMRI index of functional asymmetry
90-1	36324-36331	Reduced	_	
90-2	36332-36340	language	_	
90-3	36341-36355	lateralization	_	
90-4	36356-36358	in	_	
90-5	36359-36372	first-episode	_	
90-6	36373-36386	schizophrenia	_	
90-7	36386-36387	:	_	
90-8	36388-36390	an	_	
90-9	36391-36395	fMRI	_	
90-10	36396-36401	index	_	
90-11	36402-36404	of	_	
90-12	36405-36415	functional	_	
90-13	36416-36425	asymmetry	_	

#Text=Diminished language lateralization in schizophrenia corresponds to impaired inter-hemispheric functional connectivity
91-1	36426-36436	Diminished	_	
91-2	36437-36445	language	_	
91-3	36446-36460	lateralization	_	
91-4	36461-36463	in	_	
91-5	36464-36477	schizophrenia	_	
91-6	36478-36489	corresponds	_	
91-7	36490-36492	to	_	
91-8	36493-36501	impaired	_	
91-9	36502-36519	inter-hemispheric	_	
91-10	36520-36530	functional	_	
91-11	36531-36543	connectivity	_	

#Text=Focal and global brain measurements in siblings of patients with schizophrenia
92-1	36544-36549	Focal	_	
92-2	36550-36553	and	_	
92-3	36554-36560	global	_	
92-4	36561-36566	brain	_	
92-5	36567-36579	measurements	_	
92-6	36580-36582	in	_	
92-7	36583-36591	siblings	_	
92-8	36592-36594	of	_	
92-9	36595-36603	patients	_	
92-10	36604-36608	with	_	
92-11	36609-36622	schizophrenia	_	

#Text=Complementary hemispheric specialization for language production and visuospatial attention
93-1	36623-36636	Complementary	_	
93-2	36637-36648	hemispheric	_	
93-3	36649-36663	specialization	_	
93-4	36664-36667	for	_	
93-5	36668-36676	language	_	
93-6	36677-36687	production	_	
93-7	36688-36691	and	_	
93-8	36692-36704	visuospatial	_	
93-9	36705-36714	attention	_	

#Text=Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia
94-1	36715-36721	Cortex	_	
94-2	36722-36729	mapping	_	
94-3	36730-36737	reveals	_	
94-4	36738-36748	regionally	_	
94-5	36749-36757	specific	_	
94-6	36758-36766	patterns	_	
94-7	36767-36769	of	_	
94-8	36770-36777	genetic	_	
94-9	36778-36781	and	_	
94-10	36782-36798	disease-specific	_	
94-11	36799-36810	gray-matter	_	
94-12	36811-36819	deficits	_	
94-13	36820-36822	in	_	
94-14	36823-36828	twins	_	
94-15	36829-36839	discordant	_	
94-16	36840-36843	for	_	
94-17	36844-36857	schizophrenia	_	

#Text=Distinct inter-hemispheric dysconnectivity in schizophrenia patients with and without auditory verbal hallucinations
95-1	36858-36866	Distinct	_	
95-2	36867-36884	inter-hemispheric	_	
95-3	36885-36900	dysconnectivity	_	
95-4	36901-36903	in	_	
95-5	36904-36917	schizophrenia	_	
95-6	36918-36926	patients	_	
95-7	36927-36931	with	_	
95-8	36932-36935	and	_	
95-9	36936-36943	without	_	
95-10	36944-36952	auditory	_	
95-11	36953-36959	verbal	_	
95-12	36960-36974	hallucinations	_	

#Text=Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings
96-1	36975-36983	Impaired	_	
96-2	36984-36994	cerebellar	_	
96-3	36995-37005	functional	_	
96-4	37006-37018	connectivity	_	
96-5	37019-37021	in	_	
96-6	37022-37035	schizophrenia	_	
96-7	37036-37044	patients	_	
96-8	37045-37048	and	_	
96-9	37049-37054	their	_	
96-10	37055-37062	healthy	_	
96-11	37063-37071	siblings	_	

#Text=Schizophrenia as a transcallosal misconnection syndrome
97-1	37072-37085	Schizophrenia	_	
97-2	37086-37088	as	_	
97-3	37089-37090	a	_	
97-4	37091-37104	transcallosal	_	
97-5	37105-37118	misconnection	_	
97-6	37119-37127	syndrome	_	

#Text=Reduced interhemispheric transmission in schizophrenia patients: evidence from event-related potentials
98-1	37128-37135	Reduced	_	
98-2	37136-37152	interhemispheric	_	
98-3	37153-37165	transmission	_	
98-4	37166-37168	in	_	
98-5	37169-37182	schizophrenia	_	
98-6	37183-37191	patients	_	
98-7	37191-37192	:	_	
98-8	37193-37201	evidence	_	
98-9	37202-37206	from	_	
98-10	37207-37220	event-related	_	
98-11	37221-37231	potentials	_	

#Text=Principles of human brain organization derived from split-brain studies
99-1	37232-37242	Principles	_	
99-2	37243-37245	of	_	
99-3	37246-37251	human	_	
99-4	37252-37257	brain	_	
99-5	37258-37270	organization	_	
99-6	37271-37278	derived	_	
99-7	37279-37283	from	_	
99-8	37284-37295	split-brain	_	
99-9	37296-37303	studies	_	

#Text=Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability
100-1	37304-37316	Hypothalamic	_	
100-2	37317-37330	abnormalities	_	
100-3	37331-37333	in	_	
100-4	37334-37347	schizophrenia	_	
100-5	37347-37348	:	_	
100-6	37349-37352	sex	_	
100-7	37353-37360	effects	_	
100-8	37361-37364	and	_	
100-9	37365-37372	genetic	_	
100-10	37373-37386	vulnerability	_	

#Text=Two distinct forms of functional lateralization in the human brain
101-1	37387-37390	Two	_	
101-2	37391-37399	distinct	_	
101-3	37400-37405	forms	_	
101-4	37406-37408	of	_	
101-5	37409-37419	functional	_	
101-6	37420-37434	lateralization	_	
101-7	37435-37437	in	_	
101-8	37438-37441	the	_	
101-9	37442-37447	human	_	
101-10	37448-37453	brain	_	

#Text=Hemispheric asymmetry and homotopy of resting state functional connectivity correlate with visuospatial abilities in school-age children
102-1	37454-37465	Hemispheric	_	
102-2	37466-37475	asymmetry	_	
102-3	37476-37479	and	_	
102-4	37480-37488	homotopy	_	
102-5	37489-37491	of	_	
102-6	37492-37499	resting	_	
102-7	37500-37505	state	_	
102-8	37506-37516	functional	_	
102-9	37517-37529	connectivity	_	
102-10	37530-37539	correlate	_	
102-11	37540-37544	with	_	
102-12	37545-37557	visuospatial	_	
102-13	37558-37567	abilities	_	
102-14	37568-37570	in	_	
102-15	37571-37581	school-age	_	
102-16	37582-37590	children	_	

#Text=Brain-wide functional inter-hemispheric disconnection is a potential biomarker for schizophrenia and distinguishes it from depression
103-1	37591-37601	Brain-wide	_	
103-2	37602-37612	functional	_	
103-3	37613-37630	inter-hemispheric	_	
103-4	37631-37644	disconnection	_	
103-5	37645-37647	is	_	
103-6	37648-37649	a	_	
103-7	37650-37659	potential	_	
103-8	37660-37669	biomarker	_	
103-9	37670-37673	for	_	
103-10	37674-37687	schizophrenia	_	
103-11	37688-37691	and	_	
103-12	37692-37705	distinguishes	_	
103-13	37706-37708	it	_	
103-14	37709-37713	from	_	
103-15	37714-37724	depression	_	

#Text=Decreased resting-state interhemispheric functional connectivity in unaffected siblings of schizophrenia patients
104-1	37725-37734	Decreased	_	
104-2	37735-37748	resting-state	_	
104-3	37749-37765	interhemispheric	_	
104-4	37766-37776	functional	_	
104-5	37777-37789	connectivity	_	
104-6	37790-37792	in	_	
104-7	37793-37803	unaffected	_	
104-8	37804-37812	siblings	_	
104-9	37813-37815	of	_	
104-10	37816-37829	schizophrenia	_	
104-11	37830-37838	patients	_	

#Text=Comparison of characteristics between region-and voxel-based network analyses in resting-state fMRI data
105-1	37839-37849	Comparison	_	
105-2	37850-37852	of	_	
105-3	37853-37868	characteristics	_	
105-4	37869-37876	between	_	
105-5	37877-37887	region-and	_	
105-6	37888-37899	voxel-based	_	
105-7	37900-37907	network	_	
105-8	37908-37916	analyses	_	
105-9	37917-37919	in	_	
105-10	37920-37933	resting-state	_	
105-11	37934-37938	fMRI	_	
105-12	37939-37943	data	_	

#Text=Revisiting human hemispheric specialization with neuroimaging
106-1	37944-37954	Revisiting	_	
106-2	37955-37960	human	_	
106-3	37961-37972	hemispheric	_	
106-4	37973-37987	specialization	_	
106-5	37988-37992	with	_	
106-6	37993-38005	neuroimaging	_	

#Text=Decreased interhemispheric coordination in schizophrenia: a resting state fMRI study
107-1	38006-38015	Decreased	_	
107-2	38016-38032	interhemispheric	_	
107-3	38033-38045	coordination	_	
107-4	38046-38048	in	_	
107-5	38049-38062	schizophrenia	_	
107-6	38062-38063	:	_	
107-7	38064-38065	a	_	
107-8	38066-38073	resting	_	
107-9	38074-38079	state	_	
107-10	38080-38084	fMRI	_	
107-11	38085-38090	study	_	

#Text=Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity
108-1	38091-38096	Focal	_	
108-2	38097-38102	white	_	
108-3	38103-38109	matter	_	
108-4	38110-38117	density	_	
108-5	38118-38125	changes	_	
108-6	38126-38128	in	_	
108-7	38129-38142	schizophrenia	_	
108-8	38142-38143	:	_	
108-9	38144-38151	reduced	_	
108-10	38152-38169	inter-hemispheric	_	
108-11	38170-38182	connectivity	_	

#Text=Schizophrenia, neurodevelopment and corpus callosum
109-1	38183-38196	Schizophrenia	_	
109-2	38196-38197	,	_	
109-3	38198-38214	neurodevelopment	_	
109-4	38215-38218	and	_	
109-5	38219-38225	corpus	_	
109-6	38226-38234	callosum	_	

#Text=Brain hemispheric structural efficiency and interconnectivity rightward asymmetry in human and nonhuman primates
110-1	38235-38240	Brain	_	
110-2	38241-38252	hemispheric	_	
110-3	38253-38263	structural	_	
110-4	38264-38274	efficiency	_	
110-5	38275-38278	and	_	
110-6	38279-38296	interconnectivity	_	
110-7	38297-38306	rightward	_	
110-8	38307-38316	asymmetry	_	
110-9	38317-38319	in	_	
110-10	38320-38325	human	_	
110-11	38326-38329	and	_	
110-12	38330-38338	nonhuman	_	
110-13	38339-38347	primates	_	

#Text=AICHA: an atlas of intrinsic connectivity of homotopic areas
111-1	38348-38353	AICHA	_	
111-2	38353-38354	:	_	
111-3	38355-38357	an	_	
111-4	38358-38363	atlas	_	
111-5	38364-38366	of	_	
111-6	38367-38376	intrinsic	_	
111-7	38377-38389	connectivity	_	
111-8	38390-38392	of	_	
111-9	38393-38402	homotopic	_	
111-10	38403-38408	areas	_	

#Text=The positive and negative Syndrome Scale (PANSS) for Schizophrenia
112-1	38409-38412	The	_	
112-2	38413-38421	positive	_	
112-3	38422-38425	and	_	
112-4	38426-38434	negative	_	
112-5	38435-38443	Syndrome	_	
112-6	38444-38449	Scale	_	
112-7	38450-38451	(	_	
112-8	38451-38456	PANSS	_	
112-9	38456-38457	)	_	
112-10	38458-38461	for	_	
112-11	38462-38475	Schizophrenia	_	

#Text=Bilateral functional asymmetry disparity in positive and negative schizophrenia revealed by resting-state fMRI
113-1	38476-38485	Bilateral	_	
113-2	38486-38496	functional	_	
113-3	38497-38506	asymmetry	_	
113-4	38507-38516	disparity	_	
113-5	38517-38519	in	_	
113-6	38520-38528	positive	_	
113-7	38529-38532	and	_	
113-8	38533-38541	negative	_	
113-9	38542-38555	schizophrenia	_	
113-10	38556-38564	revealed	_	
113-11	38565-38567	by	_	
113-12	38568-38581	resting-state	_	
113-13	38582-38586	fMRI	_	

#Text=Interhemispheric hypoconnectivity in schizophrenia: fiber integrity and volume differences of the corpus callosum in patients and unaffected relatives
114-1	38587-38603	Interhemispheric	_	
114-2	38604-38620	hypoconnectivity	_	
114-3	38621-38623	in	_	
114-4	38624-38637	schizophrenia	_	
114-5	38637-38638	:	_	
114-6	38639-38644	fiber	_	
114-7	38645-38654	integrity	_	
114-8	38655-38658	and	_	
114-9	38659-38665	volume	_	
114-10	38666-38677	differences	_	
114-11	38678-38680	of	_	
114-12	38681-38684	the	_	
114-13	38685-38691	corpus	_	
114-14	38692-38700	callosum	_	
114-15	38701-38703	in	_	
114-16	38704-38712	patients	_	
114-17	38713-38716	and	_	
114-18	38717-38727	unaffected	_	
114-19	38728-38737	relatives	_	

#Text=Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: Objectives, sample characteristics, recruitment and assessment methods
115-1	38738-38745	Genetic	_	
115-2	38746-38750	Risk	_	
115-3	38751-38754	and	_	
115-4	38755-38762	Outcome	_	
115-5	38763-38765	of	_	
115-6	38766-38775	Psychosis	_	
115-7	38776-38777	(	_	
115-8	38777-38782	GROUP	_	
115-9	38782-38783	)	_	
115-10	38783-38784	,	_	
115-11	38785-38786	a	_	
115-12	38787-38792	multi	_	
115-13	38793-38797	site	_	
115-14	38798-38810	longitudinal	_	
115-15	38811-38817	cohort	_	
115-16	38818-38823	study	_	
115-17	38824-38831	focused	_	
115-18	38832-38834	on	_	
115-19	38835-38851	gene-environment	_	
115-20	38852-38863	interaction	_	
115-21	38863-38864	:	_	
115-22	38865-38875	Objectives	_	
115-23	38875-38876	,	_	
115-24	38877-38883	sample	_	
115-25	38884-38899	characteristics	_	
115-26	38899-38900	,	_	
115-27	38901-38912	recruitment	_	
115-28	38913-38916	and	_	
115-29	38917-38927	assessment	_	
115-30	38928-38935	methods	_	

#Text=Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study
116-1	38936-38945	Treatment	_	
116-2	38946-38948	of	_	
116-3	38949-38962	schizophrenia	_	
116-4	38963-38967	with	_	
116-5	38968-38982	antipsychotics	_	
116-6	38983-38985	in	_	
116-7	38986-38995	Norwegian	_	
116-8	38996-39005	emergency	_	
116-9	39006-39011	wards	_	
116-10	39011-39012	,	_	
116-11	39013-39014	a	_	
116-12	39015-39030	cross-sectional	_	
116-13	39031-39039	national	_	
116-14	39040-39045	study	_	

#Text=Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study
117-1	39046-39054	Uncinate	_	
117-2	39055-39065	fasciculus	_	
117-3	39066-39074	findings	_	
117-4	39075-39077	in	_	
117-5	39078-39091	schizophrenia	_	
117-6	39091-39092	:	_	
117-7	39093-39094	a	_	
117-8	39095-39103	magnetic	_	
117-9	39104-39113	resonance	_	
117-10	39114-39123	diffusion	_	
117-11	39124-39130	tensor	_	
117-12	39131-39138	imaging	_	
117-13	39139-39144	study	_	

#Text=Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum
118-1	39145-39152	Reduced	_	
118-2	39153-39169	interhemispheric	_	
118-3	39170-39182	connectivity	_	
118-4	39183-39185	in	_	
118-5	39186-39212	schizophrenia-tractography	_	
118-6	39213-39218	based	_	
118-7	39219-39231	segmentation	_	
118-8	39232-39234	of	_	
118-9	39235-39238	the	_	
118-10	39239-39245	corpus	_	
118-11	39246-39254	callosum	_	

#Text=Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography
119-1	39255-39263	Striatal	_	
119-2	39264-39272	dopamine	_	
119-3	39273-39284	transporter	_	
119-4	39285-39292	binding	_	
119-5	39293-39295	in	_	
119-6	39296-39313	neuroleptic-naive	_	
119-7	39314-39322	patients	_	
119-8	39323-39327	with	_	
119-9	39328-39341	schizophrenia	_	
119-10	39342-39349	studied	_	
119-11	39350-39354	with	_	
119-12	39355-39363	positron	_	
119-13	39364-39372	emission	_	
119-14	39373-39383	tomography	_	

#Text=Homotopic connectivity in drug-naïve, first-episode, early-onset schizophrenia
120-1	39384-39393	Homotopic	_	
120-2	39394-39406	connectivity	_	
120-3	39407-39409	in	_	
120-4	39410-39420	drug-naïve	_	
120-5	39420-39421	,	_	
120-6	39422-39435	first-episode	_	
120-7	39435-39436	,	_	
120-8	39437-39448	early-onset	_	
120-9	39449-39462	schizophrenia	_	

#Text=A. Functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO)
121-1	39463-39464	A	_	
121-2	39464-39465	.	_	
121-3	39466-39476	Functional	_	
121-4	39477-39480	MRI	_	
121-5	39481-39490	technique	_	
121-6	39491-39500	combining	_	
121-7	39501-39511	principles	_	
121-8	39512-39514	of	_	
121-9	39515-39528	echo-shifting	_	
121-10	39529-39533	with	_	
121-11	39534-39535	a	_	
121-12	39536-39541	train	_	
121-13	39542-39544	of	_	
121-14	39545-39557	observations	_	
121-15	39558-39559	(	_	
121-16	39559-39565	PRESTO	_	
121-17	39565-39566	)	_	

#Text=Evidence from intrinsic activity that asymmetry of the human brain is controlled by multiple factors
122-1	39567-39575	Evidence	_	
122-2	39576-39580	from	_	
122-3	39581-39590	intrinsic	_	
122-4	39591-39599	activity	_	
122-5	39600-39604	that	_	
122-6	39605-39614	asymmetry	_	
122-7	39615-39617	of	_	
122-8	39618-39621	the	_	
122-9	39622-39627	human	_	
122-10	39628-39633	brain	_	
122-11	39634-39636	is	_	
122-12	39637-39647	controlled	_	
122-13	39648-39650	by	_	
122-14	39651-39659	multiple	_	
122-15	39660-39667	factors	_	

#Text=Decreased resting-state interhemispheric functional connectivity correlated with neurocognitive deficits in drug-naive first-episode adolescent-onset schizophrenia
123-1	39668-39677	Decreased	_	
123-2	39678-39691	resting-state	_	
123-3	39692-39708	interhemispheric	_	
123-4	39709-39719	functional	_	
123-5	39720-39732	connectivity	_	
123-6	39733-39743	correlated	_	
123-7	39744-39748	with	_	
123-8	39749-39763	neurocognitive	_	
123-9	39764-39772	deficits	_	
123-10	39773-39775	in	_	
123-11	39776-39786	drug-naive	_	
123-12	39787-39800	first-episode	_	
123-13	39801-39817	adolescent-onset	_	
123-14	39818-39831	schizophrenia	_	

#Text=Impaired hemispheric communication in schizophrenia: a study using the consonant–vowel–consonant task
124-1	39832-39840	Impaired	_	
124-2	39841-39852	hemispheric	_	
124-3	39853-39866	communication	_	
124-4	39867-39869	in	_	
124-5	39870-39883	schizophrenia	_	
124-6	39883-39884	:	_	
124-7	39885-39886	a	_	
124-8	39887-39892	study	_	
124-9	39893-39898	using	_	
124-10	39899-39902	the	_	
124-11	39903-39928	consonant–vowel–consonant	_	
124-12	39929-39933	task	_	

#Text=Imaging genetic liability to schizophrenia: systematic review of fMRI studies of patients' nonpsychotic relatives
125-1	39934-39941	Imaging	_	
125-2	39942-39949	genetic	_	
125-3	39950-39959	liability	_	
125-4	39960-39962	to	_	
125-5	39963-39976	schizophrenia	_	
125-6	39976-39977	:	_	
125-7	39978-39988	systematic	_	
125-8	39989-39995	review	_	
125-9	39996-39998	of	_	
125-10	39999-40003	fMRI	_	
125-11	40004-40011	studies	_	
125-12	40012-40014	of	_	
125-13	40015-40023	patients	_	
125-14	40023-40024	'	_	
125-15	40025-40037	nonpsychotic	_	
125-16	40038-40047	relatives	_	

#Text=Decreased volume of left and total anterior insular lobule in schizophrenia
126-1	40048-40057	Decreased	_	
126-2	40058-40064	volume	_	
126-3	40065-40067	of	_	
126-4	40068-40072	left	_	
126-5	40073-40076	and	_	
126-6	40077-40082	total	_	
126-7	40083-40091	anterior	_	
126-8	40092-40099	insular	_	
126-9	40100-40106	lobule	_	
126-10	40107-40109	in	_	
126-11	40110-40123	schizophrenia	_	

#Text=From sensation to cognition
127-1	40125-40129	From	_	
127-2	40130-40139	sensation	_	
127-3	40140-40142	to	_	
127-4	40143-40152	cognition	_	

#Text=Abnormal asymmetry of white matter integrity in schizophrenia revealed by voxelwise diffusion tensor imaging
128-1	40153-40161	Abnormal	_	
128-2	40162-40171	asymmetry	_	
128-3	40172-40174	of	_	
128-4	40175-40180	white	_	
128-5	40181-40187	matter	_	
128-6	40188-40197	integrity	_	
128-7	40198-40200	in	_	
128-8	40201-40214	schizophrenia	_	
128-9	40215-40223	revealed	_	
128-10	40224-40226	by	_	
128-11	40227-40236	voxelwise	_	
128-12	40237-40246	diffusion	_	
128-13	40247-40253	tensor	_	
128-14	40254-40261	imaging	_	

#Text=Interhemispheric cooperation during word processing: evidence for callosal transfer dysfunction in schizophrenic patients
129-1	40262-40278	Interhemispheric	_	
129-2	40279-40290	cooperation	_	
129-3	40291-40297	during	_	
129-4	40298-40302	word	_	
129-5	40303-40313	processing	_	
129-6	40313-40314	:	_	
129-7	40315-40323	evidence	_	
129-8	40324-40327	for	_	
129-9	40328-40336	callosal	_	
129-10	40337-40345	transfer	_	
129-11	40346-40357	dysfunction	_	
129-12	40358-40360	in	_	
129-13	40361-40374	schizophrenic	_	
129-14	40375-40383	patients	_	

#Text=Hemispheric cooperation-a crucial factor in schizophrenia? Neurophysiological evidence
130-1	40384-40395	Hemispheric	_	
130-2	40396-40409	cooperation-a	_	
130-3	40410-40417	crucial	_	
130-4	40418-40424	factor	_	
130-5	40425-40427	in	_	
130-6	40428-40441	schizophrenia	_	
130-7	40441-40442	?	_	
130-8	40443-40461	Neurophysiological	_	
130-9	40462-40470	evidence	_	

#Text=A family affair: brain abnormalities in siblings of patients with schizophrenia
131-1	40471-40472	A	_	
131-2	40473-40479	family	_	
131-3	40480-40486	affair	_	
131-4	40486-40487	:	_	
131-5	40488-40493	brain	_	
131-6	40494-40507	abnormalities	_	
131-7	40508-40510	in	_	
131-8	40511-40519	siblings	_	
131-9	40520-40522	of	_	
131-10	40523-40531	patients	_	
131-11	40532-40536	with	_	
131-12	40537-40550	schizophrenia	_	

#Text=Abnormalities in hemispheric specialization of caudate nucleus connectivity in schizophrenia
132-1	40551-40564	Abnormalities	_	
132-2	40565-40567	in	_	
132-3	40568-40579	hemispheric	_	
132-4	40580-40594	specialization	_	
132-5	40595-40597	of	_	
132-6	40598-40605	caudate	_	
132-7	40606-40613	nucleus	_	
132-8	40614-40626	connectivity	_	
132-9	40627-40629	in	_	
132-10	40630-40643	schizophrenia	_	

#Text=Auditory hallucinations and reduced language lateralization in schizophrenia: a meta-analysis of dichotic listening studies
133-1	40644-40652	Auditory	_	
133-2	40653-40667	hallucinations	_	
133-3	40668-40671	and	_	
133-4	40672-40679	reduced	_	
133-5	40680-40688	language	_	
133-6	40689-40703	lateralization	_	
133-7	40704-40706	in	_	
133-8	40707-40720	schizophrenia	_	
133-9	40720-40721	:	_	
133-10	40722-40723	a	_	
133-11	40724-40737	meta-analysis	_	
133-12	40738-40740	of	_	
133-13	40741-40749	dichotic	_	
133-14	40750-40759	listening	_	
133-15	40760-40767	studies	_	

#Text=Reduced laterality as a trait marker of schizophrenia--evidence from structural and functional neuroimaging
134-1	40768-40775	Reduced	_	
134-2	40776-40786	laterality	_	
134-3	40787-40789	as	_	
134-4	40790-40791	a	_	
134-5	40792-40797	trait	_	
134-6	40798-40804	marker	_	
134-7	40805-40807	of	_	
134-8	40808-40821	schizophrenia	_	
134-9	40821-40822	-	_	
134-10	40822-40823	-	_	
134-11	40823-40831	evidence	_	
134-12	40832-40836	from	_	
134-13	40837-40847	structural	_	
134-14	40848-40851	and	_	
134-15	40852-40862	functional	_	
134-16	40863-40875	neuroimaging	_	

#Text=Cerebral asymmetry in schizophrenia
135-1	40876-40884	Cerebral	_	
135-2	40885-40894	asymmetry	_	
135-3	40895-40897	in	_	
135-4	40898-40911	schizophrenia	_	

#Text=Reduced functional connectivity and asymmetry of the planum temporale in patients with schizophrenia and first-degree relatives
136-1	40912-40919	Reduced	_	
136-2	40920-40930	functional	_	
136-3	40931-40943	connectivity	_	
136-4	40944-40947	and	_	
136-5	40948-40957	asymmetry	_	
136-6	40958-40960	of	_	
136-7	40961-40964	the	_	
136-8	40965-40971	planum	_	
136-9	40972-40981	temporale	_	
136-10	40982-40984	in	_	
136-11	40985-40993	patients	_	
136-12	40994-40998	with	_	
136-13	40999-41012	schizophrenia	_	
136-14	41013-41016	and	_	
136-15	41017-41029	first-degree	_	
136-16	41030-41039	relatives	_	

#Text=Association between symptoms of psychosis and reduced functional connectivity of auditory cortex
137-1	41040-41051	Association	_	
137-2	41052-41059	between	_	
137-3	41060-41068	symptoms	_	
137-4	41069-41071	of	_	
137-5	41072-41081	psychosis	_	
137-6	41082-41085	and	_	
137-7	41086-41093	reduced	_	
137-8	41094-41104	functional	_	
137-9	41105-41117	connectivity	_	
137-10	41118-41120	of	_	
137-11	41121-41129	auditory	_	
137-12	41130-41136	cortex	_	

#Text=Neuroimaging findings from childhood onset schizophrenia patients and their non-psychotic siblings
138-1	41137-41149	Neuroimaging	_	
138-2	41150-41158	findings	_	
138-3	41159-41163	from	_	
138-4	41164-41173	childhood	_	
138-5	41174-41179	onset	_	
138-6	41180-41193	schizophrenia	_	
138-7	41194-41202	patients	_	
138-8	41203-41206	and	_	
138-9	41207-41212	their	_	
138-10	41213-41226	non-psychotic	_	
138-11	41227-41235	siblings	_	

#Text=A meta-analysis of diffusion tensor imaging studies of the corpus callosum in schizophrenia
139-1	41236-41237	A	_	
139-2	41238-41251	meta-analysis	_	
139-3	41252-41254	of	_	
139-4	41255-41264	diffusion	_	
139-5	41265-41271	tensor	_	
139-6	41272-41279	imaging	_	
139-7	41280-41287	studies	_	
139-8	41288-41290	of	_	
139-9	41291-41294	the	_	
139-10	41295-41301	corpus	_	
139-11	41302-41310	callosum	_	
139-12	41311-41313	in	_	
139-13	41314-41327	schizophrenia	_	

#Text=Schizophrenia: a disease of heteromodal association cortex?
140-1	41328-41341	Schizophrenia	_	
140-2	41341-41342	:	_	
140-3	41343-41344	a	_	
140-4	41345-41352	disease	_	
140-5	41353-41355	of	_	
140-6	41356-41367	heteromodal	_	
140-7	41368-41379	association	_	
140-8	41380-41386	cortex	_	
140-9	41386-41387	?	_	

#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
141-1	41388-41396	Spurious	_	
141-2	41397-41400	but	_	
141-3	41401-41411	systematic	_	
141-4	41412-41424	correlations	_	
141-5	41425-41427	in	_	
141-6	41428-41438	functional	_	
141-7	41439-41451	connectivity	_	
141-8	41452-41455	MRI	_	
141-9	41456-41464	networks	_	
141-10	41465-41470	arise	_	
141-11	41471-41475	from	_	
141-12	41476-41483	subject	_	
141-13	41484-41490	motion	_	

#Text=Brain Network Connectivity in individuals with Schizophrenia and their Siblings
142-1	41491-41496	Brain	_	
142-2	41497-41504	Network	_	
142-3	41505-41517	Connectivity	_	
142-4	41518-41520	in	_	
142-5	41521-41532	individuals	_	
142-6	41533-41537	with	_	
142-7	41538-41551	Schizophrenia	_	
142-8	41552-41555	and	_	
142-9	41556-41561	their	_	
142-10	41562-41570	Siblings	_	

#Text=Abnormal brain lateralization and connectivity in Schizophrenia
143-1	41571-41579	Abnormal	_	
143-2	41580-41585	brain	_	
143-3	41586-41600	lateralization	_	
143-4	41601-41604	and	_	
143-5	41605-41617	connectivity	_	
143-6	41618-41620	in	_	
143-7	41621-41634	Schizophrenia	_	

#Text=Abnormal asymmetry of brain connectivity in schizophrenia
144-1	41635-41643	Abnormal	_	
144-2	41644-41653	asymmetry	_	
144-3	41654-41656	of	_	
144-4	41657-41662	brain	_	
144-5	41663-41675	connectivity	_	
144-6	41676-41678	in	_	
144-7	41679-41692	schizophrenia	_	

#Text=Resting-state functional network correlates of psychotic symptoms in schizophrenia
145-1	41693-41706	Resting-state	_	
145-2	41707-41717	functional	_	
145-3	41718-41725	network	_	
145-4	41726-41736	correlates	_	
145-5	41737-41739	of	_	
145-6	41740-41749	psychotic	_	
145-7	41750-41758	symptoms	_	
145-8	41759-41761	in	_	
145-9	41762-41775	schizophrenia	_	

#Text=An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data
146-1	41776-41778	An	_	
146-2	41779-41787	improved	_	
146-3	41788-41797	framework	_	
146-4	41798-41801	for	_	
146-5	41802-41810	confound	_	
146-6	41811-41821	regression	_	
146-7	41822-41825	and	_	
146-8	41826-41835	filtering	_	
146-9	41836-41839	for	_	
146-10	41840-41847	control	_	
146-11	41848-41850	of	_	
146-12	41851-41857	motion	_	
146-13	41858-41866	artifact	_	
146-14	41867-41869	in	_	
146-15	41870-41873	the	_	
146-16	41874-41887	preprocessing	_	
146-17	41888-41890	of	_	
146-18	41891-41904	resting-state	_	
146-19	41905-41915	functional	_	
146-20	41916-41928	connectivity	_	
146-21	41929-41933	data	_	

#Text=Dynamics of hemispheric specialization and integration in the context of motor control
147-1	41934-41942	Dynamics	_	
147-2	41943-41945	of	_	
147-3	41946-41957	hemispheric	_	
147-4	41958-41972	specialization	_	
147-5	41973-41976	and	_	
147-6	41977-41988	integration	_	
147-7	41989-41991	in	_	
147-8	41992-41995	the	_	
147-9	41996-42003	context	_	
147-10	42004-42006	of	_	
147-11	42007-42012	motor	_	
147-12	42013-42020	control	_	

#Text=Handedness, language lateralisation and anatomical asymmetry in schizophrenia
148-1	42021-42031	Handedness	_	
148-2	42031-42032	,	_	
148-3	42033-42041	language	_	
148-4	42042-42056	lateralisation	_	
148-5	42057-42060	and	_	
148-6	42061-42071	anatomical	_	
148-7	42072-42081	asymmetry	_	
148-8	42082-42084	in	_	
148-9	42085-42098	schizophrenia	_	

#Text=Language lateralization in monozygotic twins discordant and concordant for schizophrenia. A functional MRI pilot study
149-1	42099-42107	Language	_	
149-2	42108-42122	lateralization	_	
149-3	42123-42125	in	_	
149-4	42126-42137	monozygotic	_	
149-5	42138-42143	twins	_	
149-6	42144-42154	discordant	_	
149-7	42155-42158	and	_	
149-8	42159-42169	concordant	_	
149-9	42170-42173	for	_	
149-10	42174-42187	schizophrenia	_	
149-11	42187-42188	.	_	
149-12	42189-42190	A	_	
149-13	42191-42201	functional	_	
149-14	42202-42205	MRI	_	
149-15	42206-42211	pilot	_	
149-16	42212-42217	study	_	

#Text=Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison
150-1	42218-42226	Cortical	_	
150-2	42227-42236	thickness	_	
150-3	42237-42239	in	_	
150-4	42240-42253	first-episode	_	
150-5	42254-42267	schizophrenia	_	
150-6	42268-42276	patients	_	
150-7	42277-42280	and	_	
150-8	42281-42292	individuals	_	
150-9	42293-42295	at	_	
150-10	42296-42300	high	_	
150-11	42301-42309	familial	_	
150-12	42310-42314	risk	_	
150-13	42314-42315	:	_	
150-14	42316-42317	a	_	
150-15	42318-42333	cross-sectional	_	
150-16	42334-42344	comparison	_	

#Text=Regional variation in interhemispheric coordination of intrinsic hemodynamic fluctuations
151-1	42345-42353	Regional	_	
151-2	42354-42363	variation	_	
151-3	42364-42366	in	_	
151-4	42367-42383	interhemispheric	_	
151-5	42384-42396	coordination	_	
151-6	42397-42399	of	_	
151-7	42400-42409	intrinsic	_	
151-8	42410-42421	hemodynamic	_	
151-9	42422-42434	fluctuations	_	

#Text=Mechanisms of hemispheric specialization: insights from analyses of connectivity
152-1	42435-42445	Mechanisms	_	
152-2	42446-42448	of	_	
152-3	42449-42460	hemispheric	_	
152-4	42461-42475	specialization	_	
152-5	42475-42476	:	_	
152-6	42477-42485	insights	_	
152-7	42486-42490	from	_	
152-8	42491-42499	analyses	_	
152-9	42500-42502	of	_	
152-10	42503-42515	connectivity	_	

#Text=Lateralization of auditory-cortex functions
153-1	42516-42530	Lateralization	_	
153-2	42531-42533	of	_	
153-3	42534-42549	auditory-cortex	_	
153-4	42550-42559	functions	_	

#Text=Mapping brain asymmetry
154-1	42560-42567	Mapping	_	
154-2	42568-42573	brain	_	
154-3	42574-42583	asymmetry	_	

#Text=Abnormal rich club organization and functional brain dynamics in schizophrenia
155-1	42584-42592	Abnormal	_	
155-2	42593-42597	rich	_	
155-3	42598-42602	club	_	
155-4	42603-42615	organization	_	
155-5	42616-42619	and	_	
155-6	42620-42630	functional	_	
155-7	42631-42636	brain	_	
155-8	42637-42645	dynamics	_	
155-9	42646-42648	in	_	
155-10	42649-42662	schizophrenia	_	

#Text=Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age
156-1	42663-42672	Asymmetry	_	
156-2	42673-42675	in	_	
156-3	42676-42684	dopamine	_	
156-4	42685-42687	D2	_	
156-5	42687-42688	/	_	
156-6	42688-42689	3	_	
156-7	42690-42699	receptors	_	
156-8	42700-42702	of	_	
156-9	42703-42710	caudate	_	
156-10	42711-42718	nucleus	_	
156-11	42719-42721	is	_	
156-12	42722-42726	lost	_	
156-13	42727-42731	with	_	
156-14	42732-42735	age	_	

#Text=Functional specialization in the human brain estimated by intrinsic hemispheric interaction
157-1	42736-42746	Functional	_	
157-2	42747-42761	specialization	_	
157-3	42762-42764	in	_	
157-4	42765-42768	the	_	
157-5	42769-42774	human	_	
157-6	42775-42780	brain	_	
157-7	42781-42790	estimated	_	
157-8	42791-42793	by	_	
157-9	42794-42803	intrinsic	_	
157-10	42804-42815	hemispheric	_	
157-11	42816-42827	interaction	_	

#Text=Modulation of interhemispheric functional coordination in electroconvulsive therapy for depression
158-1	42828-42838	Modulation	_	
158-2	42839-42841	of	_	
158-3	42842-42858	interhemispheric	_	
158-4	42859-42869	functional	_	
158-5	42870-42882	coordination	_	
158-6	42883-42885	in	_	
158-7	42886-42903	electroconvulsive	_	
158-8	42904-42911	therapy	_	
158-9	42912-42915	for	_	
158-10	42916-42926	depression	_	

#Text=Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia
159-1	42927-42940	Hyperactivity	_	
159-2	42941-42944	and	_	
159-3	42945-42962	hyperconnectivity	_	
159-4	42963-42965	of	_	
159-5	42966-42969	the	_	
159-6	42970-42977	default	_	
159-7	42978-42985	network	_	
159-8	42986-42988	in	_	
159-9	42989-43002	schizophrenia	_	
159-10	43003-43006	and	_	
159-11	43007-43009	in	_	
159-12	43010-43022	first-degree	_	
159-13	43023-43032	relatives	_	
159-14	43033-43035	of	_	
159-15	43036-43043	persons	_	
159-16	43044-43048	with	_	
159-17	43049-43062	schizophrenia	_	

#Text=Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia
160-1	43063-43071	Abnormal	_	
160-2	43072-43082	prefrontal	_	
160-3	43083-43091	cortical	_	
160-4	43092-43100	activity	_	
160-5	43101-43104	and	_	
160-6	43105-43117	connectivity	_	
160-7	43118-43124	during	_	
160-8	43125-43133	response	_	
160-9	43134-43143	selection	_	
160-10	43144-43146	in	_	
160-11	43147-43152	first	_	
160-12	43153-43160	episode	_	
160-13	43161-43170	psychosis	_	
160-14	43170-43171	,	_	
160-15	43172-43179	chronic	_	
160-16	43180-43193	schizophrenia	_	
160-17	43193-43194	,	_	
160-18	43195-43198	and	_	
160-19	43199-43209	unaffected	_	
160-20	43210-43218	siblings	_	
160-21	43219-43221	of	_	
160-22	43222-43233	individuals	_	
160-23	43234-43238	with	_	
160-24	43239-43252	schizophrenia	_	

#Text=A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics
161-1	43253-43254	A	_	
161-2	43255-43268	comprehensive	_	
161-3	43269-43279	assessment	_	
161-4	43280-43282	of	_	
161-5	43283-43291	regional	_	
161-6	43292-43301	variation	_	
161-7	43302-43304	in	_	
161-8	43305-43308	the	_	
161-9	43309-43315	impact	_	
161-10	43316-43318	of	_	
161-11	43319-43323	head	_	
161-12	43324-43338	micromovements	_	
161-13	43339-43341	on	_	
161-14	43342-43352	functional	_	
161-15	43353-43365	connectomics	_	

#Text=DPABI: Data processing & analysis for (resting-state) brain imaging
162-1	43366-43371	DPABI	_	
162-2	43371-43372	:	_	
162-3	43373-43377	Data	_	
162-4	43378-43388	processing	_	
162-5	43389-43390	&	_	
162-6	43391-43399	analysis	_	
162-7	43400-43403	for	_	
162-8	43404-43405	(	_	
162-9	43405-43418	resting-state	_	
162-10	43418-43419	)	_	
162-11	43420-43425	brain	_	
162-12	43426-43433	imaging	_	

#Text=Disrupted axonal fiber connectivity in schizophrenia
163-1	43434-43443	Disrupted	_	
163-2	43444-43450	axonal	_	
163-3	43451-43456	fiber	_	
163-4	43457-43469	connectivity	_	
163-5	43470-43472	in	_	
163-6	43473-43486	schizophrenia	_	

#Text=Delayed development of brain connectivity in adolescents with schizophrenia and their unaffected siblings
164-1	43487-43494	Delayed	_	
164-2	43495-43506	development	_	
164-3	43507-43509	of	_	
164-4	43510-43515	brain	_	
164-5	43516-43528	connectivity	_	
164-6	43529-43531	in	_	
164-7	43532-43543	adolescents	_	
164-8	43544-43548	with	_	
164-9	43549-43562	schizophrenia	_	
164-10	43563-43566	and	_	
164-11	43567-43572	their	_	
164-12	43573-43583	unaffected	_	
164-13	43584-43592	siblings	_	

#Text=Developmental changes in topological asymmetry between hemispheric brain white matter networks from adolescence to young adulthood
165-1	43593-43606	Developmental	_	
165-2	43607-43614	changes	_	
165-3	43615-43617	in	_	
165-4	43618-43629	topological	_	
165-5	43630-43639	asymmetry	_	
165-6	43640-43647	between	_	
165-7	43648-43659	hemispheric	_	
165-8	43660-43665	brain	_	
165-9	43666-43671	white	_	
165-10	43672-43678	matter	_	
165-11	43679-43687	networks	_	
165-12	43688-43692	from	_	
165-13	43693-43704	adolescence	_	
165-14	43705-43707	to	_	
165-15	43708-43713	young	_	
165-16	43714-43723	adulthood	_	

#Text=Functional homotopic changes in multiple sclerosis with resting-state functional MR imaging
166-1	43724-43734	Functional	_	
166-2	43735-43744	homotopic	_	
166-3	43745-43752	changes	_	
166-4	43753-43755	in	_	
166-5	43756-43764	multiple	_	
166-6	43765-43774	sclerosis	_	
166-7	43775-43779	with	_	
166-8	43780-43793	resting-state	_	
166-9	43794-43804	functional	_	
166-10	43805-43807	MR	_	
166-11	43808-43815	imaging	_	

#Text=Growing together and growing apart: regional and sex differences in the lifespan developmental trajectories of functional homotopy
167-1	43816-43823	Growing	_	
167-2	43824-43832	together	_	
167-3	43833-43836	and	_	
167-4	43837-43844	growing	_	
167-5	43845-43850	apart	_	
167-6	43850-43851	:	_	
167-7	43852-43860	regional	_	
167-8	43861-43864	and	_	
167-9	43865-43868	sex	_	
167-10	43869-43880	differences	_	
167-11	43881-43883	in	_	
167-12	43884-43887	the	_	
167-13	43888-43896	lifespan	_	
167-14	43897-43910	developmental	_	
167-15	43911-43923	trajectories	_	
167-16	43924-43926	of	_	
167-17	43927-43937	functional	_	
167-18	43938-43946	homotopy	_	
